| ATC kode | |
| QA | Fordøjelse og metabolisme |
| QA01 | Stomatologiske præparater |
| QA01A | Stomatologiske præparater |
| QA01AA | Midler til caries-profylakse |
| QA01AA01 | Natriumfluorid |
| QA01AA02 | Natriummonofluorphosphat |
| QA01AA03 | Olaflur |
| QA01AA04 | Stannofluorid |
| QA01AA30 | Kombinationer |
| QA01AA51 | Stannofluorid, komb. |
| QA01AB | Antiinfektiva til lokal oral brug |
| QA01AB02 | Hydrogenperoxid |
| QA01AB03 | Chlorhexidin |
| QA01AB04 | Amphotericin |
| QA01AB05 | Polynoxylin |
| QA01AB06 | Domiphen |
| QA01AB07 | Oxyquinolin |
| QA01AB08 | Neomycin |
| QA01AB09 | Miconazol |
| QA01AB10 | Natamycin |
| QA01AB11 | Diverse |
| QA01AB12 | Hexetidin |
| QA01AB13 | Tetracyclin |
| QA01AB14 | Benzoxoniumchlorid |
| QA01AB15 | Tibezoniumiodid |
| QA01AB16 | Mepartricin |
| QA01AB17 | Metronidazol |
| QA01AB18 | Clotrimazol |
| QA01AB19 | Natriumperborat |
| QA01AB20 | Antiinfektiva til lokal og oral brug, komb. |
| QA01AB21 | Chlortetracyclin |
| QA01AB22 | Doxycyclin |
| QA01AB23 | Minocyclin |
| QA01AB24 | Octenidin |
| QA01AB25 | Oxytetracyclin |
| QA01AB53 | Chlorhexidin og cetylpyridinium |
| QA01AC | Kortikosteroider til lokal oral brug |
| QA01AC01 | Triamcinolon |
| QA01AC02 | Dexamethason |
| QA01AC03 | Hydrocortison |
| QA01AC04 | Prednisolon |
| QA01AC54 | Prednisolon, komb. |
| QA01AD | Andre midler til lokal oral brug |
| QA01AD01 | Adrenalin |
| QA01AD02 | Benzydamin |
| QA01AD05 | Acetylsalicylsyre |
| QA01AD06 | Adrenalon |
| QA01AD07 | Amlexanox |
| QA01AD08 | Becaplermin |
| QA01AD11 | Diverse midler til lokal oral brug |
| QA02 | Midler mod syrerelaterede forstyrrelser |
| QA02A | Antacida |
| QA02AA | Magnesiumforbindelser |
| QA02AA01 | Magnesiumcarbonat |
| QA02AA02 | Magnesiumoxid |
| QA02AA03 | Magnesiumperoxid |
| QA02AA04 | Magnesiumhydroxid |
| QA02AA05 | Magnesiumsilicat |
| QA02AA10 | Kombinationer af magnesiumforbindelser |
| QA02AB | Aluminiumforbindelser |
| QA02AB01 | Aluminiumoxid |
| QA02AB02 | Algeldrat (aluminiumhydroxid) |
| QA02AB03 | Aluminiumphosphat |
| QA02AB04 | Dihydroxyaluminiumnatriumcarbonat |
| QA02AB05 | Aluminiumacetoacetat |
| QA02AB06 | Aloglutamol |
| QA02AB07 | Aluminiumglycinat |
| QA02AB10 | Kombinationer af aluminiumforbindelser |
| QA02AC | Calciumforbindelser |
| QA02AC01 | Calciumcarbonat |
| QA02AC02 | Calciumsilicat |
| QA02AC10 | Kombinationer af calciumforbindelser |
| QA02AD | Komb. og komplex. af al-, ca- og mg-forbindelser |
| QA02AD01 | Almindelige salt-kombinationer |
| QA02AD02 | Magaldrat |
| QA02AD03 | Almagat |
| QA02AD04 | Hydrotalcit |
| QA02AD05 | Almasilat |
| QA02AF | Antacida indeh. midler mod meteorisme |
| QA02AF01 | Magaldrat og midl. mod meteorisme |
| QA02AF02 | Alm. saltblandinger og midl. mod meteorisme |
| QA02AG | Antacida indeh. antispasmodika |
| QA02AH | Antacida indeh. natriumhydrogencarbonat |
| QA02AX | Antacida, andre kombinationer |
| QA02B | Midler mod mavesår og gastro-oesofageal reflux (gord) |
| QA02BA | H2-receptor antagonister |
| QA02BA01 | Cimetidin |
| QA02BA02 | Ranitidin |
| QA02BA03 | Famotidin |
| QA02BA04 | Nizatidin |
| QA02BA05 | Niperotidin |
| QA02BA06 | Roxatidin |
| QA02BA07 | Ranitidinbismuthcitrat |
| QA02BA08 | Lafutidin |
| QA02BA51 | Cimetidin, kombinationer |
| QA02BA53 | Famotidin, komb. |
| QA02BB | Prostaglandiner |
| QA02BB01 | Misoprostol |
| QA02BB02 | Enprostil |
| QA02BC | Protonpumpe-hæmmere |
| QA02BC01 | Omeprazol |
| QA02BC02 | Pantoprazol |
| QA02BC03 | Lanzoprazol |
| QA02BC04 | Rabeprazol |
| QA02BC05 | Esomeprazol |
| QA02BC06 | Dexlansoprazol |
| QA02BC07 | Dexrabeprazol |
| QA02BC08 | Vonoprazan |
| QA02BC09 | Tegoprazan |
| QA02BC10 | Fexuprazan |
| QA02BC11 | Ilaprazol |
| QA02BC51 | Omeprazol, kombinationer |
| QA02BC53 | Lansoprazol, kombinationer |
| QA02BC54 | Rabeprazol, kombinationer |
| QA02BD | Komb. til fjernelse af heliobacter pylori |
| QA02BD01 | Omeprazol, amoxicillin og metronidazol |
| QA02BD02 | Lansoprazol, tetracyclin og metronidazol |
| QA02BD03 | Lansoprazol, amoxicillin og metronidazol |
| QA02BD04 | Pantoprazol, amoxicillin og clarithromycin |
| QA02BD05 | Omeprazol, amoxicillin og clarithromycin |
| QA02BD06 | Esomeprazol, amoxicillin og clarithromycin |
| QA02BD07 | Lansoprazol, amoxicillin og clarithromycin |
| QA02BD08 | Bismuthsubcitrat, tetracyclin og metronidazol |
| QA02BD09 | Lansoprazol, clarithromycin og tinidazol |
| QA02BD10 | Lansoprazol, amoxicillin og levofloxacin |
| QA02BD11 | Pantoprazol, amoxicillin, clarithromycin og metronidazol |
| QA02BD12 | Rabeprazol, amoxicillin og clarithromycin |
| QA02BD13 | Rabeprazol, amoxicillin og metronidazol |
| QA02BD14 | Vonoprazan, amoxicillin og clarithromycin |
| QA02BD15 | Vonoprazan, amoxicillin og metronidazol |
| QA02BD16 | Omeprazol, amoxicillin og rifabutin |
| QA02BD17 | Vonoprazan og amoxicillin |
| QA02BX | Andre midler mod mavesår og gastro-oesophageal reflux (gord) |
| QA02BX01 | Carbenoxolon |
| QA02BX02 | Sucralfat |
| QA02BX03 | Pirenzepin |
| QA02BX04 | Methiosulfoniumchlorid |
| QA02BX05 | Bismuthsubcitrat |
| QA02BX06 | Proglumid |
| QA02BX07 | Gefarnat |
| QA02BX08 | Sulglicotid |
| QA02BX09 | Acetoxolon |
| QA02BX10 | Zolimidin |
| QA02BX11 | Troxipid |
| QA02BX12 | Bismuthsubnitrat |
| QA02BX13 | Alginsyre |
| QA02BX14 | Rebamipid |
| QA02BX15 | Teprenon |
| QA02BX16 | Irsogladin |
| QA02BX51 | Carbenoxolon, komb. excl. psykoleptika |
| QA02BX71 | Carbenoxolon, komb. med psykoleptika |
| QA02BX77 | Gefarnat, komb. med psykoleptika |
| QA02X | Andre midler mod syrerelaterede forstyrrelser |
| QA03 | Midler mod funktionelle gastrointestinale forstyrrelser |
| QA03A | Midler mod funktionelle gastrointestinale forstyrrelser |
| QA03AA | Synt. antikolinergika, estere m. tertiær aminogruppe |
| QA03AA01 | Oxyphencyclimin |
| QA03AA03 | Camylofin |
| QA03AA04 | Mebeverin |
| QA03AA05 | Trimebutin |
| QA03AA06 | Rociverin |
| QA03AA07 | Dicycloverin |
| QA03AA08 | Dihexyverin |
| QA03AA09 | Difemerin |
| QA03AA30 | Piperidolat |
| QA03AB | Synt. antikolinergika, kvarternære ammoniumforb. |
| QA03AB01 | Benzilon |
| QA03AB02 | Glycopyrron |
| QA03AB03 | Oxyphenon |
| QA03AB04 | Penthienat |
| QA03AB05 | Propanthelin |
| QA03AB06 | Otiloniumbromid |
| QA03AB07 | Methanthelin |
| QA03AB08 | Tridihexethyl |
| QA03AB09 | Isopropamid |
| QA03AB10 | Hexocyclium |
| QA03AB11 | Poldin |
| QA03AB12 | Mepenzolat |
| QA03AB13 | Bevonium |
| QA03AB14 | Pipenzolat |
| QA03AB15 | Diphemanil |
| QA03AB16 | (2-benzhydryloxyethyl)diethylmethylammoniumiodid |
| QA03AB17 | Tiemoniumiodid |
| QA03AB18 | Prifiniumbromid |
| QA03AB19 | Timepidiumbromid |
| QA03AB21 | Fenpiverinium |
| QA03AB53 | Oxyphenon, kombinationer |
| QA03AB90 | Benzetimid |
| QA03AB92 | Carbachol |
| QA03AB93 | Neostigmin |
| QA03AC | Synt. antispasmodika, amider med tertiære aminer |
| QA03AC02 | Dimethylaminopropionylphenothiazin |
| QA03AC04 | Nicofetamid |
| QA03AC05 | Tiropramid |
| QA03AD | Papaveriner og derivater |
| QA03AD01 | Papaverin |
| QA03AD02 | Drotaverin |
| QA03AD30 | Moxaverin |
| QA03AE | Serotoninreceptor antagonister |
| QA03AE01 | Alosetron |
| QA03AE03 | Cilansetron |
| QA03AX | Andre midler mod funktionelle gastrointestinale forstyrrelser |
| QA03AX01 | Fenpipran |
| QA03AX02 | Diisopromin |
| QA03AX03 | Chlorbenzoxamin |
| QA03AX04 | Pinaverium |
| QA03AX05 | Fenoverin |
| QA03AX06 | Idanpramin |
| QA03AX07 | Proxazol |
| QA03AX08 | Alverin |
| QA03AX09 | Trepibuton |
| QA03AX10 | Isomethepten |
| QA03AX11 | Caroverin |
| QA03AX12 | Phloroglucinol |
| QA03AX13 | Siliconer |
| QA03AX14 | Valethamat |
| QA03AX15 | Pebermynteolie |
| QA03AX30 | Trimethyldiphenylpropylamin |
| QA03AX58 | Alverin, komb. |
| QA03AX63 | Siliconer, komb. |
| QA03AX90 | Physiostigmin |
| QA03AX91 | Macrogolricinoleat |
| QA03B | Belladonna og derivater, usammensatte |
| QA03BA | Belladonna-alkaloider, tertiære aminer |
| QA03BA01 | Atropin |
| QA03BA03 | Hyoscyamin |
| QA03BA04 | Belladonna total-alkaloid |
| QA03BA18 | Prifiniumbromid |
| QA03BB | Belladonna alkaloider, semisynt. kvarternære ammoniumforb. |
| QA03BB01 | Butylscopolamin |
| QA03BB02 | Methylatropin |
| QA03BB03 | Methylscopolamin |
| QA03BB04 | Fentonium |
| QA03BB05 | Cimetropiumbromid |
| QA03BB06 | Homatropinmethylbromid |
| QA03C | Antispasmodika i komb. med psykoleptika |
| QA03CA | Syntetiske antikolinergika |
| QA03CA09 | Pipenzolat og psykoleptika |
| QA03CB | Belladonna og derivater i komb. med psykoleptika |
| QA03CB04 | Homatropinmethylbromid og psykoleptika |
| QA03CC | Andre antispasmodika i komb. med psykoleptika |
| QA03D | Antispasmodika i komb. med analgetika |
| QA03DA | Syntetiske antikolinergika i komb. med analgetika |
| QA03DB | Belladonna og derivater i komb. med analgetika |
| QA03DB04 | Butylscopolamin og analgetika |
| QA03DC | Andre antispasmotika i komb. med analgetika |
| QA03E | Antispasmodika og antikolinergika i komb. med andre stoffer |
| QA03EA | Antispasmodika, psykoleptika og analgetika i komb. |
| QA03ED | Antispasmotika i komb. med andre stoffer |
| QA03F | Propulsiva |
| QA03FA | Propulsiva |
| QA03FA01 | Metoclopramid |
| QA03FA02 | Cisaprid |
| QA03FA03 | Domperidon |
| QA03FA04 | Bromoprid |
| QA03FA05 | Alizaprid |
| QA03FA06 | Cleboprid |
| QA03FA07 | Itoprid |
| QA03FA08 | Cinitaprid |
| QA03FA09 | Mosaprid |
| QA03FA10 | Acotiamid |
| QA03FA90 | Physiostigmin |
| QA04 | Antiemetika og midler mod kvalme |
| QA04A | Antiemetika og midler mod kvalme |
| QA04AA | Serotonin (5ht3) antagonister |
| QA04AA01 | Ondansetron |
| QA04AA02 | Granisetron |
| QA04AA03 | Tropisetron |
| QA04AA04 | Dolasetron |
| QA04AA05 | Palonosetron |
| QA04AA55 | Palonosetron, kombinationer |
| QA04AD | Andre antiemetika |
| QA04AD01 | Scopolamin |
| QA04AD02 | Ceriumoxalat |
| QA04AD04 | Chlorbutanol |
| QA04AD05 | Metopimazin |
| QA04AD10 | Dronabinol |
| QA04AD11 | Nabilon |
| QA04AD12 | Aprepitant |
| QA04AD13 | Casopitant |
| QA04AD14 | Rolapitant |
| QA04AD51 | Scopolamin, kombinationer |
| QA04AD54 | Chlorbutanol, komb. |
| QA04AD90 | Maropitant |
| QA05 | Galde- og leverterapi |
| QA05A | Galdeterapi |
| QA05AA | Galdesyrer og derivater |
| QA05AA01 | Chenodeoxycholsyre |
| QA05AA02 | Ursodeoxycholsyre |
| QA05AA03 | Cholinsyre |
| QA05AA04 | Obeticholsyre |
| QA05AA05 | Ursodoxicoltaurin |
| QA05AB | Præparater til galdegangs-terapi |
| QA05AB01 | Nicotinylmethylamid |
| QA05AX | Andre midler til galdeterapi |
| QA05AX01 | Piprozolin |
| QA05AX02 | Hymecromon |
| QA05AX03 | Cyclobutyrol |
| QA05AX04 | Maralixibatchlorid |
| QA05AX05 | Odevixibat |
| QA05AX06 | Elafibranor |
| QA05AX07 | Seladelpar |
| QA05AX90 | Menbuton |
| QA05B | Leverterapi, lipotropica |
| QA05BA | Leverterapi |
| QA05BA01 | Argininglutamat |
| QA05BA03 | Silymarin |
| QA05BA04 | Citiolon |
| QA05BA05 | Epomediol |
| QA05BA06 | Ornithinoxoglurat |
| QA05BA07 | Tidiacinarginin |
| QA05BA08 | Glycyrrhizinsyre |
| QA05BA09 | Metadoxin |
| QA05BA10 | Phospholipider |
| QA05BA90 | Methionin |
| QA05C | Midler til galdeterapi og lipotropica i komb. |
| QA06 | Midler mod obstipatio |
| QA06A | Midler mod obstipatio |
| QA06AA | Blødgørende midler |
| QA06AA01 | Paraffinolie |
| QA06AA02 | Natriumdocusat |
| QA06AA51 | Paraffinolie, kombinationer |
| QA06AB | Kontaktlaxantia |
| QA06AB01 | Oxyphenisatin |
| QA06AB02 | Bisacodyl |
| QA06AB03 | Dantron |
| QA06AB04 | Phenolphthalein |
| QA06AB05 | Ricinusolie |
| QA06AB06 | Senna-glycosider |
| QA06AB07 | Cascara |
| QA06AB08 | Natriumpicosulfat |
| QA06AB09 | Bisoxatin |
| QA06AB20 | Kontaktlaxantia i kombination |
| QA06AB30 | Kontaktlaxantia i komb. med belladonna-alkaloider |
| QA06AB52 | Bisacodyl, komb. |
| QA06AB53 | Dantron, kombinationer |
| QA06AB56 | Senna-glycosider, kombinationer |
| QA06AB57 | Cascara, kombinationer |
| QA06AB58 | Natriumpicosulfat, kombinationer |
| QA06AC | Volumendannende laksantia |
| QA06AC01 | Ispaghula (loppefrø) |
| QA06AC02 | Ethulose |
| QA06AC03 | Sterculia |
| QA06AC05 | Hørfrø |
| QA06AC06 | Methylcellulose |
| QA06AC07 | Triticum (hvedefibre) |
| QA06AC08 | Polycarbophilcalcium |
| QA06AC51 | Ispaghula, kombinationer |
| QA06AC53 | Sterculia, kombinationer |
| QA06AC55 | Hørfrø, kombinationer |
| QA06AD | Osmotisk virkende laxantia |
| QA06AD01 | Magnesiumcarbonat |
| QA06AD02 | Magnesiumoxid |
| QA06AD03 | Magnesiumperoxid |
| QA06AD04 | Magnesiumsulfat |
| QA06AD10 | Mineralsalte i kombination |
| QA06AD11 | Lactulose |
| QA06AD12 | Lactitol |
| QA06AD13 | Natriumsulfat |
| QA06AD14 | Pentaerithrityltetranitrat |
| QA06AD15 | Macrogol |
| QA06AD16 | Mannitol |
| QA06AD17 | Natriumphosphat |
| QA06AD18 | Sorbitol |
| QA06AD19 | Magnesiumcitrat |
| QA06AD21 | Natriumtartrat |
| QA06AD61 | Lactulose, kombinationer |
| QA06AD65 | Macrogol, komb. |
| QA06AG | Klysma |
| QA06AG01 | Natriumphosphat |
| QA06AG02 | Bisacodyl |
| QA06AG03 | Dantron, incl. kombinationer |
| QA06AG04 | Glycerol |
| QA06AG06 | Olie |
| QA06AG07 | Sorbitol |
| QA06AG10 | Natriumdocusat incl. kombinationer |
| QA06AG11 | Natriumlaurilsulfoacetat, inkl. kombinationspræparater |
| QA06AG20 | Klysma, kombinationer |
| QA06AH | Perifere opioid receptor antagonister |
| QA06AH01 | Methylnaltrexonbromid |
| QA06AH02 | Alvimopan |
| QA06AH03 | Naloxegol |
| QA06AH04 | Naloxon |
| QA06AH05 | Naldemedin |
| QA06AX | Andre midler mod obstipatio |
| QA06AX01 | Glycerol |
| QA06AX02 | Carbondioxid-producerende midler |
| QA06AX03 | Lubiproston |
| QA06AX04 | Linaclotid |
| QA06AX05 | Prucaloprid |
| QA06AX06 | Tegaserod |
| QA06AX07 | Plecanatid |
| QA06AX08 | Tenapanor |
| QA06AX09 | Elobixibat |
| QA07 | Diarremidler, intestinale antiinflammatorika/antiinfektiva |
| QA07A | Intestinale antiinfektiva |
| QA07AA | Antibiotika |
| QA07AA01 | Neomycin |
| QA07AA02 | Nystatin |
| QA07AA03 | Natamycin |
| QA07AA04 | Streptomycin |
| QA07AA05 | Polymyxin |
| QA07AA06 | Paromomycin |
| QA07AA07 | Amphotericin |
| QA07AA08 | Kanamycin |
| QA07AA09 | Vancomycin |
| QA07AA10 | Colistin |
| QA07AA11 | Rifaximin |
| QA07AA12 | Fidaxomicin |
| QA07AA13 | Rifamycin |
| QA07AA51 | Neomycin, kombinationer |
| QA07AA54 | Streptomycin, kombinationer |
| QA07AA90 | Dihydrostreptomycin |
| QA07AA91 | Gentamicin |
| QA07AA92 | Apramycin |
| QA07AA93 | Bacitracin |
| QA07AA94 | Enramycin |
| QA07AA95 | Avilamycin |
| QA07AA96 | Bambermycin |
| QA07AA98 | Colistin, kombinationer med andre antibakterika |
| QA07AA99 | Antibiotika, kombinationer |
| QA07AB | Sulfonamider |
| QA07AB02 | Phthalylsulfathiazol |
| QA07AB03 | Sulfaguanidin |
| QA07AB04 | Succinylsulfathiazol |
| QA07AB20 | Sulfonamider, kombinationer |
| QA07AB90 | Formosulfathiazol |
| QA07AB92 | Phthalylsulfathiazol, komb. |
| QA07AB99 | Kombinationer |
| QA07AC | Imidazol-derivater |
| QA07AC01 | Miconazol |
| QA07AX | Andre intestinale antiinfektiva |
| QA07AX01 | Broxyquinolin |
| QA07AX02 | Acetarsol |
| QA07AX03 | Nifuroxazid |
| QA07AX04 | Nifurzid |
| QA07AX90 | Poly (2-propenal, 2-propenoinsyre) |
| QA07AX91 | Halquinol |
| QA07B | Intestinale adsorbenter |
| QA07BA | Kul-præparater |
| QA07BA01 | Kul, aktivt |
| QA07BA51 | Kul, aktivt, komb. |
| QA07BB | Bismuth-forbindelser |
| QA07BC | Andre intestinale adsorbenter |
| QA07BC01 | Pectin |
| QA07BC02 | Kaolin |
| QA07BC03 | Crospovidone |
| QA07BC04 | Attapulgit |
| QA07BC05 | Diosmectit |
| QA07BC30 | Kombinationer |
| QA07BC54 | Attapulgit, komb. |
| QA07C | Elektrolyter med kulhydrater |
| QA07CQ | Orale rehydreringsmidler til veterinært brug |
| QA07CQ01 | Orale elektrolytter |
| QA07CQ02 | Orale elektrolytter og kulhydrater |
| QA07D | Antipropulsiva |
| QA07DA | Antipropulsiva |
| QA07DA01 | Diphenoxylat |
| QA07DA02 | Opium |
| QA07DA03 | Loperamid |
| QA07DA04 | Difenoxin |
| QA07DA05 | Loperamidoxid |
| QA07DA06 | Eluxadolin |
| QA07DA52 | Morphin, kombinationer |
| QA07DA53 | Ioperamid, komb. |
| QA07E | Intestinale antiinflammatorika |
| QA07EA | Kortikosteroider til lokalt brug |
| QA07EB | Antiallergiske midler exkl. kortikosteroider |
| QA07EC | Aminosalicylsyre og lignende stoffer |
| QA07EC04 | Balsalazid |
| QA07F | Mikroorganismer til diare-behandling |
| QA07FA | Mikroorganismer til diarre-behandling |
| QA07FA01 | Mælkesyreproducerende mikroorganismer |
| QA07FA02 | Saccharomyces boulardii |
| QA07FA03 | Escherichia coli |
| QA07FA51 | Mælkesyreproducerende mikroorganismer, komb. |
| QA07FA90 | Probiotika |
| QA07X | Andre midler mod diare |
| QA07XA | Andre midler mod diare |
| QA07XA01 | Albumintannat |
| QA07XA02 | Ceratonia |
| QA07XA03 | Calcium-forbindelser |
| QA07XA04 | Racecadotril |
| QA07XA06 | Crofelemer |
| QA07XA51 | Albumintannat, komb. |
| QA07XA90 | Aluminiumsalicylater, basiske |
| QA07XA91 | Zinkoxid |
| QA07XA92 | Zinkdinatriumedetate |
| QA07XA99 | Andre midler mod diare, komb. |
| QA08 | Midler mod fedme, excl. diætmidler |
| QA08AA | Centralt virkende anoreksika |
| QA08AA11 | Lorcaserin |
| QA08AA12 | Setmelanotid |
| QA08AA51 | Phentermin og topiramat |
| QA08AA62 | Bupropion og naltrexon |
| QA08AB | Midler mod fedme med perifer virkning |
| QA08AB01 | Orlistat |
| QA08AB90 | Mitratapid |
| QA08AB91 | Dirlotapid |
| QA08AX | Andre midler mod fedme |
| QA08AX01 | Rimonabant |
| QA09 | Digestiva, incl. enzymer |
| QA09A | Digestiva, incl. enzymer |
| QA09AA | Enzympræparater |
| QA09AA01 | Diastase |
| QA09AA02 | Multienzymer (lipase, protease etc.) |
| QA09AA03 | Pepsin |
| QA09AA04 | Tilactase |
| QA09AB | Syreholdige midler |
| QA09AB01 | Glutaminsyre-hydrochlorid |
| QA09AB02 | Betainhydrochlorid |
| QA09AB03 | Saltsyre |
| QA09AB04 | Citronsyre |
| QA09AC | Enzym- og syrepræparater i kombination |
| QA09AC01 | Pepsin og syrepræparater |
| QA09AC02 | Multienzymer og syrepræparater |
| QA10 | Midler anvendt ved diabetes |
| QA10A | Insuliner og analoger |
| QA10AB | Insuliner og analoger til injektion, hurtigtvirkende |
| QA10AB01 | Insulin (human) |
| QA10AB02 | Insulin (okse) |
| QA10AB03 | Insulin (svin) |
| QA10AB04 | Insulin lispro |
| QA10AB05 | Insulin aspart |
| QA10AB06 | Insulin glulisin |
| QA10AB30 | Insuliner i komb. |
| QA10AC | Insuliner og analoger til injektion, middellang virkningstid |
| QA10AC01 | Insulin (human) |
| QA10AC02 | Insulin (okse) |
| QA10AC03 | Insulin (svin) |
| QA10AC04 | Insulin lispro |
| QA10AC30 | Insuliner i komb. |
| QA10AD | Insuliner og analoger til injektion, middellang virkn.tid komb. m. hurti |
| QA10AD01 | Insulin (human) |
| QA10AD02 | Insulin (okse) |
| QA10AD03 | Insulin (svin) |
| QA10AD04 | Insulin lispro |
| QA10AD05 | Insulin aspart |
| QA10AD06 | Insulin degludec og insulin aspart |
| QA10AD30 | Insuliner i komb. |
| QA10AE | Insuliner og analoger til injektion, langtidsvirkende |
| QA10AE01 | Insulin (human) |
| QA10AE02 | Insulin (okse) |
| QA10AE03 | Insulin (svin) |
| QA10AE04 | Insulin glargin |
| QA10AE05 | Insulin detemir |
| QA10AE06 | Insulin degludec |
| QA10AE07 | Insulin icodec |
| QA10AE30 | Insuliner i komb. |
| QA10AE54 | Insulin glargin og lixisenatid |
| QA10AE56 | Insulin degludec og liraglutid |
| QA10AF | Insuliner og analoger, til inhalation |
| QA10AF01 | Insulin (human) |
| QA10B | Blodglucose-sænkende midler, ekskl. insuliner |
| QA10BA | Biguanider |
| QA10BA01 | Phenformin |
| QA10BA02 | Metformin |
| QA10BA03 | Buformin |
| QA10BB | Sulfonylcarbamid |
| QA10BB01 | Glibenclamid |
| QA10BB02 | Chlorpropamid |
| QA10BB03 | Tolbutamid |
| QA10BB04 | Glibornurid |
| QA10BB05 | Tolazamid |
| QA10BB06 | Carbutamid |
| QA10BB07 | Glipizid |
| QA10BB08 | Gliquidon |
| QA10BB09 | Gliclazid |
| QA10BB10 | Metahexamid |
| QA10BB11 | Glisoxepid |
| QA10BB12 | Glimepirid |
| QA10BB31 | Acetohexamid |
| QA10BC | Sulfonamider (heterocycliske) |
| QA10BC01 | Glymidin |
| QA10BD | Komb. af orale blodglucose-sænkende midler |
| QA10BD01 | Phenformin og sulfonylcarbamider |
| QA10BD02 | Metformin og sulfonylcarbamider |
| QA10BD03 | Metformin og rosiglitazon |
| QA10BD04 | Glimepirid og rosiglitazon |
| QA10BD05 | Metformin og pioglitazon |
| QA10BD06 | Glimepirid og pioglitazon |
| QA10BD07 | Metformin og sitagliptin |
| QA10BD08 | Metformin og vildagliptin |
| QA10BD09 | Pioglitazon og alogliptin |
| QA10BD10 | Metformin og saxagliptin |
| QA10BD11 | Metformin og linagliptin |
| QA10BD12 | Pioglitazon og sitagliptin |
| QA10BD13 | Metformin og alogliptin |
| QA10BD14 | Metformin og repaglinid |
| QA10BD15 | Metformin og dapagliflozin |
| QA10BD16 | Metformin og canagliflozin |
| QA10BD17 | Metformin og acarbose |
| QA10BD18 | Metformin og gemigliptin |
| QA10BD19 | Linagliptin og empagliflozin |
| QA10BD20 | Metformin og empagliflozin |
| QA10BD21 | Saxagliptin og dapagliflozin |
| QA10BD22 | Metformin og evogliptin |
| QA10BD23 | Metformin og ertugliflozin |
| QA10BD24 | Sitagliptin og ertugliflozin |
| QA10BD25 | Metformin, saxagliptin og dapagliflozin |
| QA10BD26 | Metformin og lobeglitazon |
| QA10BD27 | Metformin, linagliptin og empagliflozin |
| QA10BD28 | Metformin og teneligliptin |
| QA10BD29 | Sitagliptin og dapagliflozin |
| QA10BD30 | Gemigliptin og dapagliflozin |
| QA10BF | Alfa-glucosidase hæmmere |
| QA10BF01 | Acarbose |
| QA10BF02 | Miglitol |
| QA10BF03 | Voglibose |
| QA10BG | Thiazolindioner |
| QA10BG01 | Troglitazon |
| QA10BG02 | Rosiglitazon |
| QA10BG03 | Pioglitazon |
| QA10BG04 | Lobeglitazon |
| QA10BH | Dipeptidyl peptidase 4 (dpp-4)-hæmmere |
| QA10BH01 | Sitagliptin |
| QA10BH02 | Vildagliptin |
| QA10BH03 | Saxagliptin |
| QA10BH04 | Alogliptin |
| QA10BH05 | Linagliptin |
| QA10BH06 | Gemigliptin |
| QA10BH07 | Evogliptin |
| QA10BH08 | Teneligliptin |
| QA10BH51 | Sitagliptin og simvastatin |
| QA10BH52 | Gemigliptin og rosuvastatin |
| QA10BJ | Glucagon-lignende peptid-1 (glp-1) analog |
| QA10BJ01 | Exenatid |
| QA10BJ02 | Liraglutid |
| QA10BJ03 | Lixisenatid |
| QA10BJ04 | Albiglutid |
| QA10BJ05 | Dulaglutid |
| QA10BJ06 | Semaglutid |
| QA10BJ07 | Beinaglutid |
| QA10BK | Natrium-glucose co-transporter 2 (sglt2) inhibitorer |
| QA10BK01 | Dapagliflozin |
| QA10BK02 | Canagliflozin |
| QA10BK03 | Empagliflozin |
| QA10BK04 | Ertugliflozin |
| QA10BK05 | Ipragliflozin |
| QA10BK06 | Sotagliflozin |
| QA10BK07 | Luseogliflozin |
| QA10BK08 | Bexagliflozin |
| QA10BK09 | Enavogliflozin |
| QA10BK90 | Velagliflozin |
| QA10BX | Andre blodglucose-sænkende midler, ekskl. insuliner |
| QA10BX01 | Guar gummi |
| QA10BX02 | Rapaglinid |
| QA10BX03 | Nateglinid |
| QA10BX05 | Pramlintid |
| QA10BX06 | Benfluorex |
| QA10BX08 | Mitiglinid |
| QA10BX15 | Imeglimin |
| QA10BX16 | Tirzepatid |
| QA10BX17 | Carfloglitazar |
| QA10BX18 | Dorzagliatin |
| QA10X | Andre midler anvendt ved diabetes |
| QA10XA | Aldose-reductase hæmmere |
| QA10XA01 | Tolrestat |
| QA10XX | Andre midler mod diabetes |
| QA10XX01 | Teplizumab |
| QA10XX02 | Donislecel |
| QA11 | Vitaminer |
| QA11A | Multivitaminer, kombinationer |
| QA11AA | Multivitaminer med mineraler |
| QA11AA01 | Multivitaminer og jern |
| QA11AA02 | Multivitaminer og calcium |
| QA11AA03 | Multivitaminer og andre mineraler, incl. komb. |
| QA11AA04 | Multivitaminer og sporstoffer |
| QA11AB | Multivitaminer, andre kombinationer |
| QA11B | Multivitaminer, usammensatte |
| QA11BA | Multivitaminer, usammensatte |
| QA11C | Vitamin a og d, incl. kombinationer af begge |
| QA11CA | Vitamin a, usammensatte |
| QA11CA01 | Retinol (vit. a) |
| QA11CA02 | Betacaroten |
| QA11CB | Vitamin a og d i kombination |
| QA11CC | Vitamin d og analoger |
| QA11CC01 | Ergocalciferol |
| QA11CC02 | Dihydrotachysterol |
| QA11CC03 | Alfacalcidol |
| QA11CC04 | Calcitriol |
| QA11CC05 | Colecalciferol |
| QA11CC06 | Calcifediol |
| QA11CC07 | Paricalcitol |
| QA11CC20 | Kombinationer af vitamin d og analoger |
| QA11CC55 | Cholecalciferol, kombinationer |
| QA11D | Vitamin b1, usammensat og i komb. med vitamin b6 og b12 |
| QA11DA | Thiamin (vit. b1), usammensat |
| QA11DA01 | Thiamin (vit. b1) |
| QA11DA02 | Sulbutiamin |
| QA11DA03 | Benfotiamin |
| QA11E | Vitamin b-kompleks, incl. kombinationer |
| QA11EA | Vitamin b-kompleks, usammensatte |
| QA11EB | Vitamin b-kompleks, med vitamin c |
| QA11EC | Vitamin b-kompleks, med mineraler |
| QA11ED | Vitamin b-kompleks, med anaboliske steroider |
| QA11EX | Vitamin b-kompleks, andre kombinationer |
| QA11G | Ascorbinsyre (vit. c), incl. kombinationer |
| QA11GA | Ascorbinsyre (vit. c), usammensat |
| QA11GA01 | Ascorbinsyre (vit. c) |
| QA11GB | Ascorbinsyre (vit. c), kombinationer |
| QA11GB01 | Ascorbinsyre (vit. c) og calcium |
| QA11H | Andre usammensatte vitamin-præparater |
| QA11HA | Andre usammensatte vitamin-præparater |
| QA11HA01 | Nicotinamid |
| QA11HA02 | Pyridoxin (vit. b6) |
| QA11HA03 | Tocopherol (vit. e) |
| QA11HA04 | Riboflavin (vit. b2) |
| QA11HA05 | Biotin |
| QA11HA06 | Pyridoxalphosphat |
| QA11HA07 | Inositol |
| QA11HA08 | Tocofersolan |
| QA11HA30 | Dexpanthenol |
| QA11HA31 | Calciumpantothenat |
| QA11HA32 | Pantethin |
| QA11HA90 | Betacaroten |
| QA11J | Andre vitamin-produkter, kombinationer |
| QA11JA | Kombinationer af vitaminer |
| QA11JB | Vitaminer med mineraler |
| QA11JC | Vitaminer, andre kombinationer |
| QA12 | Mineraltilskud |
| QA12A | Calcium |
| QA12AA | Calcium |
| QA12AA01 | Calciumphosphat |
| QA12AA02 | Calciumglubionat |
| QA12AA03 | Calciumgluconat |
| QA12AA04 | Calciumcarbonat |
| QA12AA05 | Calciumlactat |
| QA12AA06 | Calciumlactatgluconat |
| QA12AA07 | Calciumchlorid |
| QA12AA08 | Calciumglycerophosphat |
| QA12AA09 | Calciumcitrat-lysinkompleks |
| QA12AA10 | Calciumglucoheptonat |
| QA12AA11 | Calciumpangamat |
| QA12AA13 | Calciumcitrat |
| QA12AA20 | Calcium (forskellige salte i kombination) |
| QA12AA30 | Calciumlaevulat |
| QA12AX | Calcium, kombinationer med d-vitamin og/eller andre stoffer |
| QA12B | Kalium |
| QA12BA | Kalium |
| QA12BA01 | Kaliumchlorid |
| QA12BA02 | Kaliumcitrat |
| QA12BA03 | Kaliumhydrogentartrat |
| QA12BA04 | Kaliumhydrogencarbonat |
| QA12BA05 | Kaliumgluconat |
| QA12BA30 | Kalium (forskellige salte i kombination) |
| QA12BA51 | Kalium, kombinationer |
| QA12C | Andre mineraltilskud |
| QA12CA | Natrium |
| QA12CA01 | Natriumchlorid |
| QA12CA02 | Natriumsulfat |
| QA12CB | Zink |
| QA12CB01 | Zinksulfat |
| QA12CB02 | Zinkgluconat |
| QA12CB03 | Zinkproteinkompleks |
| QA12CC | Magnesium |
| QA12CC01 | Magnesiumchlorid |
| QA12CC02 | Magnesiumsulfat |
| QA12CC03 | Magnesiumgluconat |
| QA12CC04 | Magnesiumcitrat |
| QA12CC05 | Magnesiumaspartat |
| QA12CC06 | Magnesiumlactat |
| QA12CC07 | Magnesiumlævulinat |
| QA12CC08 | Magnesiumpidolat |
| QA12CC09 | Magnesiumorotat |
| QA12CC10 | Magnesiumoxid |
| QA12CC30 | Magnesium, forskellige salte i komb. |
| QA12CD | Fluorid |
| QA12CD01 | Natriumfluorid |
| QA12CD02 | Natriummonofluorphosphat |
| QA12CD51 | Fluorid, komb. |
| QA12CE | Selen |
| QA12CE01 | Natriumselenat |
| QA12CE02 | Natriumselenit |
| QA12CE99 | Selen, kombinationer |
| QA12CX | Andre mineralprodukter |
| QA12CX90 | Toldimfos |
| QA12CX91 | Butafosfan |
| QA12CX99 | Andre mineralprodukter, kombinationer |
| QA13 | Tonika |
| QA13A | Tonika |
| QA14 | Anabolika til systemisk brug |
| QA14A | Anaboliske steroider |
| QA14AA | Androstan-derivater |
| QA14AA01 | Androstanolon |
| QA14AA02 | Stanozolol |
| QA14AA03 | Metandienon |
| QA14AA04 | Metenolon |
| QA14AA05 | Oxymetholon |
| QA14AA06 | Quinbolon |
| QA14AA07 | Prasteron |
| QA14AA08 | Oxandrolon |
| QA14AA09 | Norethandrolon |
| QA14AB | Estren-derivater |
| QA14AB01 | Nandrolon |
| QA14AB02 | Ethylestrenol |
| QA14AB03 | Oxaboloncipionat |
| QA14B | Andre anabolika |
| QA15 | Appetitstimulerende midler |
| QA16 | Andre midler til fordøjelseskanal og metabolisme |
| QA16A | Andre midler til fordøjelseskanal og metabolisme |
| QA16AA | Aminosyrer og derivater |
| QA16AA01 | Levocarnitin |
| QA16AA02 | Ademethionin |
| QA16AA03 | Levogluthamid |
| QA16AA04 | Mercaptamin |
| QA16AA05 | Cargluminsyre |
| QA16AA06 | Betain |
| QA16AA07 | Metreleptin |
| QA16AA51 | Levocarnitin, komb. |
| QA16AB | Enzymer |
| QA16AB01 | Alglucerase |
| QA16AB02 | Imiglucerase |
| QA16AB03 | Agalsidase alfa |
| QA16AB04 | Agalsidase beta |
| QA16AB05 | Laronidase |
| QA16AB06 | Sacrosidase |
| QA16AB07 | Alglucosidase alfa |
| QA16AB08 | Galsulfase |
| QA16AB09 | Idursulfase |
| QA16AB10 | Velaglucerase alfa |
| QA16AB11 | Taliglucerase alfa |
| QA16AB12 | Elosulfase alfa |
| QA16AB13 | Asfotase alfa |
| QA16AB14 | Sebelipase alfa |
| QA16AB15 | Velmanase alfa |
| QA16AB16 | Idursulfase beta |
| QA16AB17 | Cerliponase alfa |
| QA16AB18 | Vestronidase alfa |
| QA16AB19 | Pegvaliase |
| QA16AB20 | Pegunigalsidase alfa |
| QA16AB21 | Atidarsagene autotemcel |
| QA16AB22 | Avalglucosidase alfa |
| QA16AB23 | Cipaglucosidase alfa |
| QA16AB24 | Pegzilarginase |
| QA16AB25 | Olipudase alfa |
| QA16AB26 | Eladocagene exuparvovec |
| QA16AB27 | Pabinafusp alfa |
| QA16AX | Diverse midler t. fordøjelseskanal og metabolisme |
| QA16AX01 | Tioctinsyre |
| QA16AX02 | Anetholtrithion |
| QA16AX03 | Natriumphenylbutyrat |
| QA16AX04 | Nitisinon |
| QA16AX05 | Zinkacetat |
| QA16AX06 | Miglustat |
| QA16AX07 | Sapropterin |
| QA16AX08 | Teduglutid |
| QA16AX09 | Glycerolphenylbutyrat |
| QA16AX10 | Eliglustat |
| QA16AX11 | Natriumbenzoat |
| QA16AX12 | Trientin |
| QA16AX13 | Uridintriacetat |
| QA16AX14 | Migalastat |
| QA16AX15 | Telotristat |
| QA16AX16 | Givosiran |
| QA16AX17 | Triheptanoin |
| QA16AX18 | Lumasiran |
| QA16AX19 | Fosdenopterin |
| QA16AX20 | Lonafarnib |
| QA16AX21 | Elivaldogene autotemcel |
| QA16AX22 | Tiomolibdinsyre |
| QA16AX23 | Leriglitazon |
| QA16AX24 | Govorestat |
| QA16AX25 | Nedosiran |
| QA16AX30 | Natriumbenzoat og natriumphenylacetat |
| QA16Q | Andre midler til ford.kanal og metab. til vet. brug |
| QA16QA | Midler mod og/eller til behandling af acetonemi |
| QA16QA01 | Propylenglycol |
| QA16QA02 | Natriumpropionat |
| QA16QA03 | Glycerol |
| QA16QA04 | Ammoniumlactat |
| QA16QA05 | Clanobutin |
| QA16QA06 | Monensin |
| QA16QA52 | Natriumpropionat, komb. |
| QB | Blod og bloddannende organer |
| QB01 | Antithrombosemidler |
| QB01A | Antithrombosemidler |
| QB01AA | Vitamin k antagonister |
| QB01AA01 | Dicoumarol |
| QB01AA02 | Phenindion |
| QB01AA03 | Warfarin |
| QB01AA04 | Phenprocoumon |
| QB01AA07 | Acenocoumarol |
| QB01AA08 | Ethylbiscoumacetat |
| QB01AA09 | Clorindion |
| QB01AA10 | Diphenadion |
| QB01AA11 | Tioclomarol |
| QB01AA12 | Fluindion |
| QB01AB | Heparin-gruppen |
| QB01AB01 | Heparin |
| QB01AB02 | Antithrombin |
| QB01AB04 | Dalteparin |
| QB01AB05 | Enoxaparin |
| QB01AB06 | Nadroparin |
| QB01AB07 | Parnaparin |
| QB01AB08 | Reviparin |
| QB01AB09 | Danaparoid |
| QB01AB10 | Tinzaparin |
| QB01AB11 | Sulodexid |
| QB01AB12 | Bemiparin |
| QB01AB51 | Heparin, kombinationer |
| QB01AC | Blodplade-aggregationshæmmere excl. heparin |
| QB01AC01 | Ditazol |
| QB01AC02 | Cloricromen |
| QB01AC03 | Picotamid |
| QB01AC04 | Clopidogrel |
| QB01AC05 | Ticlopidin |
| QB01AC06 | Acetylsalicylsyre |
| QB01AC07 | Dipyridamol |
| QB01AC08 | Calciumcarbasalat |
| QB01AC09 | Epoprostenol |
| QB01AC10 | Indobufen |
| QB01AC11 | Iloprost |
| QB01AC13 | Abciximab |
| QB01AC15 | Aloxiprin |
| QB01AC16 | Intrifiban |
| QB01AC17 | Tirofiban |
| QB01AC18 | Triflusal |
| QB01AC19 | Beraprost |
| QB01AC21 | Treprostinil |
| QB01AC22 | Prasugrel |
| QB01AC23 | Cilostazol |
| QB01AC24 | Ticagrelor |
| QB01AC25 | Cangrelor |
| QB01AC26 | Vorapaxar |
| QB01AC27 | Selexipag |
| QB01AC28 | Limaprost |
| QB01AC30 | Kombinationer |
| QB01AC56 | Acetylsalicylsyre, kombinationer med protonpumpeinhibitorer |
| QB01AD | Enzymer |
| QB01AD01 | Streptokinase |
| QB01AD02 | Alteplase |
| QB01AD03 | Anistreplase |
| QB01AD04 | Urokinase |
| QB01AD05 | Fibrinolysin |
| QB01AD06 | Brinase |
| QB01AD07 | Reteplase |
| QB01AD08 | Saruplase |
| QB01AD09 | Ancrod |
| QB01AD10 | Drotrecogin alfa |
| QB01AD11 | Tenecteplase |
| QB01AD12 | Protein c |
| QB01AD13 | Apadamtase alfa og cinaxadamtase alfa |
| QB01AE | Direkte thrombin-inhibitorer |
| QB01AE01 | Desirudin |
| QB01AE02 | Lepirudin |
| QB01AE03 | Argatroban |
| QB01AE04 | Melagatran |
| QB01AE05 | Ximelagatran |
| QB01AE06 | Bivalirudin |
| QB01AE07 | Dabigatran etexilat |
| QB01AF | Direkte faktor xa-hæmmere |
| QB01AF01 | Rivaroxaban |
| QB01AF02 | Apixaban |
| QB01AF03 | Edoxaban |
| QB01AF04 | Betrixaban |
| QB01AF51 | Rivaroxaban og acetylsalicylsyre |
| QB01AX | Andre antithrombosemidler |
| QB01AX01 | Defibrotid |
| QB01AX04 | Dermatansulfat |
| QB01AX05 | Fondaparinux |
| QB01AX07 | Caplacizumab |
| QB02 | Hæmostatika |
| QB02A | Antifibrinolytika |
| QB02AA | Aminosyrer |
| QB02AA01 | Aminocapronsyre |
| QB02AA02 | Tranexamsyre |
| QB02AA03 | Aminomethylbenzoesyre |
| QB02AB | Proteinase hæmmere |
| QB02AB01 | Aprotinin |
| QB02AB02 | Alfa1 antitrypsin |
| QB02AB04 | Camostat |
| QB02AB05 | Ulinastatin |
| QB02B | Vitamin k og andre hæmostatika |
| QB02BA | Vitamin k |
| QB02BA01 | Phytomenadion |
| QB02BA02 | Menadion |
| QB02BB | Fibrinogen |
| QB02BB01 | Humant fibrinogen |
| QB02BC | Hæmostatika til lokal brug |
| QB02BC01 | Absorberbar gelatinesvamp |
| QB02BC02 | Oxideret cellulose |
| QB02BC03 | Tetragalacturonsyre-hydroxymethylester |
| QB02BC05 | Adrenalon |
| QB02BC06 | Thrombin |
| QB02BC07 | Collagen |
| QB02BC08 | Calciumalginat |
| QB02BC09 | Adrenalin |
| QB02BC30 | Kombinationer |
| QB02BD | Blodkoagulationsfaktorer |
| QB02BD01 | Koagulationsfaktor ix, ii, vii og x i komb. |
| QB02BD02 | Koagulationsfaktor viii |
| QB02BD03 | Faktor viii inhibitor bypassing activity |
| QB02BD04 | Koagulationsfaktor ix |
| QB02BD05 | Koagulationsfaktor vii |
| QB02BD06 | Von willebrand faktor og koag.faktor viii i komb. |
| QB02BD07 | Koagulationsfaktor xiii |
| QB02BD08 | Koagulationsfaktor viia |
| QB02BD10 | Von willebrand faktor |
| QB02BD11 | Catridecacog |
| QB02BD13 | Koagulationsfaktor x |
| QB02BD14 | Susoctocog alfa |
| QB02BD15 | Valoctocogene roxaparvovec |
| QB02BD16 | Etranacogen dezaparvovec |
| QB02BD17 | Fidanacogene elaparvovec |
| QB02BD30 | Thrombin |
| QB02BX | Andre hæmostatika til systemisk brug |
| QB02BX01 | Etamsylat |
| QB02BX02 | Carbazochrom |
| QB02BX03 | Batroxobin |
| QB02BX04 | Romiplostim |
| QB02BX05 | Eltrombopag |
| QB02BX06 | Emicizumab |
| QB02BX07 | Lusutrombopag |
| QB02BX08 | Avatrombopag |
| QB02BX09 | Fostamatinib |
| QB02BX10 | Concizumab |
| QB02BX11 | Marstacimab |
| QB03 | Midler mod anæmi |
| QB03A | Jernpræparater |
| QB03AA | Jern(ii), orale præparater |
| QB03AA01 | Ferroglycinsulfat |
| QB03AA02 | Ferrofumarat |
| QB03AA03 | Ferrogluconat |
| QB03AA04 | Ferrocarbonat |
| QB03AA05 | Ferrochlorid |
| QB03AA06 | Ferrosuccinat |
| QB03AA07 | Ferrosulfat |
| QB03AA08 | Ferrotartrat |
| QB03AA09 | Ferroaspartat |
| QB03AA10 | Ferroascorbat |
| QB03AA11 | Ferroiodid |
| QB03AA12 | Ferronatriumcitrat |
| QB03AB | Jern(iii), orale præparater |
| QB03AB01 | Ferrinatriumcitrat |
| QB03AB02 | Ferrioxidsaccharat |
| QB03AB03 | Natriumferedetat |
| QB03AB04 | Ferrihydroxid |
| QB03AB05 | Ferrioxid polymaltosekomplekser |
| QB03AB07 | Chondroitinsulfat-jern kompleks |
| QB03AB08 | Ferriacetyltransferrin |
| QB03AB09 | Ferriproteinsuccinylat |
| QB03AB10 | Ferrimaltol |
| QB03AB90 | Jern-dextran (ban, usan) |
| QB03AC | Jern(iii), parenterale præparater |
| QB03AD | Jern i kombination med folsyre |
| QB03AD01 | Ferroaminosyrekompleks og folsyre |
| QB03AD02 | Ferrofumarat og folsyre |
| QB03AD03 | Ferrosulfat og folsyre |
| QB03AD04 | Ferrioxid-polymaltosekomplekser og folsyre |
| QB03AD05 | Ferrogluconat og folsyre |
| QB03AE | Jern i andre kombinationer |
| QB03AE01 | Jern, vitamin b12 og folsyre |
| QB03AE02 | Jern, multivitaminer og folsyre |
| QB03AE03 | Jern og multivitaminer |
| QB03AE04 | Jern, multivitaminer og mineraler |
| QB03AE10 | Diverse kombinationer |
| QB03B | Vitamin b12 og folsyre |
| QB03BA | Vitamin b12 (cyanocobalamin og derivater) |
| QB03BA01 | Cyanocobalamin |
| QB03BA02 | Cyanocobalamin-tannin kompleks |
| QB03BA03 | Hydroxocobalamin |
| QB03BA04 | Cobamamid |
| QB03BA05 | Mecobalamin |
| QB03BA51 | Cyanocobalamin, kombinationer |
| QB03BA53 | Hydroxocobalamin, komb. |
| QB03BB | Folsyre og derivater |
| QB03BB01 | Folsyre |
| QB03BB51 | Folsyre, kombinationer |
| QB03X | Andre midler mod anæmi |
| QB03XA | Andre midler mod anæmi |
| QB03XA01 | Erythropoietin |
| QB03XA02 | Darbepoetin alfa |
| QB03XA03 | Methoxypolyethylenglycol-epoetin beta |
| QB03XA04 | Peginesatid |
| QB03XA05 | Roxadustat |
| QB03XA06 | Luspatercept |
| QB03XA07 | Daprodustat |
| QB03XA08 | Vadadustat |
| QB03XA09 | Molidustat |
| QB03XA10 | Efepoetin alfa |
| QB05 | Blod-substitutter og perfusionsopløsninger |
| QB05A | Blod og beslægtede produkter |
| QB05AA | Blod-substitutter og plasmaprotein-fraktioner |
| QB05AA01 | Albumin |
| QB05AA02 | Andre plasmaprotein-fraktioner |
| QB05AA03 | Fluorcarbon blodsubstitutter |
| QB05AA05 | Dextran |
| QB05AA06 | Gelatineforbindelser |
| QB05AA07 | Hydroxyethylstivelse |
| QB05AA08 | Hæmoglobin crosfumaril |
| QB05AA09 | Hæmoglobin raffimer |
| QB05AA10 | Hæmoglobin glutamer (bovine) |
| QB05AA90 | Hæmoglobin glutamer |
| QB05AA91 | Hæmoglobin betafumaril (bovint) |
| QB05AX | Andre blodprodukter |
| QB05AX01 | Erythrocytter |
| QB05AX02 | Thrombocytter |
| QB05AX03 | Blodplasma |
| QB05AX04 | Stamceller fra navlestrengsblod |
| QB05B | Opløsninger til intravenøs brug |
| QB05BA | Opløsninger til parenteral ernæring |
| QB05BA01 | Aminosyrer |
| QB05BA02 | Fedtemulsioner |
| QB05BA03 | Kulhydrater |
| QB05BA04 | Proteinhydrolysater |
| QB05BA10 | Komb. af opløsninger til parenteral ernæring |
| QB05BB | Opløsninger med virkning på elektrolytbalancen |
| QB05BB01 | Elektrolytter |
| QB05BB02 | Elektrolytter med kulhydrater |
| QB05BB03 | Trometamol |
| QB05BB04 | Elektrolytter i komb. med andre stoffer |
| QB05BC | Opløsninger til osmotisk diurese |
| QB05BC01 | Mannitol |
| QB05BC02 | Carbamid |
| QB05C | Skyllevæsker |
| QB05CA | Antiinfektiva |
| QB05CA01 | Cetylpyridin |
| QB05CA02 | Chlorhexidin |
| QB05CA03 | Nitrofural |
| QB05CA04 | Sulfamethizol |
| QB05CA05 | Taurolidin |
| QB05CA06 | Mandelsyre |
| QB05CA07 | Noxytiolin |
| QB05CA08 | Ethacridinlactat |
| QB05CA09 | Neomycin |
| QB05CA10 | Antiinfektiva, kombinationer |
| QB05CB | Saltopløsninger |
| QB05CB01 | Natriumchlorid |
| QB05CB02 | Natriumcitrat |
| QB05CB03 | Magnesiumcitrat |
| QB05CB04 | Natriumhydrogencarbonat |
| QB05CB10 | Kombinationer af saltopløsninger |
| QB05CX | Andre skyllevæsker |
| QB05CX01 | Glucose |
| QB05CX02 | Sorbitol |
| QB05CX03 | Glycin |
| QB05CX04 | Mannitol |
| QB05CX10 | Andre skyllevæsker, kombinationer |
| QB05D | Peritonealdialysevæsker |
| QB05X | Additiver til intravenøse opløsninger |
| QB05XA | Elektrolytopløsninger |
| QB05XA01 | Kaliumchlorid |
| QB05XA02 | Natriumhydrogencarbonat |
| QB05XA03 | Natriumchlorid |
| QB05XA04 | Ammoniumchlorid |
| QB05XA05 | Magnesiumsulfat |
| QB05XA06 | Kaliumphosphat incl. komb. med kaliumsalte |
| QB05XA07 | Calciumchlorid |
| QB05XA08 | Natriumacetat |
| QB05XA09 | Natriumphosphat |
| QB05XA10 | Magnesiumphosphat |
| QB05XA11 | Magnesiumchlorid |
| QB05XA12 | Zinkchlorid |
| QB05XA13 | Saltsyre |
| QB05XA14 | Natriumglycerolphosphat |
| QB05XA15 | Kaliumlactat |
| QB05XA16 | Kardioplegi-opløsninger |
| QB05XA17 | Kaliumacetat |
| QB05XA18 | Zinksulfat |
| QB05XA19 | Calciumgluconat |
| QB05XA20 | Natriumselenit |
| QB05XA30 | Kombinationer af elektrolytter |
| QB05XA31 | Elektrolytter i komb. med andre stoffer |
| QB05XB | Aminosyrer |
| QB05XB01 | Argininhydrochlorid |
| QB05XB02 | Alanylglutamin |
| QB05XB03 | Lysin |
| QB05XC | Vitaminer |
| QB05XX | Andre additiver til intravenøse opløsninger |
| QB05XX02 | Trometamol |
| QB05Z | Hæmodialytika og hæmofiltrater |
| QB06 | Andre hæmatologiske midler |
| QB06A | Andre hæmatologiske midler |
| QB06AA | Enzymer |
| QB06AA02 | Fibrinolysin og desoxyribonuclease |
| QB06AA03 | Hyaluronidase |
| QB06AA04 | Chymotrypsin |
| QB06AA07 | Trypsin |
| QB06AA10 | Desoxyribonuclease |
| QB06AA55 | Streptokinase, kombinationer |
| QB06AB | Hæmprodukter |
| QB06AB01 | Hæmin |
| QB06AC | Midler til arvelig angioødem |
| QB06AC01 | C1-inhibitor, fra plasma |
| QB06AC02 | Icatibant |
| QB06AC03 | Ecallantid |
| QB06AC04 | Conestat alfa |
| QB06AC05 | Lanadelumab |
| QB06AC06 | Berotralstat |
| QB06AC07 | Garadacimab |
| QB06AC08 | Sebetralstat |
| QB06AX | Andre hæmatologiske midler |
| QB06AX01 | Crizanlizumab |
| QB06AX02 | Betibeglogenautotemcel |
| QB06AX03 | Voxelotor |
| QB06AX04 | Mitapivat |
| QB06AX05 | Exagamglogene autotemcel |
| QC | Kardiovaskulære system |
| QC01 | Hjerteterapi |
| QC01A | Hjerteglycosider |
| QC01AA | Digitalis-glycosider |
| QC01AA01 | Acetyldigitoxin |
| QC01AA02 | Acetyldigoxin |
| QC01AA03 | Digitalisblad |
| QC01AA04 | Digitoxin |
| QC01AA05 | Digoxin |
| QC01AA06 | Lanatosid c |
| QC01AA07 | Deslanosid |
| QC01AA08 | Metildigoxin |
| QC01AA09 | Gitoformat |
| QC01AA52 | Acetyldigoxin, komb. |
| QC01AB | Scilla-glycosider |
| QC01AB01 | Proscillaridin |
| QC01AB51 | Proscillaridin, komb. |
| QC01AC | Strophantus-glycosider |
| QC01AC01 | G-strophantin |
| QC01AC03 | Cymarin |
| QC01AX | Andre hjerteglycosider |
| QC01AX02 | Peruvosid |
| QC01B | Antiarytmika, klasse i og iii |
| QC01BA | Antiarytmika, klasse ia |
| QC01BA01 | Quinidin |
| QC01BA02 | Procainamid |
| QC01BA03 | Disopyramid |
| QC01BA04 | Spartein |
| QC01BA05 | Ajmalin |
| QC01BA08 | Prajmalin |
| QC01BA12 | Lorajmin |
| QC01BA13 | Hydroquinidin |
| QC01BA51 | Quinidin, komb. excl. psykoleptika |
| QC01BA71 | Quinidin, komb. med psykoleptika |
| QC01BB | Antiarytmika, klasse ib |
| QC01BB01 | Lidocain |
| QC01BB02 | Mexiletin |
| QC01BB03 | Tocainid |
| QC01BB04 | Aprindin |
| QC01BC | Antiarytmika, klasse ic |
| QC01BC03 | Propafenon |
| QC01BC04 | Flecainid |
| QC01BC07 | Lorcainid |
| QC01BC08 | Encainid |
| QC01BC09 | Ethacizin |
| QC01BD | Antiarytmika, klasse iii |
| QC01BD01 | Amiodaron |
| QC01BD02 | Bretyliumtosylat |
| QC01BD03 | Bunaftin |
| QC01BD04 | Dofetilid |
| QC01BD05 | Ibutilid |
| QC01BD06 | Tedisamil |
| QC01BD07 | Dronedaron |
| QC01BG | Andre antiarytmika, klasse i og iii |
| QC01BG01 | Moracizin |
| QC01BG07 | Cibenzolin |
| QC01BG11 | Vernakalant |
| QC01C | Hjertestimulerende midler excl. hjerteglycosider |
| QC01CA | Adrenerge og dopaminerge midler |
| QC01CA01 | Etilefrin |
| QC01CA02 | Isoprenalin |
| QC01CA03 | Noradrenalin |
| QC01CA04 | Dopamin |
| QC01CA05 | Norfenefrin |
| QC01CA06 | Phenylephrin |
| QC01CA07 | Dobutamin |
| QC01CA08 | Oxedrin |
| QC01CA09 | Metaraminol |
| QC01CA10 | Methoxamin |
| QC01CA11 | Mephentermin |
| QC01CA12 | Dimetofrin |
| QC01CA13 | Prenalterol |
| QC01CA14 | Dopexamin |
| QC01CA15 | Gepefrin |
| QC01CA16 | Ibopamin |
| QC01CA17 | Midodrin |
| QC01CA18 | Octopamin |
| QC01CA19 | Fenoldopam |
| QC01CA21 | Cafedrin |
| QC01CA22 | Arbutamin |
| QC01CA23 | Theodrenalin |
| QC01CA24 | Adrenalin |
| QC01CA25 | Amezinium metilsulfat |
| QC01CA26 | Ephedrin |
| QC01CA27 | Droxidopa |
| QC01CA28 | Centhaquin |
| QC01CA30 | Kombinationer |
| QC01CA51 | Etilefrin, komb. |
| QC01CE | Phosphodiesterase-inhibitorer |
| QC01CE01 | Amrinon |
| QC01CE02 | Milrinon |
| QC01CE03 | Enoximon |
| QC01CE04 | Bucladesin |
| QC01CE90 | Pimobendan |
| QC01CX | Andre hjertestimulerende midler |
| QC01CX06 | Angiotensinamid |
| QC01CX07 | Xamoterol |
| QC01CX08 | Levosimendan |
| QC01CX09 | Angiotensin ii |
| QC01CX10 | Omecamtiv mecarbil |
| QC01D | Vasodilatorer anvendt ved hjertesygdom |
| QC01DA | Organiske nitrater |
| QC01DA02 | Glyceryltrinitrat |
| QC01DA04 | Methylpropylpropandioldinitrat |
| QC01DA05 | Pentaerithrityltetranitrat |
| QC01DA07 | Propatylnitrat |
| QC01DA08 | Isosorbiddinitrat |
| QC01DA09 | Trolnitrat |
| QC01DA13 | Erythrityltetranitrat |
| QC01DA14 | Isosorbidmononitrat |
| QC01DA20 | Organiske nitrater i komb. |
| QC01DA38 | Tenitramin |
| QC01DA52 | Glyceryltrinitrat, kombinationer |
| QC01DA54 | Methylpropylpropandioldinitrat, komb. |
| QC01DA55 | Pentaerithrityltetranitrat, komb. |
| QC01DA57 | Propatylnitrat, komb. |
| QC01DA58 | Isosorbiddinitrat, komb. |
| QC01DA59 | Trolnitrat, komb. |
| QC01DA63 | Erythrityltetranitrat, komb. |
| QC01DA70 | Organiske nitrater i komb. m. psykoleptika |
| QC01DB | Quinolon-vasodilatorer |
| QC01DB01 | Flosequinan |
| QC01DX | Andre vasodilatorer anvendt ved hjertesygdom |
| QC01DX01 | Itramintosilat |
| QC01DX02 | Prenylamin |
| QC01DX03 | Oxyfedrin |
| QC01DX04 | Benziodaron |
| QC01DX05 | Carbocromen |
| QC01DX06 | Hexobendin |
| QC01DX07 | Etafenon |
| QC01DX08 | Heptaminol |
| QC01DX09 | Imolamin |
| QC01DX10 | Dilazep |
| QC01DX11 | Trapidil |
| QC01DX12 | Molsidomin |
| QC01DX13 | Efloxat |
| QC01DX14 | Cinepazet |
| QC01DX15 | Cloridarol |
| QC01DX16 | Nicorandil |
| QC01DX18 | Linsidomin |
| QC01DX19 | Nesiritid |
| QC01DX21 | Serelaxin |
| QC01DX22 | Vericiguat |
| QC01DX51 | Itramintosilat, komb. |
| QC01DX52 | Prenylamin, komb. |
| QC01DX53 | Oxyfedrin, komb. |
| QC01DX54 | Benziodaron, komb. |
| QC01E | Andre hjertemidler |
| QC01EA | Prostaglandiner |
| QC01EA01 | Alprostadil |
| QC01EB | Andre hjertemidler |
| QC01EB02 | Campher |
| QC01EB03 | Indometacin |
| QC01EB04 | Crataegus-glycosider |
| QC01EB05 | Creatinolphosphat |
| QC01EB06 | Fosfocreatin |
| QC01EB07 | Fructose-1,6-diphosphat |
| QC01EB09 | Ubidecarenon |
| QC01EB10 | Adenosin |
| QC01EB11 | Tiracizin |
| QC01EB13 | Acadesin |
| QC01EB15 | Trimetazidin |
| QC01EB16 | Ibuprofen |
| QC01EB17 | Ivabradin |
| QC01EB18 | Ranolazin |
| QC01EB21 | Regadenoson |
| QC01EB22 | Meldonium |
| QC01EB23 | Tiazotinsyre |
| QC01EB24 | Mavacamten |
| QC01EB25 | Acoramidis |
| QC01EB90 | Sirolimus |
| QC01EX | Andre hjertemidler i komb. |
| QC02 | Antihypertensiva |
| QC02A | Antiadrenerge midler, centralt virkende |
| QC02AA | Rauwolfia-alkaloider |
| QC02AA01 | Rescinnamin |
| QC02AA02 | Reserpin |
| QC02AA03 | Rauwolfia-alkaloider i kombination |
| QC02AA04 | Rauwolfia-alkaloider, hel rod |
| QC02AA05 | Deserpidin |
| QC02AA06 | Methoserpidin |
| QC02AA07 | Bietaserpin |
| QC02AA52 | Reserpin, komb. |
| QC02AA53 | Rauwolfia-alkaloider, komb. |
| QC02AA57 | Bietaserpin, komb. |
| QC02AB | Methyldopa |
| QC02AB01 | Methyldopa (l-form) |
| QC02AB02 | Methyldopa (racemisk) |
| QC02AC | Imidazolin-receptor agonister |
| QC02AC01 | Clonidin |
| QC02AC02 | Guanfacin |
| QC02AC04 | Tolonidin |
| QC02AC05 | Moxonidin |
| QC02AC06 | Rilmenidin |
| QC02B | Antiadrenerge midler, ganglie-blokerende |
| QC02BA | Sulfonium-derivater |
| QC02BA01 | Trimethaphan |
| QC02BB | Sekundære og tertiære aminer |
| QC02BB01 | Mecamylamin |
| QC02BC | Biskvaternære ammoniumforbindelsel |
| QC02C | Antiadrenerge midler, perifert virkende |
| QC02CA | Alfa-adrenoreceptor blokerende midler |
| QC02CA01 | Prazosin |
| QC02CA02 | Indoramin |
| QC02CA03 | Trimazosin |
| QC02CA04 | Doxazosin |
| QC02CA06 | Urapidil |
| QC02CC | Guanidin-derivater |
| QC02CC01 | Betanidin |
| QC02CC02 | Guanethidin |
| QC02CC03 | Guanoxan |
| QC02CC04 | Debrisoquin |
| QC02CC05 | Guanoclor |
| QC02CC06 | Guanazodin |
| QC02CC07 | Guanoxabenz |
| QC02D | Arteriolær glat muskulatur, midler m. virkn. på |
| QC02DA | Thiazid-derivater |
| QC02DA01 | Diazoxid |
| QC02DB | Hydrazinophthalazin-derivater |
| QC02DB01 | Dihydralazin |
| QC02DB02 | Hydralazin |
| QC02DB03 | Endralazin |
| QC02DB04 | Cadralazin |
| QC02DC | Pyrimidin-derivater |
| QC02DC01 | Minoxidil |
| QC02DD | Nitroferricyanid-derivater |
| QC02DD01 | Nitroprussid |
| QC02DG | Guanidin-derivater |
| QC02DG01 | Pinacidil |
| QC02K | Andre antihypertensiva |
| QC02KA | Alkaloider, excl. rauwolfia |
| QC02KA01 | Veratrum |
| QC02KB | Tyrosin-hydroxylase hæmmere |
| QC02KB01 | Metirosin |
| QC02KC | Mao-hæmmere |
| QC02KC01 | Pargylin |
| QC02KD | Serotonin antagonister |
| QC02KD01 | Ketanserin |
| QC02KN | Andre antihypertensiva |
| QC02KN01 | Aprocitentan |
| QC02KX | Antihypertensiva til pulmonal arteriel hypertension |
| QC02KX01 | Bosentan |
| QC02KX02 | Ambrisentan |
| QC02KX03 | Sitaxentan |
| QC02KX04 | Macitentan |
| QC02KX05 | Riociguat |
| QC02KX06 | Sotatercept |
| QC02KX52 | Ambrisentan og tadalafil |
| QC02KX54 | Macitentan og tadalafil |
| QC02L | Antihypertensiva og diuretika i komb. |
| QC02N | Komb. af antihypertensiva i atc-grp. qc02 |
| QC03 | Diuretika |
| QC03A | Low-ceiling diuretika, thiazider |
| QC03AA | Thiazider, usammensatte |
| QC03AA01 | Bendroflumethiazid |
| QC03AA02 | Hydroflumethiazid |
| QC03AA03 | Hydrochlorthiazid |
| QC03AA04 | Chlorthiazid |
| QC03AA05 | Polythiazid |
| QC03AA06 | Trichlormethiazid |
| QC03AA07 | Cyclopenthiazid |
| QC03AA08 | Methyclothiazid |
| QC03AA09 | Cyclothiazid |
| QC03AA13 | Mebutizid |
| QC03AA56 | Trichlormethiazid, kombinationer |
| QC03AB | Thiazider og kalium i kombination |
| QC03AB01 | Bendroflumethiazid og kalium |
| QC03AB02 | Hydroflumethiazid og kalium |
| QC03AB03 | Hydrochlorthiazid og kalium |
| QC03AB04 | Chlorthiazid og kalium |
| QC03AB05 | Polythiazid og kalium |
| QC03AB06 | Trichlormethiazid og kalium |
| QC03AB07 | Cyclopenthiazid og kalium |
| QC03AB08 | Methyclothiazid og kalium |
| QC03AB09 | Cyclothiazid og kalium |
| QC03AH | Thiazider, komb. m. psykoleptika og/eller analgetika |
| QC03AH01 | Chlorthiazid, komb. |
| QC03AH02 | Hydroflumethiazid, komb. |
| QC03AX | Thiazider, komb. med andre stoffer |
| QC03AX01 | Hydrochlorthiazid, komb. |
| QC03B | Low-ceiling diuretika, excl. thiazider |
| QC03BA | Sulfonamider, usammensatte |
| QC03BA02 | Quinethazon |
| QC03BA03 | Clopamid |
| QC03BA04 | Chlorthalidon |
| QC03BA05 | Mefrusid |
| QC03BA07 | Clofenamid |
| QC03BA08 | Metolazon |
| QC03BA09 | Meticran |
| QC03BA10 | Xipamid |
| QC03BA11 | Indapamid |
| QC03BA12 | Clorexolon |
| QC03BA13 | Fenquizon |
| QC03BA82 | Clorexolon, komb. m. psykoleptika |
| QC03BB | Sulfonamider og kalium i kombination |
| QC03BB02 | Quinethazon og kalium |
| QC03BB03 | Clopamid og kalium |
| QC03BB04 | Chlorthalidon og kalium |
| QC03BB05 | Mefrusid og kalium |
| QC03BB07 | Clofenamid og kalium |
| QC03BC | Kviksølvholdige diuretika |
| QC03BC01 | Mersalyl |
| QC03BD | Xanthin-derivater |
| QC03BD01 | Theobromin |
| QC03BK | Sulfonamider, komb. med andre stoffer |
| QC03BX | Andre low-ceiling diuretika |
| QC03BX03 | Cicletanin |
| QC03C | High-ceiling diuretika |
| QC03CA | Sulfonamider, usammensatte |
| QC03CA01 | Furosemid |
| QC03CA02 | Bumetanid |
| QC03CA03 | Piretanid |
| QC03CA04 | Torasemid |
| QC03CB | Sulfonamider og kalium i kombination |
| QC03CB01 | Furosemid og kalium |
| QC03CB02 | Bumetanid og kalium |
| QC03CC | Aryloxyeddikesyre-derivater |
| QC03CC01 | Etacrynsyre |
| QC03CC02 | Tienilsyre |
| QC03CD | Pyrazolon-derivater |
| QC03CD01 | Muzolimin |
| QC03CX | Andre high-ceiling diuretika |
| QC03CX01 | Etozolin |
| QC03D | Kaliumbesparende midler |
| QC03DA | Aldosteron antagonister |
| QC03DA01 | Spironolacton |
| QC03DA02 | Kaliumcanrenoat |
| QC03DA03 | Canrenon |
| QC03DA04 | Eplerenon |
| QC03DA05 | Finerenon |
| QC03DB | Andre kaliumbesparende midler |
| QC03DB01 | Amilorid |
| QC03DB02 | Triamteren |
| QC03E | Diuretika og kaliumbesparende midler i komb. |
| QC03EA | Low-ceiling diuretika og kaliumbesparende midler |
| QC03EA01 | Hydrochlorthiazid og kaliumbesparende midler |
| QC03EA02 | Trichlormethiazid og kaliumbesparende midler |
| QC03EA03 | Epitizid og kaliumbesparende midler |
| QC03EA04 | Altizid og kaliumbesparende midler |
| QC03EA05 | Mebutizid og kaliumbesparende midler |
| QC03EA06 | Chlorthalidon og kaliumbesparende midler |
| QC03EA07 | Cyclopenthiazid og kaliumbesparende midler |
| QC03EA12 | Metolazon og kaliumbesparende midler |
| QC03EA13 | Bendroflumethiazid og kaliumbesparende midler |
| QC03EA14 | Butizid og kaliumbesparende midler |
| QC03EB | High-ceiling diuretika og kaliumbesparende midler |
| QC03EB01 | Furosemid og kaliumbesparende midler |
| QC03EB02 | Bumetanid og kaliumbesparende midler |
| QC03X | Andre diuretika |
| QC03XA | Vasopressin antagonister |
| QC03XA01 | Tolvaptan |
| QC03XA02 | Conivaptan |
| QC04 | Perifere vasodilatorer |
| QC04A | Perifere vasodilatorer |
| QC04AA | 2-amino-1-phenylethanol derivater |
| QC04AA01 | Isoxsuprin |
| QC04AA02 | Buphenin |
| QC04AA31 | Bamethan |
| QC04AB | Imidazolin-derivater |
| QC04AB01 | Phentolamin |
| QC04AB02 | Tolazolin |
| QC04AC | Nicotinsyre og derivater |
| QC04AC01 | Nicotinsyre |
| QC04AC02 | Nicotinylalkohol (pyridylcarbinol) |
| QC04AC03 | Inositolnicotinat |
| QC04AC07 | Ciclonicat |
| QC04AD | Purin-derivater |
| QC04AD01 | Pentifyllin |
| QC04AD02 | Xantinolnicotinat |
| QC04AD03 | Pentoxifyllin |
| QC04AD04 | Etofyllinnicotinat |
| QC04AD90 | Propentofyllin |
| QC04AE | Sekale-alkaloider |
| QC04AE01 | Ergoloid-mesylater |
| QC04AE02 | Nicergolin |
| QC04AE04 | Dihydroergocristin |
| QC04AE51 | Ergoloid-mesylater, komb. |
| QC04AE54 | Dihydroergocristin, komb. |
| QC04AF | Enzymer |
| QC04AF01 | Kallidinogenase |
| QC04AX | Andre perifere vasodilatorer |
| QC04AX01 | Cyclandelat |
| QC04AX02 | Phenoxybenzamin |
| QC04AX07 | Vincamin |
| QC04AX10 | Moxisylyt |
| QC04AX11 | Bencyclan |
| QC04AX17 | Vinburnin |
| QC04AX19 | Sulcotidil |
| QC04AX20 | Buflomedil |
| QC04AX21 | Naftidrofuryl |
| QC04AX23 | Butalamin |
| QC04AX24 | Visnadin |
| QC04AX26 | Cetiedil |
| QC04AX27 | Cinepazid |
| QC04AX28 | Ifenprodil |
| QC04AX30 | Azapetin |
| QC04AX32 | Fasudil |
| QC04AX33 | Clazosentan |
| QC05 | Vasoprotectives |
| QC05A | Midler til behandling af hæmorider og analfissurer til lokalt brug |
| QC05AA | Korticosteroider |
| QC05AA12 | Triamcinolon |
| QC05AB | Antibiotika |
| QC05AD | Lokalanæstatika |
| QC05AE | Muskelrelaxantia |
| QC05AE01 | Glyceryltrinitrat |
| QC05AE02 | Isosorbiddinitrat |
| QC05AE03 | Diltiazem |
| QC05AX | Andre midler til behandling af hæmorider og analfissurer til lokalt brug |
| QC05AX01 | Aluminiumpræparater |
| QC05AX02 | Bismuthpræparater, kombinationer |
| QC05AX03 | Andre præparater, kombinationer |
| QC05AX04 | Zinkpræparater |
| QC05AX05 | Tribenosid |
| QC05AX06 | Phenylephrin |
| QC05BA | Hepariner eller heparinoider til lokalt brug |
| QC05BA51 | Heparinoid, komb. |
| QC05CX02 | Naftazon |
| QC05CX03 | Hestekastanjefrø |
| QC05X | Andre vasoprotectiva |
| QC05XX | Andre vasoprotectiva |
| QC05XX01 | Beperminogene perplasmid |
| QC05XX90 | Beraprost |
| QC07 | Beta-blokerende midler |
| QC07A | Beta-blokerende midler |
| QC07AA | Beta-blokerende midler, non-selektive |
| QC07AA01 | Alprenolol |
| QC07AA02 | Oxprenolol |
| QC07AA03 | Pindolol |
| QC07AA05 | Propranolol |
| QC07AA06 | Timolol |
| QC07AA07 | Sotalol |
| QC07AA12 | Nadolol |
| QC07AA14 | Mepindolol |
| QC07AA15 | Carteolol |
| QC07AA16 | Tertatolol |
| QC07AA17 | Bopindolol |
| QC07AA19 | Bupranolol |
| QC07AA23 | Penbutolol |
| QC07AA27 | Cloranolol |
| QC07AA90 | Carazolol |
| QC07AB | Beta-blokerende midler, selektive |
| QC07AB01 | Practolol |
| QC07AB02 | Metoprolol |
| QC07AB03 | Atenolol |
| QC07AB04 | Acebutolol |
| QC07AB05 | Betaxolol |
| QC07AB06 | Bevantolol |
| QC07AB07 | Bisoprolol |
| QC07AB08 | Celiprolol |
| QC07AB09 | Esmolol |
| QC07AB10 | Epanolol |
| QC07AB11 | S-atenolol |
| QC07AB12 | Nebivolol |
| QC07AB13 | Talinolol |
| QC07AB14 | Landiolol |
| QC07AG | Alfa- og beta-blokerende midler |
| QC07AG01 | Labetalol |
| QC07AG02 | Carvedilol |
| QC07B | Betablokkere og thiazider |
| QC07BB12 | Nebivolol og thiazider |
| QC07C | Betablokkere og andre diuretika |
| QC07D | Beta-blokkere, thiazider og andre diuretika |
| QC07E | Beta-blokkere og vasodilatorer |
| QC07F | Beta-blokkere, andre kombinationer |
| QC07FB | Beta-blokerende midler og calciumantagonister |
| QC07FB02 | Metoprolol og felodipin |
| QC07FB03 | Atenolol og nifedipin |
| QC07FB07 | Bisoprolol og amlodipin |
| QC07FB12 | Nevibolol og amlodipin |
| QC07FB13 | Metoprolol og amlodipin |
| QC07FX | Beta-blokerende midler, andre kombinationer |
| QC07FX01 | Propranolol og andre kombinationer |
| QC07FX02 | Sotalol og acetylsalicylsyre |
| QC07FX03 | Metoprolol og acetylsalicylsyre |
| QC07FX04 | Bisoprolol og acetylsalicylsyre |
| QC07FX05 | Metoprolol og ivabradin |
| QC07FX06 | Carvedilol og ivabradin |
| QC08 | Calciumantagonister |
| QC08C | Selektive calciumantagonister m. overv. vaskulær effekt |
| QC08CA | Dihydropyridin-derivater |
| QC08CA01 | Amlodipin |
| QC08CA02 | Felodipin |
| QC08CA03 | Isradipin |
| QC08CA04 | Nicardipin |
| QC08CA05 | Nifedipin |
| QC08CA06 | Nimodipin |
| QC08CA07 | Nisoldipin |
| QC08CA08 | Nitrendipin |
| QC08CA09 | Lacidipin |
| QC08CA10 | Nilvadipin |
| QC08CA11 | Manidipin |
| QC08CA12 | Barnidipin |
| QC08CA13 | Lercanidipin |
| QC08CA14 | Cilnidipin |
| QC08CA15 | Benidipin |
| QC08CA16 | Clevidipin |
| QC08CA17 | Levamlodipin |
| QC08CA51 | Amlodipin og celecoxib |
| QC08CA55 | Nifedipin, kombinationer |
| QC08CX | Andre selekt. calciumantagonister m.overv. vaskulær effekt |
| QC08CX01 | Mibefradil |
| QC08D | Selektive calciumantagonister m. direkte cardiel effekt |
| QC08DA | Phenylalkylamin-derivater |
| QC08DA01 | Verapamil |
| QC08DA02 | Gallopamil |
| QC08DA03 | Etripamil |
| QC08DA51 | Verapamil, kombinationer |
| QC08DB | Benzothiazepin-derivater |
| QC08DB01 | Dilthiazem |
| QC08E | Non-selektive calciumantagonister |
| QC08EA | Phenylalkylamin-derivater |
| QC08EA01 | Fendilin |
| QC08EA02 | Bepridil |
| QC08EX | Andre non-selektive calciumantagonister |
| QC08EX01 | Lidoflazin |
| QC08EX02 | Perhexilin |
| QC08G | Calciumantagonister og diuretika |
| QC08GA | Calciumantagonister og diuretika |
| QC08GA01 | Nifedipin og diuretika |
| QC08GA02 | Amlodipin og diuretika |
| QC09 | Midler med virkn. på renin-angiotensin-systemet |
| QC09A | Ace-hæmmere, usammensatte |
| QC09AA | Ace-hæmmere, usammensatte |
| QC09AA01 | Captopril |
| QC09AA02 | Enalapril |
| QC09AA03 | Lisinopril |
| QC09AA04 | Perindopril |
| QC09AA05 | Ramipril |
| QC09AA06 | Quinapril |
| QC09AA07 | Benazepril |
| QC09AA08 | Cilazapril |
| QC09AA09 | Fosinopril |
| QC09AA10 | Trandolapril |
| QC09AA11 | Spirapril |
| QC09AA12 | Delapril |
| QC09AA13 | Moexipril |
| QC09AA14 | Temocapril |
| QC09AA15 | Zofenopril |
| QC09AA16 | Imidapril |
| QC09B | Ace-hæmmere, komb. |
| QC09BA | Ace-hæmmere og diuretika |
| QC09BA01 | Captopril og diuretika |
| QC09BA02 | Enalapril og diuretika |
| QC09BA03 | Lisinopril og diuretika |
| QC09BA04 | Perindopril og diuretika |
| QC09BA05 | Ramipril og diuretika |
| QC09BA06 | Quinapril og diuretika |
| QC09BA07 | Benazepril og diuretika |
| QC09BA08 | Cilazapril og diuretika |
| QC09BA09 | Fosinopril og diuretika |
| QC09BA12 | Delapril og diuretika |
| QC09BA13 | Moexipril og diuretika |
| QC09BA15 | Zofenopril og diuretika |
| QC09BB | Ace-hæmmere og calciumantagonister |
| QC09BB02 | Enalapril og lercanidipin |
| QC09BB03 | Lisinopril og amlodipin |
| QC09BB04 | Perindopril og amlodipin |
| QC09BB05 | Ramipril og felodipin |
| QC09BB06 | Enalapril og nitrendipin |
| QC09BB07 | Ramipril og amlodipin |
| QC09BB10 | Trandolapril og verapamil |
| QC09BB12 | Delapril og manidipin |
| QC09BB13 | Benazepril og amlodipin |
| QC09BX | Ace inhibitorer, andre kombinationer |
| QC09BX01 | Perindopril, amlodipin og indapamid |
| QC09BX02 | Perindopril og bisoprolol |
| QC09BX03 | Ramipril, amlodipin og hydrochlorothiazid |
| QC09BX04 | Perindopril, bisoprolol og amlodipin |
| QC09BX05 | Ramipril og bisoprolol |
| QC09BX06 | Perindopril, bisoprolol, amlodipin og indapamid |
| QC09BX07 | Zofenopril og nebivolol |
| QC09BX90 | Benazepril og pimobendan |
| QC09C | Angiotensin ii receptor blokkere (arbs), usammensatte |
| QC09CA | Angiotensin ii receptor blokkere (arbs), usammensatte |
| QC09CA01 | Losartan |
| QC09CA02 | Eprosartan |
| QC09CA03 | Valsartan |
| QC09CA04 | Irbesartan |
| QC09CA05 | Tasosartan |
| QC09CA06 | Candesartan |
| QC09CA07 | Telmisartan |
| QC09CA08 | Olmesartanmedoxomil |
| QC09CA09 | Azilsartan medoxomil |
| QC09CA10 | Fimasartan |
| QC09D | Angiotensin ii receptor blokkere (arbs), kombinationer |
| QC09DA | Angiotensin ii receptor blokkere (arbs) og diuretika |
| QC09DA01 | Losartan og diuretika |
| QC09DA02 | Eprosartan og diuretika |
| QC09DA03 | Valsartan og diuretika |
| QC09DA04 | Irbesartan og diuretika |
| QC09DA06 | Candesartan og diuretika |
| QC09DA07 | Telmisartan og diuretika |
| QC09DA08 | Olmesartanmedoxomil og diuretika |
| QC09DA09 | Azilsartan medoxomil og diuretika |
| QC09DA10 | Fimasartan og diuretika |
| QC09DB | Angiotensin ii receptor blokkere (arbs) og calciumantagonister (ccb) |
| QC09DB01 | Valsartan og amlodipin |
| QC09DB02 | Olmesartanmedoxomil og amlodipin |
| QC09DB04 | Telmisartan og amlodipin |
| QC09DB05 | Irbesartan og amlodipin |
| QC09DB06 | Losartan og amlodipin |
| QC09DB07 | Candesartan og amlodipin |
| QC09DB08 | Valsartan og lercanidipin |
| QC09DB09 | Fimasartan og amlodipin |
| QC09DX | Angiotensin ii receptor blokkere (arbs), andre kombinationer |
| QC09DX01 | Valsartan, amlodipin og hydrochlorthiazid |
| QC09DX02 | Valsartan og aliskiren |
| QC09DX03 | Olmesartan medoxomil, amlodipin og hydrochlorthiazid |
| QC09DX04 | Valsartan og sacubitril |
| QC09DX05 | Valsartan og nebivolol |
| QC09DX06 | Candesartan, amlodipin og hydrochlorothiazid |
| QC09DX07 | Irbesartan, amlodipin og hydrochlorthiazid |
| QC09DX08 | Telmisartan, amlodipin og hydrochlorthiazid |
| QC09X | Andre midler med virkning på renin-angiotensin-systemet |
| QC09XA | Renin-inhibitorer |
| QC09XA01 | Remikiren |
| QC09XA02 | Aliskiren |
| QC09XA52 | Aliskiren og hydrochlorthiazid |
| QC09XA53 | Aliskiren og amlodipin |
| QC09XA54 | Aliskiren, amlodipin og hydrochlorthiazid |
| QC09XX | Andre midler med virkning på renin-angiotensin systemet |
| QC09XX01 | Sparsentan |
| QC10 | Lipid-modificerende midler |
| QC10A | Lipid-modificerende midler, usammensatte |
| QC10AA | Hmg coa-reduktase-hæmmere |
| QC10AA01 | Simvastatin |
| QC10AA02 | Lovastatin |
| QC10AA03 | Pravastatin |
| QC10AA04 | Fluvastatin |
| QC10AA05 | Atorvastatin |
| QC10AA06 | Cerivastatin |
| QC10AA07 | Rosuvastatin |
| QC10AA08 | Pitavastatin |
| QC10AB | Fibrater |
| QC10AB01 | Clofibrat |
| QC10AB02 | Bezafibrat |
| QC10AB03 | Aluminiumclofibrat |
| QC10AB04 | Gemfibrozil |
| QC10AB05 | Fenofibrat |
| QC10AB06 | Simfibrat |
| QC10AB07 | Ronifibrat |
| QC10AB08 | Ciprofibrat |
| QC10AB09 | Etofibrat |
| QC10AB10 | Clofibrid |
| QC10AB11 | Cholinfenofibrat |
| QC10AB12 | Pemafibrat |
| QC10AC | Galdesyrebindende midler |
| QC10AC01 | Colestyramin |
| QC10AC02 | Colestipol |
| QC10AC03 | Colextran |
| QC10AC04 | Colesevelam |
| QC10AD | Nicotinsyre og derivater |
| QC10AD01 | Niceritrol |
| QC10AD02 | Nicotinsyre |
| QC10AD03 | Nicofuranose |
| QC10AD04 | Aluminiumnicotinat |
| QC10AD05 | Nicotinylalkohol (pyridylcarbinol) |
| QC10AD06 | Acipimox |
| QC10AD52 | Nicotinsyre, kombinationer |
| QC10AX | Andre lipid-modificerende midler |
| QC10AX01 | Dextrothyroxin |
| QC10AX02 | Probucol |
| QC10AX03 | Tiadenol |
| QC10AX05 | Meglutol |
| QC10AX06 | Omega-3-triglycerider inkl. andre estre og syrer |
| QC10AX07 | Magnesiumpyridoxal 5-phosphatglutamat |
| QC10AX08 | Policosanol |
| QC10AX09 | Ezetimib |
| QC10AX10 | Alipogen tiparvovec |
| QC10AX11 | Mipomersen |
| QC10AX12 | Lomitapid |
| QC10AX13 | Evolocumab |
| QC10AX14 | Alirocumab |
| QC10AX15 | Bempedoinsyre |
| QC10AX16 | Inclisiran |
| QC10AX17 | Evinacumab |
| QC10AX18 | Volanesorsen |
| QC10B | Lipid-modificerende midler, komb. |
| QC10BA | Lipid-modificerende midler, kombinationer |
| QC10BA01 | Lovastatin og nicotinsyre |
| QC10BA02 | Simvastatin og ezetimib |
| QC10BA03 | Pravastatin og fenofibrat |
| QC10BA04 | Simvastatin og fenofibrat |
| QC10BA05 | Atorvastatin og ezetimib |
| QC10BA06 | Rosuvastatin og ezetimib |
| QC10BA07 | Rosuvastatin og omega-3-fedtsyrer |
| QC10BA08 | Atorvastatin og omega-3-fedtsyrer |
| QC10BA09 | Rosuvastatin og fenofibrat |
| QC10BA10 | Bempedoinsyre og ezetimib |
| QC10BA11 | Pravastatin og ezetimib |
| QC10BA12 | Pravastatin, ezetimib og fenofibrat |
| QC10BA13 | Pitavastatin og ezetimib |
| QC10BX | Lipid-modificerende midler i kombination med andre lægemidler |
| QC10BX01 | Simvastatin og acetylsalicylsyre |
| QC10BX02 | Pravastatin og acetylsalicylsyre |
| QC10BX03 | Atorvastatin og amlodipin |
| QC10BX04 | Simvastatin, acetylsalicylsyre og ramipril |
| QC10BX05 | Rosuvastatin og acetylsalicylsyre |
| QC10BX06 | Atorvastatin, acetylsalicylsyre og ramipril |
| QC10BX07 | Rosuvastatin, amlodipin og lisinopril |
| QC10BX08 | Atorvastatin og acetylsalicylsyre |
| QC10BX09 | Rosuvastatin og amlodipin |
| QC10BX10 | Rosuvastatin og valsartan |
| QC10BX11 | Atorvastatin, amlodipin og perindopril |
| QC10BX12 | Atorvastatin, acetylsalicylsyre og perindopril |
| QC10BX13 | Rosuvastatin, perindopril og indapamid |
| QC10BX14 | Rosuvastatin, amlodipin og perindopril |
| QC10BX15 | Atorvastatin og perindopril |
| QC10BX16 | Rosuvastatin og fimasartan |
| QC10BX17 | Rosuvastatin og ramipril |
| QC10BX18 | Atorvastatin, amlodipin og ramipril |
| QC10BX19 | Atorvastatin, amlodipin og candesartan |
| QC10BX20 | Rosuvastatin og telmisartan |
| QC10BX21 | Rosuvastatin og perindopril |
| QC10BX22 | Rosuvastatin og nebivolol |
| QD | Dermatologica |
| QD01 | Fungicider til dermatologisk brug |
| QD01A | Fungicider til lokalt brug |
| QD01AA | Antibiotika |
| QD01AA01 | Nystatin |
| QD01AA02 | Natamycin |
| QD01AA03 | Hachimycin |
| QD01AA04 | Pecilocin |
| QD01AA06 | Mepartricin |
| QD01AA07 | Pyrrolnitrin |
| QD01AA08 | Griseofulvin |
| QD01AA20 | Antibiotika i kombination med kortikosteroider |
| QD01AC | Imidazol- og triazol-derivater |
| QD01AC01 | Clotrimazol |
| QD01AC02 | Miconazol |
| QD01AC03 | Econazol |
| QD01AC04 | Clomidazol |
| QD01AC05 | Isoconazol |
| QD01AC06 | Tiabendazol |
| QD01AC07 | Tioconazol |
| QD01AC08 | Ketoconazol |
| QD01AC09 | Sulconazol |
| QD01AC10 | Bifonazol |
| QD01AC11 | Oxiconazol |
| QD01AC12 | Fenticonazol |
| QD01AC13 | Omoconazol |
| QD01AC14 | Sertaconazol |
| QD01AC15 | Fluconazol |
| QD01AC16 | Flutrimazol |
| QD01AC17 | Eberconazol |
| QD01AC18 | Luliconazol |
| QD01AC19 | Efinaconazol |
| QD01AC20 | Imidazoler/triazoler i kombination med kortikosteroider |
| QD01AC21 | Neticonazol |
| QD01AC22 | Lanoconazol |
| QD01AC52 | Miconazol, komb. |
| QD01AC60 | Bifonazol, komb. |
| QD01AC90 | Enilconazol |
| QD01AE | Andre fungicider til lokalt brug |
| QD01AE01 | Bromchlorsalicylanilid |
| QD01AE02 | Methylrosanilin |
| QD01AE03 | Tribrommetacresol |
| QD01AE04 | Undecylensyre |
| QD01AE05 | Polynoxylin |
| QD01AE06 | Chlorphenoxyethanol |
| QD01AE07 | Chlorphenesin |
| QD01AE08 | Ticlaton |
| QD01AE09 | Sulbentin |
| QD01AE10 | Ethylhydroxybenzoat |
| QD01AE11 | Haloprogin |
| QD01AE12 | Salicylsyre |
| QD01AE13 | Selensulfid |
| QD01AE14 | Ciclopirox |
| QD01AE15 | Terbinafin |
| QD01AE16 | Amorolfin |
| QD01AE17 | Dimazol |
| QD01AE18 | Tolnaftat |
| QD01AE19 | Tolciclat |
| QD01AE20 | Andre fungicider til lokalt brug, komb. |
| QD01AE21 | Flucytosin |
| QD01AE22 | Naftifin |
| QD01AE23 | Butenafin |
| QD01AE24 | Tavaborol |
| QD01AE25 | Liranaftat |
| QD01AE54 | Undecylensyre, komb. |
| QD01AE90 | Pereddikesyre |
| QD01AE91 | Bronopol |
| QD01AE92 | Bensuldazinsyre |
| QD01B | Fungicider til systemisk brug |
| QD01BA | Fungicider til systemisk brug |
| QD01BA01 | Griseofulvin |
| QD01BA02 | Terbinafin |
| QD01BA03 | Fosravuconazol |
| QD02 | Blødgørende og hudbeskyttende midler |
| QD02A | Blødgørende og hudbeskyttende midler |
| QD02AA | Siliconepræparater |
| QD02AB | Zinkoxid-præparater |
| QD02AC | Paraffinolie- og fedtholdige midler |
| QD02AD | Flydende plastre |
| QD02AE | Carbamid-præparater |
| QD02AE01 | Carbamid |
| QD02AE51 | Carbamid, komb. |
| QD02AF | Salicylsyre-præparater |
| QD02AX | Andre blødgørende og hudbeskyttende midler |
| QD02B | Midler til beskyttelse mod uv-stråling |
| QD02BA | Midler til beskyttelse mod uv-stråling, udvortes |
| QD02BA01 | Aminobenzoesyre |
| QD02BA02 | Octylmethoxycinnamat |
| QD02BB | Midler til beskyttelse mod uv-stråling, systemisk |
| QD02BB01 | Betacaroten |
| QD02BB02 | Afamelanotid |
| QD03 | Midler til sårbehandling |
| QD03A | Sårhelende midler |
| QD03AA | Levertranssalver |
| QD03AX | Andre sårhelende midler |
| QD03AX01 | Cadexomer iod |
| QD03AX02 | Dextranomer |
| QD03AX03 | Dexpanthenol |
| QD03AX04 | Calciumpantothenat |
| QD03AX05 | Hyaluronsyre |
| QD03AX06 | Becaplermin |
| QD03AX07 | Glyceryltrinitrat |
| QD03AX08 | Isosorbiddinitrat |
| QD03AX09 | Crilanomer |
| QD03AX10 | Enoxolon |
| QD03AX11 | Natriumchlorit |
| QD03AX12 | Trolamin |
| QD03AX13 | Birkebark |
| QD03AX14 | Asiatisk centellaurt, inkl. kombinationer |
| QD03AX15 | Trafermin |
| QD03AX16 | Beremagen geperpavec |
| QD03AX90 | Ketanserin |
| QD03B | Enzymer |
| QD03BA | Proteolytiske enzymer |
| QD03BA01 | Trypsin |
| QD03BA02 | Collagenase |
| QD03BA52 | Collagenase, kombinationer |
| QD04 | Kløestillende midler, incl. antihistaminer, anæstetika, etc. |
| QD04A | Kløestillende midler, incl. antihistaminer, anæstetika, etc. |
| QD04AA | Antihistaminer til udvortes brug |
| QD04AA01 | Thonzylamin |
| QD04AA02 | Mepyramin |
| QD04AA03 | Thenalidin |
| QD04AA04 | Tripelennamin |
| QD04AA09 | Chlorpyramin |
| QD04AA10 | Promethazin |
| QD04AA12 | Tolpropamin |
| QD04AA13 | Dimetinden |
| QD04AA14 | Clemastin |
| QD04AA15 | Bamipin |
| QD04AA16 | Pheniramin |
| QD04AA22 | Isothipendyl |
| QD04AA32 | Diphenhydramin |
| QD04AA33 | Diphenhydraminmethylbromid |
| QD04AA34 | Chlorphenoxamin |
| QD04AB | Anæstetika til udvortes brug |
| QD04AB01 | Lidocain |
| QD04AB02 | Cinchocain |
| QD04AB03 | Oxybuprocain |
| QD04AB04 | Benzocain |
| QD04AB05 | Quinisocain |
| QD04AB06 | Tetracain |
| QD04AB07 | Pramocain |
| QD04AB51 | Lidocain, kombinationer |
| QD04AX | Andre kløestillende midler |
| QD04AX01 | Doxepin |
| QD05 | Midler mod keratoseborrheiske forstyrrelser |
| QD05A | Midler mod keratoseborrheiske forstyrrelser, lokalt brug |
| QD05AA | Tjæreholdige præparater |
| QD05AC | Antracen-derivater |
| QD05AC01 | Dithranol |
| QD05AC51 | Dithranol, kombinationer |
| QD05AD | Psoralener til udvortes brug |
| QD05AD01 | Trioxysalen, udvortes |
| QD05AD02 | Methoxalen, udvortes |
| QD05AX | Andre midler mod keratoseborrheiske forstyrrelser, lokalt brug |
| QD05AX01 | Fumarsyre |
| QD05AX02 | Calcipotriol |
| QD05AX03 | Calcitriol |
| QD05AX04 | Tacalcitol |
| QD05AX05 | Tazaroten |
| QD05AX06 | Roflumilast |
| QD05AX07 | Tapinarof |
| QD05AX52 | Calcipotriol, comb. |
| QD05AX55 | Tazaroten og ulobetasol |
| QD05B | Midler mod keratoseborrheiske forstyrrelser, systemisk brug |
| QD05BA | Psoralener til systemisk brug |
| QD05BA01 | Trioxysalen, systemisk |
| QD05BA02 | Methoxalen, systemisk |
| QD05BA03 | Bergapten |
| QD05BB | Retinoider til psoriasisbehandling |
| QD05BB01 | Etretinat |
| QD05BB02 | Acitretin |
| QD05BX | Andre midler mod psoriasis til systemisk brug |
| QD05BX51 | Fumarsyre-derivater, komb. |
| QD06 | Antibiotika og kemoterapeutika til dermatologisk brug |
| QD06A | Antibiotika til lokalt brug |
| QD06AA | Tetracyclin og derivater |
| QD06AA01 | Demeclocyclin |
| QD06AA02 | Chlortetracyclin |
| QD06AA03 | Oxytetracyclin |
| QD06AA04 | Tetracyclin |
| QD06AA52 | Chlortetracyclin, komb. |
| QD06AA53 | Oxytetracyclin, kombinationer |
| QD06AA54 | Tetracyclin, kombinationer |
| QD06AX | Andre antibiotika til lokalt brug |
| QD06AX01 | Fusidinsyre |
| QD06AX02 | Chloramphenicol |
| QD06AX04 | Neomycin |
| QD06AX05 | Bacitracin |
| QD06AX07 | Gentamicin |
| QD06AX08 | Tyrothricin |
| QD06AX09 | Mupiprocin |
| QD06AX10 | Virginiamycin |
| QD06AX11 | Rifaximin |
| QD06AX12 | Amikacin |
| QD06AX13 | Retapamulin |
| QD06AX14 | Ozenoxacin |
| QD06AX15 | Rifamycin |
| QD06AX99 | Andre antibiotika til lokalt brug, komb. |
| QD06B | Kemoterapeutika til lokalt brug |
| QD06BA | Sulfonamider |
| QD06BA01 | Sølvsulfadiazin |
| QD06BA02 | Sulfathiazol |
| QD06BA03 | Mafenid |
| QD06BA04 | Sulfamethizol |
| QD06BA05 | Sulfanilamid |
| QD06BA06 | Sulfamerazin |
| QD06BA30 | Komb. af kemoterapeutika til lokalt brug |
| QD06BA51 | Sølv-sulfadiazin, komb. |
| QD06BA53 | Mafenid, komb. |
| QD06BA90 | Formosulfathiazol |
| QD06BA99 | Sulfonamider, komb. |
| QD06BB | Antivirale midler |
| QD06BB01 | Idoxuridin |
| QD06BB02 | Tromantadin |
| QD06BB03 | Aciclovir |
| QD06BB04 | Podophyllotoxin |
| QD06BB05 | Inosin |
| QD06BB06 | Penciclovir |
| QD06BB07 | Lysozym |
| QD06BB08 | Ibacitabin |
| QD06BB09 | Edoxudin |
| QD06BB10 | Imiquimod |
| QD06BB11 | Docosanol |
| QD06BB12 | Sinecatechins |
| QD06BB53 | Aciclovir, kombinationer |
| QD06BX | Andre kemoterapeutika |
| QD06BX01 | Metronidazol |
| QD06BX02 | Ingenolmebutat |
| QD06BX03 | Tirbanibulin |
| QD06C | Antibiotika og kemoterapeutika, komb. |
| QD07 | Kortikosteroider, dermatologiske præparater |
| QD07A | Kortikosteroider, usammensatte |
| QD07AA | Kortikosteroider, svage (gruppe i) |
| QD07AA01 | Methylprednisolon |
| QD07AA02 | Hydrocortison |
| QD07AA03 | Prednisolon |
| QD07AB | Kortikosteroider, middelstærke (gruppe ii) |
| QD07AB01 | Clobetason |
| QD07AB02 | Hydrocortisonbutyrat |
| QD07AB03 | Flumetason |
| QD07AB04 | Fluocortin |
| QD07AB05 | Fluperolon |
| QD07AB06 | Fluormetholon |
| QD07AB07 | Flupredniden |
| QD07AB08 | Desonid |
| QD07AB09 | Triamcinolon |
| QD07AB10 | Alclometason |
| QD07AB11 | Hydrocortisonbuteprat |
| QD07AB19 | Dexamethason |
| QD07AB21 | Clocortolon |
| QD07AB30 | Kortikosteroider i komb. |
| QD07AC | Kortikosteroider, stærke (gruppe iii) |
| QD07AC01 | Betamethason |
| QD07AC02 | Fluclorolon |
| QD07AC03 | Desoximetason |
| QD07AC04 | Fluocinolonacetonid |
| QD07AC05 | Fluocortolon |
| QD07AC06 | Diflucortolon |
| QD07AC07 | Fludroxycortid |
| QD07AC08 | Fluocinonid |
| QD07AC09 | Budesonid |
| QD07AC10 | Diflorason |
| QD07AC11 | Amcinonid |
| QD07AC12 | Halometason |
| QD07AC13 | Mometason |
| QD07AC14 | Methylprednisolonaceponat |
| QD07AC15 | Beclometason |
| QD07AC16 | Hydrocortisonaceponat |
| QD07AC17 | Fluticason |
| QD07AC18 | Prednicarbat |
| QD07AC19 | Difluprednat |
| QD07AC21 | Ulobetasol |
| QD07AC90 | Resocortolbutyrat |
| QD07AD | Kortikosteroider, meget stærke (gruppe iv) |
| QD07AD01 | Clobetasol |
| QD07AD02 | Halcinonid |
| QD07B | Kortikosteroider, komb. med antiseptika |
| QD07BA | Kortikosteroider, svage, komb. med antiseptika |
| QD07BA01 | Prednisolon og antiseptika |
| QD07BA04 | Hydrocortison og antiseptika |
| QD07BB | Kortikosteroider, middelstærke, komb. med antiseptika |
| QD07BB01 | Flumetason og antiseptika |
| QD07BB02 | Desonid og antiseptika |
| QD07BB03 | Triamcinolon og antiseptika |
| QD07BB04 | Hydrocortisonbutyrat og antiseptika |
| QD07BC | Kortikosteroider, stærke, komb. med antiseptika |
| QD07BC01 | Betamethason og antiseptika |
| QD07BC02 | Fluocinolon og antiseptika |
| QD07BC03 | Fluocortolon og antiseptika |
| QD07BC04 | Diflucortolon og antiseptika |
| QD07BD | Kortikosteroider, meget stærke, komb. med antiseptika |
| QD07C | Kortikosteroider, komb. med antibiotika |
| QD07CA | Kortikosteroider, svage, komb. med antibiotika |
| QD07CA01 | Hydrocortison og antibiotika |
| QD07CA02 | Methylprednisolon og antibiotika |
| QD07CA03 | Prednisolon og antibiotika |
| QD07CB | Kortikosteroider, middelstærke, komb. med antibiotika |
| QD07CB01 | Triamcinolon og antibiotika |
| QD07CB02 | Flupredniden og antibiotika |
| QD07CB03 | Fluormetholon og antibiotika |
| QD07CB04 | Dexamethason og antibiotika |
| QD07CB05 | Flumethason og antibiotika |
| QD07CC | Kortikosteroider, stærke, komb. med antibiotika |
| QD07CC01 | Betamethason og antibiotika |
| QD07CC02 | Fluocinolonacetonid og antibiotika |
| QD07CC03 | Fludroxycortid og antibiotika |
| QD07CC04 | Beclometason og antibiotika |
| QD07CC05 | Fluocinonid og antibiotika |
| QD07CC06 | Fluocortolon og antibiotika |
| QD07CD | Kortikosteroider, meget stærke, komb. med antibiotika |
| QD07CD01 | Clobetasol og antibiotika |
| QD07X | Kortikosteroider, andre komb. |
| QD07XA | Kortikosteroider, svage, andre komb. |
| QD07XA01 | Hydrocortison |
| QD07XA02 | Prednisolon |
| QD07XB | Kortikosteroider, middelstærke, andre komb. |
| QD07XB01 | Flumetason |
| QD07XB02 | Triamcinolon |
| QD07XB03 | Flupredniden |
| QD07XB04 | Fluormetholon |
| QD07XB05 | Dexamethason |
| QD07XB30 | Kortikosteroider i komb. |
| QD07XC | Kortikosteroider, stærke, andre komb. |
| QD07XC01 | Betamethason |
| QD07XC02 | Desoximetason |
| QD07XC03 | Mometason |
| QD07XC04 | Diflucortolon |
| QD07XC05 | Fluocortolon |
| QD07XD | Kortikosteroider, meget stærke, andre komb. |
| QD08 | Antiseptika og disinfektanter |
| QD08A | Antiseptika og disinfektanter |
| QD08AA | Acridin-derivater |
| QD08AA01 | Ethacridinlactat |
| QD08AA02 | Aminoacridin |
| QD08AA03 | Euflavin |
| QD08AA99 | Acridin-derivater, kombinationer |
| QD08AB | Aluminiumforbindelser |
| QD08AC | Biguanider og amidiner |
| QD08AC01 | Dibrompropamidin |
| QD08AC02 | Chlorhexidin |
| QD08AC03 | Propamidin |
| QD08AC04 | Hexamidin |
| QD08AC05 | Polihexanid |
| QD08AC52 | Chlorhexidin, komb. |
| QD08AC54 | Hexamidin, kombinationer |
| QD08AD | Borsyreholdige midler |
| QD08AE | Phenol og derivater |
| QD08AE01 | Hexachlorophen |
| QD08AE02 | Metacresolsulfonsyre-formaldehyd |
| QD08AE03 | Phenol |
| QD08AE04 | Triclosan |
| QD08AE05 | Chlorxylenol |
| QD08AE06 | Biphenylol |
| QD08AE99 | Phenol og derivater, komb. |
| QD08AF | Furan-derivater |
| QD08AF01 | Nitrofural |
| QD08AG | Iod-produkter |
| QD08AG01 | Iod/octylphenoxy-polyglycolether |
| QD08AG02 | Povidone-iod |
| QD08AG03 | Iod |
| QD08AG04 | Diiodohydroxypropan |
| QD08AG53 | Iod, kombinationer |
| QD08AH | Quinolin-derivater |
| QD08AH01 | Dequalin |
| QD08AH02 | Chlorquinaldol |
| QD08AH03 | Oxyquinolin |
| QD08AH30 | Clioquinol |
| QD08AJ | Kvarternære ammoniumforbindelser |
| QD08AJ01 | Benzalkon |
| QD08AJ02 | Cetrimon |
| QD08AJ03 | Cetylpyridinium |
| QD08AJ04 | Cetrimid |
| QD08AJ05 | Benzoxoniumchlorid |
| QD08AJ06 | Didecyldimethylammoniumchlorid |
| QD08AJ08 | Benzethoniumchlorid |
| QD08AJ10 | Decamethoxin |
| QD08AJ57 | Octenidin, komb. |
| QD08AJ58 | Benzetoniumchlorid, komb. |
| QD08AJ59 | Dodecloniumbromid, komb. |
| QD08AJ90 | Benzoniumchlorid |
| QD08AK | Kviksølv-forbindelser |
| QD08AK01 | Mercuriamidchlorid |
| QD08AK02 | Phenylmercuriborat |
| QD08AK03 | Mercurichlorid |
| QD08AK04 | Merbromin |
| QD08AK05 | Kviksølv, metallisk |
| QD08AK06 | Thiomersal |
| QD08AK30 | Mercuriiodid |
| QD08AK52 | Phenylmercuriborat, kombinationer |
| QD08AL | Sølv-forbindelser |
| QD08AL01 | Sølvnitrat |
| QD08AL30 | Sølv |
| QD08AX | Andre antiseptika og desinfektanter |
| QD08AX01 | Hydrogenperoxid |
| QD08AX02 | Eosin |
| QD08AX03 | Propanol |
| QD08AX04 | Tosylchloramidnatrium |
| QD08AX05 | Isopropanol |
| QD08AX06 | Kaliumpermanganat |
| QD08AX07 | Natriumhypochlorit |
| QD08AX08 | Ethanol |
| QD08AX53 | Propanol, komb. |
| QD09 | Medicinske forbindinger |
| QD09A | Medicinske forbindinger |
| QD09AA | Salve-forbindinger med antiinfektiva |
| QD09AA01 | Framycetin |
| QD09AA02 | Fusidinsyre |
| QD09AA03 | Nitrofural |
| QD09AA04 | Phenylmercurinitrat |
| QD09AA05 | Benzododecinium |
| QD09AA06 | Triclosan |
| QD09AA07 | Cetylpyridinium |
| QD09AA08 | Aluminiumchlorhydrat |
| QD09AA09 | Povidone-iod |
| QD09AA10 | Clioquinol |
| QD09AA11 | Benzalkonium |
| QD09AA12 | Chlorhexidin |
| QD09AA13 | Iodoform |
| QD09AB | Zink-bandager |
| QD09AB01 | Zinkbandage uden supplerende stoffer |
| QD09AB02 | Zinkbandage med supplerende stoffer |
| QD09AX | Paraffinolieholdige forbindinger |
| QD10 | Midler mod acne |
| QD10A | Midler mod acne til udvortes brug |
| QD10AA | Kortikosteroider, komb. til acnebehandling |
| QD10AA01 | Fluorometholon |
| QD10AA02 | Methylprednisolon |
| QD10AA03 | Dexamethason |
| QD10AB | Svovlholdige acne-midler |
| QD10AB01 | Bithionol |
| QD10AB02 | Svovl |
| QD10AB03 | Tioxolon |
| QD10AB05 | Mesulfen |
| QD10AD | Retinoider til udvortes brug mod acne |
| QD10AD01 | Tretinoin |
| QD10AD02 | Retinol |
| QD10AD03 | Adapalen |
| QD10AD04 | Isotretinoin |
| QD10AD05 | Motretinid |
| QD10AD06 | Trifaroten |
| QD10AD51 | Tretinoin, komb. |
| QD10AD53 | Adapalen, kombinationer |
| QD10AD54 | Isotretinoin, komb. |
| QD10AE | Peroxider |
| QD10AE01 | Benzoylperoxid |
| QD10AE51 | Benzoylperoxid, komb. |
| QD10AF | Antiinfektiva til acne-behandling |
| QD10AF01 | Clindamycin |
| QD10AF02 | Erythromycin |
| QD10AF03 | Chloramphenicol |
| QD10AF04 | Meclocyclin |
| QD10AF05 | Nadifloxacin |
| QD10AF06 | Sulfacetamid |
| QD10AF07 | Minocyclin |
| QD10AF51 | Clindamycin, komb. |
| QD10AF52 | Erythromycin, kombinationer |
| QD10AX | Andre midler mod acne til udvortes brug |
| QD10AX01 | Aluminiumchlorid |
| QD10AX02 | Resorcinol |
| QD10AX03 | Azelainsyre |
| QD10AX04 | Aluminiumoxid |
| QD10AX05 | Dapson |
| QD10AX06 | Clascoteron |
| QD10AX30 | Diverse kombinationer |
| QD10B | Midler mod acne til systemisk brug |
| QD10BA | Retinoider til behandling af acne |
| QD10BA01 | Isotretinoin |
| QD10BX | Andre midler mod acne til systemisk brug |
| QD10BX01 | Ichthammol |
| QD11 | Andre dermatologiske præparater |
| QD11A | Andre dermatologiske præparater |
| QD11AA | Antihidrotica |
| QD11AA01 | Glycopyrronium |
| QD11AC | Medicinsk shampoo |
| QD11AC01 | Cetrimid |
| QD11AC02 | Cadmium-forbindelser |
| QD11AC03 | Selen-forbindelser |
| QD11AC06 | Povidone-iod |
| QD11AC08 | Svovl-forbindelser |
| QD11AC09 | Xenysalat |
| QD11AC30 | Andre medicinske shampooer |
| QD11AE | Androgener til lokalt brug |
| QD11AE01 | Metandienon |
| QD11AF | Midler mod vorter og ligtorne |
| QD11AH | Midler til dermatitis, ekskl. kortikosteroider |
| QD11AH01 | Tacrolimus |
| QD11AH02 | Pimecrolimus |
| QD11AH03 | Cromoglicinsyre |
| QD11AH04 | Alitretinoin |
| QD11AH05 | Dupilumab |
| QD11AH06 | Crisaborol |
| QD11AH07 | Tralokinumab |
| QD11AH08 | Abrocitinib |
| QD11AH09 | Ruxolitinib |
| QD11AH10 | Lebrikizumab |
| QD11AH11 | Delgocitinib |
| QD11AH12 | Nemolizumab |
| QD11AH90 | Oclacitinib |
| QD11AH91 | Lokivetmab |
| QD11AH92 | Ilunocitinib |
| QD11AH93 | Atinvicitinib |
| QD11AX | Andre dermatologiske præparater |
| QD11AX01 | Minoxidil |
| QD11AX02 | Gamolensyre |
| QD11AX03 | Calciumgluconat |
| QD11AX04 | Lithiumsuccinat |
| QD11AX05 | Magnesiumsulfat |
| QD11AX06 | Mequinol |
| QD11AX08 | Tiratricol |
| QD11AX09 | Oxaceprol |
| QD11AX10 | Finasterid |
| QD11AX11 | Hydroquinon |
| QD11AX12 | Zinkpyrithion |
| QD11AX13 | Monobenzon |
| QD11AX14 | Tacrolimus |
| QD11AX16 | Eflornithin |
| QD11AX17 | Cromoglicinsyre |
| QD11AX18 | Diclofenac |
| QD11AX21 | Brimonidin |
| QD11AX22 | Ivermectin |
| QD11AX23 | Aminobenzoatkalium |
| QD11AX24 | Deoxycholsyre |
| QD11AX25 | Hydrogenperoxid |
| QD11AX26 | Caffein |
| QD11AX27 | Oxymetazolin |
| QD11AX52 | Gamolensyre, komb. |
| QD11AX57 | Collagen, komb. |
| QD11AX90 | Benzylperoxid |
| QD51 | Midler til behandling af kløer og hove |
| QG | Urogenitalsystem og kønshormoner |
| QG01 | Gynækologiske antiinfektiva og antiseptika |
| QG01A | Antiinfektiva/antiseptika, excl. komb. med kortikosteroider |
| QG01AA | Antibiotika |
| QG01AA01 | Nystatin |
| QG01AA02 | Natamycin |
| QG01AA03 | Amphotericin |
| QG01AA04 | Candicidin |
| QG01AA05 | Chloramphenicol |
| QG01AA06 | Hachimycin |
| QG01AA07 | Oxytetracyclin |
| QG01AA08 | Carfecillin |
| QG01AA09 | Mepartricin |
| QG01AA10 | Clindamycin |
| QG01AA11 | Pentamycin |
| QG01AA51 | Nystatin, komb. |
| QG01AA55 | Chloramphenicol, komb. |
| QG01AA90 | Tetracyclin |
| QG01AA91 | Gentamicin |
| QG01AA99 | Antibiotika, kombinationer |
| QG01AB | Arsen-forbindelser |
| QG01AB01 | Acetarsol |
| QG01AC | Quinolin-derivater |
| QG01AC01 | Diiodhydroxyquinolin |
| QG01AC02 | Clioquinol |
| QG01AC03 | Chlorquinaldol |
| QG01AC05 | Dequalin |
| QG01AC06 | Broxyquinolin |
| QG01AC30 | Oxyquinolin |
| QG01AC90 | Acriflaviniumchlorid |
| QG01AC99 | Kombinationer |
| QG01AD | Organiske syrer |
| QG01AD01 | Mælkesyre |
| QG01AD02 | Eddikesyre |
| QG01AD03 | Ascorbinsyre |
| QG01AE | Sulfonamider |
| QG01AE01 | Sulfatolamid |
| QG01AE10 | Sulfonamider i komb. |
| QG01AE99 | Sulfonamider, kombinationer |
| QG01AF | Imidazol-derivater |
| QG01AF01 | Metronidazol |
| QG01AF02 | Clotrimazol |
| QG01AF04 | Miconazol |
| QG01AF05 | Econazol |
| QG01AF06 | Ornidazol |
| QG01AF07 | Isoconazol |
| QG01AF08 | Tioconazol |
| QG01AF11 | Ketoconazol |
| QG01AF12 | Fenticonazol |
| QG01AF13 | Azanidazol |
| QG01AF14 | Propenidazol |
| QG01AF15 | Butoconazol |
| QG01AF16 | Omoconazol |
| QG01AF17 | Oxiconazol |
| QG01AF18 | Flutrimazol |
| QG01AF19 | Sertaconazol |
| QG01AF20 | Imidazol-derivater i komb. |
| QG01AF21 | Tinidazol |
| QG01AF55 | Econazol, kombinationer |
| QG01AG | Triazol-derivater |
| QG01AG02 | Terconazol |
| QG01AX | Andre antiinfektiva og antiseptika |
| QG01AX01 | Clodantoin |
| QG01AX02 | Inosin |
| QG01AX03 | Metacresolsulfonsyre/formaldehyd |
| QG01AX05 | Nifuratel |
| QG01AX06 | Furazolidon |
| QG01AX09 | Methylrosanilin |
| QG01AX11 | Povidone-iod |
| QG01AX12 | Ciclopirox |
| QG01AX13 | Protiofat |
| QG01AX14 | Lactobacillus |
| QG01AX15 | Kobberusnat |
| QG01AX16 | Hexetidin |
| QG01AX17 | Dapivirin |
| QG01AX66 | Octenidin, kombinationer |
| QG01AX90 | Nitrofural |
| QG01AX99 | Diverse antiinfektiva og antiseptika, komb. |
| QG01B | Antiinfektiva/antiseptika i komb. m. kortikosteroider |
| QG01BA | Antibiotika og kortikosteroider |
| QG01BC | Quinolin-derivater og kortikosteroider |
| QG01BD | Antiseptika og kortikosteroider |
| QG01BE | Sulfonamider og kortikosteroider |
| QG01BF | Imidazol-derivater og kortikosteroider |
| QG02 | Andre gynækologiske midler |
| QG02A | Oxytocica |
| QG02AB | Secale-alkaloider |
| QG02AB01 | Methylergometrin |
| QG02AB02 | Secale-alkaloider |
| QG02AB03 | Ergometrin |
| QG02AB53 | Ergometrin, komb. |
| QG02AC | Secale-alkaloider og oxytocin incl.derivater,komb. |
| QG02AC01 | Methylergometrin og oxytocin |
| QG02AC90 | Ergometrin og oxytocin |
| QG02AD | Prostaglandiner og analoger |
| QG02AD01 | Dinoprost |
| QG02AD02 | Dinoproston |
| QG02AD03 | Gemeprost |
| QG02AD04 | Carboprost |
| QG02AD05 | Sulproston |
| QG02AD06 | Misoprostol |
| QG02AD90 | Cloprostenol |
| QG02AD91 | Luprostiol |
| QG02AD92 | Fenprostalen |
| QG02AD93 | Tiaprost |
| QG02AD94 | Alfaprost |
| QG02AD95 | Etiproston |
| QG02AX | Andre oxytocica |
| QG02B | Antikonceptiva til lokalt brug |
| QG02BA | Intrauterine antikonceptionelle midler |
| QG02BA01 | Plast intrauterint indlæg |
| QG02BA02 | Plast intrauterint indlæg med kobber |
| QG02BA03 | Plast intrauterint indlæg med gestagen |
| QG02BB01 | Vaginalring med gestagen og østrogen |
| QG02BB02 | Vaginalring med gestagen |
| QG02C | Andre gynækologiske midler |
| QG02CA | Sympatomimetika, ve-dæmpende |
| QG02CA01 | Ritodrin |
| QG02CA02 | Buphenin |
| QG02CA03 | Fenoterol |
| QG02CA90 | Vetrabutin |
| QG02CA91 | Clenbuterol |
| QG02CB | Prolactin-inhibitorer |
| QG02CB01 | Bromocriptin |
| QG02CB02 | Lisurid |
| QG02CB03 | Cabergolin |
| QG02CB04 | Quinagolid |
| QG02CB05 | Metergolin |
| QG02CB06 | Tergurid |
| QG02CC | Antiinflammatorika til vaginalt brug |
| QG02CC01 | Ibuprofen |
| QG02CC02 | Naproxen |
| QG02CC03 | Benzydamin |
| QG02CC04 | Flunoxaprofen |
| QG02CX | Andre gynækologiske midler |
| QG02CX01 | Atosiban |
| QG02CX02 | Flibanserin |
| QG02CX03 | Kyskhedstræsfrugt |
| QG02CX04 | Sølvlys jordstængel |
| QG02CX05 | Bremelanotid |
| QG02CX06 | Fezolinetant |
| QG02CX90 | Denaverin |
| QG02CX91 | Lotrifen |
| QG03 | Kønshormoner og modulatorer af genitalsystemet |
| QG03A | Hormonale antikonceptiva til systemisk brug |
| QG03AA | Gestagener og østrogener, faste komb. |
| QG03AA01 | Etynodiol og estradiol |
| QG03AA02 | Quingestanol og ethinylestradiol |
| QG03AA03 | Lynestrenol og ethinylestradiol |
| QG03AA04 | Megestrol og ethinylestradiol |
| QG03AA05 | Norethisteron og ethinylestradiol |
| QG03AA06 | Norgestrel og ethinylestradiol |
| QG03AA07 | Levonorgestrel og ethinylestradiol |
| QG03AA08 | Medroxyprogesteron og ethinylestradiol |
| QG03AA09 | Desogestrel og ethinylestradiol |
| QG03AA10 | Gestoden og ethinylestradiol |
| QG03AA11 | Norgestimat og ethinylestradiol |
| QG03AA12 | Drospirenon og ethinylestradiol |
| QG03AA13 | Norelgestromin og ethinylestradiol |
| QG03AA14 | Nomegestrol og estradiol |
| QG03AA15 | Chlormadinon og ethinylestradiol |
| QG03AA16 | Dienogest og ethinylestradiol |
| QG03AA17 | Medroxyprogesteron og estradiol |
| QG03AA18 | Drospirenon og estetrol |
| QG03AB | Gestagener og østrogener, sekvenspræparater |
| QG03AB01 | Megestrol og ethinylestradiol |
| QG03AB02 | Lynestrenol og ethinylestradiol |
| QG03AB03 | Levonorgestrel og ethinylestradiol |
| QG03AB04 | Norethisteron og ethinylestradiol |
| QG03AB05 | Desogestrel og ethinylestradiol |
| QG03AB06 | Gestoden og ethinylestradiol |
| QG03AB07 | Chlormadinon og ethinylestradiol |
| QG03AB08 | Dienogest og estradiol |
| QG03AB09 | Norgestimat og ethinylestradiol |
| QG03AC | Gestagener |
| QG03AC01 | Norethisteron |
| QG03AC02 | Lynestrenol |
| QG03AC03 | Levonorgestrel |
| QG03AC04 | Quingestanol |
| QG03AC05 | Megestrol |
| QG03AC06 | Medroxyprogesteron |
| QG03AC07 | Norgestrienon |
| QG03AC08 | Etonogestrel |
| QG03AC09 | Desogestrel |
| QG03AC10 | Drospirenon |
| QG03AD | Nødprævention |
| QG03AD01 | Levonorgestrel |
| QG03AD02 | Ulipristal |
| QG03B | Androgener |
| QG03BA | 3-oxoandosten(4)-derivater |
| QG03BA01 | Fluoxymesteron |
| QG03BA02 | Methyltestosteron |
| QG03BA03 | Testosteron |
| QG03BB | 5-androstanon(3)-derivater |
| QG03BB01 | Mesterolon |
| QG03BB02 | Androstanolon |
| QG03C | Østrogener |
| QG03CA | Naturlige og semisyntetiske østrogener, usammensatte |
| QG03CA01 | Ethinylestradiol |
| QG03CA03 | Estradiol |
| QG03CA04 | Estriol |
| QG03CA06 | Chlortrianisen |
| QG03CA07 | Estron |
| QG03CA09 | Promestrien |
| QG03CA53 | Estradiol, komb. |
| QG03CA57 | Konjugerede østrogener |
| QG03CB | Syntetiske østrogener, usammensatte |
| QG03CB01 | Dienestrol |
| QG03CB02 | Diethylstilbestrol |
| QG03CB03 | Metallenestril |
| QG03CB04 | Moxestrol |
| QG03CC | Østrogener, kombinationer med andre stoffer |
| QG03CC02 | Dienestrol |
| QG03CC03 | Methallenestril |
| QG03CC04 | Estron |
| QG03CC05 | Diethylstilbestrol |
| QG03CC06 | Estriol |
| QG03CC07 | Konjugerede østrogener og bazedoxifen |
| QG03CX | Andre østrogener |
| QG03CX01 | Tibolon |
| QG03D | Gestagener |
| QG03DA | Pregnen (4) derivater |
| QG03DA01 | Gestonoron |
| QG03DA02 | Medroxyprogesteron |
| QG03DA03 | Hydroxyprogesteron |
| QG03DA04 | Progesteron |
| QG03DA90 | Proligeston |
| QG03DB | Pregnadien-derivater |
| QG03DB01 | Dydrogesteron |
| QG03DB02 | Megestrol |
| QG03DB03 | Medrogeston |
| QG03DB04 | Nomegestrol |
| QG03DB05 | Demegeston |
| QG03DB06 | Chlormadinon |
| QG03DB07 | Promegeston |
| QG03DB08 | Dienogest |
| QG03DB91 | Melengestrol |
| QG03DC | Estren-derivater |
| QG03DC01 | Allylestrenol |
| QG03DC02 | Norethisteron |
| QG03DC03 | Lynestrenol |
| QG03DC04 | Ethisteron |
| QG03DC05 | Tibolon |
| QG03DC06 | Etynodiol |
| QG03DC31 | Methylestrenolon |
| QG03DX | Andre gestagener |
| QG03DX90 | Altrenogest |
| QG03DX91 | Delmadinon |
| QG03E | Androgener og kvindelige kønshormoner i komb. |
| QG03EA | Androgener og østrogener |
| QG03EA01 | Methyltestosteron og østrogen |
| QG03EA02 | Testosteron og østrogen |
| QG03EA03 | Prasteron og østrogen |
| QG03EB | Androgen, gestagen og østrogen i kombination |
| QG03EK | Androgener og kvindelige kønshormoner i komb.m. andre stoffer |
| QG03F | Gestagener og østrogener i kombination |
| QG03FA | Gestagener og østrogener, kombinationer |
| QG03FA01 | Norethisteron og østrogen |
| QG03FA02 | Hydroxyprogesteron og østrogen |
| QG03FA03 | Ethisteron og østrogen |
| QG03FA04 | Progesteron og østrogen |
| QG03FA05 | Methylnortestosteron og østrogen |
| QG03FA06 | Etynodiol og østrogen |
| QG03FA07 | Lynestrenol og østrogen |
| QG03FA08 | Megestrol og østrogen |
| QG03FA09 | Noretynodrel og østrogen |
| QG03FA10 | Norgestrel og østrogen |
| QG03FA11 | Levonorgestrel og østrogen |
| QG03FA12 | Medroxyprogesteron og østrogen |
| QG03FA13 | Norgestimat og østrogen |
| QG03FA14 | Dydrogesteron og østrogen |
| QG03FA15 | Dienogest og østrogen |
| QG03FA16 | Trimegeston og østrogen |
| QG03FA17 | Drospirenon og østrogen |
| QG03FB | Gestagener og østrogener, sekvenspræparater |
| QG03FB01 | Norgestrel og østrogen |
| QG03FB02 | Lynestrenol og østrogen |
| QG03FB03 | Chlormadinon og østrogen |
| QG03FB04 | Megestrol og østrogen |
| QG03FB05 | Norethisteron og østrogen |
| QG03FB06 | Medroxyprogesteron og østrogen |
| QG03FB07 | Medrogeston og østrogen |
| QG03FB08 | Dydrogesteron og østrogen |
| QG03FB09 | Levonorgestrel og østrogen |
| QG03FB10 | Desogestrel og østrogen |
| QG03FB11 | Trimegeston og østrogen |
| QG03FB12 | Nomegestrol og østrogen |
| QG03G | Gonadotropiner og andre ovulationsstimulantia |
| QG03GA | Gonadotropiner |
| QG03GA01 | Choriongonadotropin |
| QG03GA02 | Humant menopausalt gonadotropin |
| QG03GA03 | Serumgonadotropin |
| QG03GA04 | Urofollitropin |
| QG03GA05 | Follitropin alfa |
| QG03GA06 | Follitropin beta |
| QG03GA07 | Lutropin alfa |
| QG03GA08 | Choriongonadotropin alfa |
| QG03GA09 | Corifollitropin alfa |
| QG03GA10 | Follitropin delta |
| QG03GA30 | Kombinationer |
| QG03GA90 | Follikelstimulerende hormon - hypofyse |
| QG03GA99 | Gonadotropiner, kombinationer |
| QG03GB | Ovulationsstimulerende midler, syntetiske |
| QG03GB01 | Cyclofenil |
| QG03GB02 | Clomifen |
| QG03GB03 | Epimestrol |
| QG03H | Antiandrogener |
| QG03X | Andre kønshormoner og genitalsystem-modulatorer |
| QG03XA | Anti-gonadotropiner og lign. midler |
| QG03XA01 | Danazol |
| QG03XA02 | Gestrinon |
| QG03XA90 | Anti-pmsg |
| QG03XA91 | Gonadotropin-releasing analog, konjugeret |
| QG03XB | Progesteron-receptormodulatorer |
| QG03XB01 | Mifepriston |
| QG03XB02 | Ulipristal |
| QG03XB51 | Mifepriston, kombinationer |
| QG03XB90 | Aglepriston |
| QG03XC | Selektive østrogenreceptor-modulatorer |
| QG03XC01 | Raloxifen |
| QG03XC03 | Lasofoxifen |
| QG03XC04 | Ormeloxifen |
| QG03XC05 | Ospemifen |
| QG03XX | Andre kønshormoner og modulatorer af genitalsystemet |
| QG03XX01 | Prasteron |
| QG03XX90 | Finrozol |
| QG04 | Urologika |
| QG04B | Urologiske midler |
| QG04BA | Acidoserende midler |
| QG04BA01 | Ammoniumchlorid |
| QG04BA03 | Calciumchlorid |
| QG04BA90 | Methionin |
| QG04BC | Midler til opløsning af urinsyrekonkrementer |
| QG04BD | Midler mod hyppig urinering og inkontinens |
| QG04BD01 | Emepron |
| QG04BD02 | Flavoxat |
| QG04BD03 | Meladrazin |
| QG04BD04 | Oxybutynin |
| QG04BD05 | Terodilin |
| QG04BD06 | Propiverin |
| QG04BD07 | Tolterodin |
| QG04BD08 | Solifenacin |
| QG04BD09 | Trospium |
| QG04BD10 | Darifenacin |
| QG04BD11 | Fesoterodin |
| QG04BD12 | Mirabegron |
| QG04BD13 | Desfesoterodin |
| QG04BD14 | Imidafenacin |
| QG04BD15 | Vibegron |
| QG04BE | Midler anvendt ved erektionsforstyrrelser |
| QG04BE01 | Alprostadil |
| QG04BE02 | Papaverin |
| QG04BE03 | Sildenafil |
| QG04BE04 | Yohimbin |
| QG04BE05 | Phentolamin |
| QG04BE06 | Moxisylyt |
| QG04BE07 | Apomorphin |
| QG04BE08 | Tadalafil |
| QG04BE09 | Vardenafil |
| QG04BE10 | Avanafil |
| QG04BE11 | Udenafil |
| QG04BE30 | Kombinationer |
| QG04BE52 | Papaverin, komb. |
| QG04BQ | Alkaliserende midler |
| QG04BQ01 | Natriumhydrogencarbonat |
| QG04BX | Andre urologika |
| QG04BX01 | Magnesiumhydroxid |
| QG04BX03 | Acetohydroxamsyre |
| QG04BX06 | Phenazopyridin |
| QG04BX10 | Succinimid |
| QG04BX11 | Collagen |
| QG04BX13 | Dimethylsulfoxid |
| QG04BX14 | Dapoxetin |
| QG04BX15 | Pentosanpolysulfat natrium |
| QG04BX16 | Tiopronin |
| QG04BX17 | Natriumsalicylat og methenamin |
| QG04BX56 | Phenazopyridin, kombinationer |
| QG04BX90 | Ephedrin |
| QG04BX91 | Phenylpropanolamin |
| QG04C | Midler anvendt ved benign prostatahypertrofi |
| QG04CA | Alfa-adrenoreceptor antagonister |
| QG04CA01 | Alfuzosin |
| QG04CA02 | Tamsulosin |
| QG04CA03 | Terazosin |
| QG04CA04 | Silodosin |
| QG04CA51 | Alfuzosin og finasterid |
| QG04CA52 | Tamsulosin og dutasterid |
| QG04CA53 | Tamsulosin og solifenacin |
| QG04CA54 | Tamsulosin og tadalafil |
| QG04CA55 | Doxazosin og finasterid |
| QG04CB | Testosteron-5-alfa reductase inhibitorer |
| QG04CB01 | Finasterid |
| QG04CB02 | Dutasterid |
| QG04CB51 | Finasterid og tadalafil |
| QG04CX | Andre midler anvendt v. benign prostatahypertrofi |
| QG04CX01 | Afrikansk blomme bark |
| QG04CX02 | Savpalmefrugt |
| QG04CX03 | Mepartricin |
| QG04CX04 | Fexapotid |
| QG04CX90 | Osateron |
| QG51 | Antiinfektiva og antiseptika til intrauterint brug |
| QG51A | Antiinfektiva og antiseptika til intrauterint brug |
| QG51AA | Antibakterielle midler |
| QG51AA01 | Oxytetracyclin |
| QG51AA02 | Tetracyclin |
| QG51AA03 | Amoxicillin |
| QG51AA04 | Gentamicin |
| QG51AA05 | Cefapirin |
| QG51AA06 | Rifaximin |
| QG51AA07 | Cefquinom |
| QG51AA08 | Chlortetracyclin |
| QG51AA09 | Formosulfathiazol |
| QG51AA30 | Antibiotika i komb. |
| QG51AC | Quinolin-derivater |
| QG51AC30 | Quinolin-derivater i komb. |
| QG51AD | Antiseptika |
| QG51AD01 | Povidone-iod |
| QG51AD02 | Policresulen |
| QG51AD03 | Peroxy-eddikesyre |
| QG51AD30 | Antiseptika i komb. |
| QG51AE | Sulfonamider |
| QG51AE10 | Sulfonamider i komb. |
| QG51AF | Imidazolin-derivater |
| QG51AF30 | Imidazol-derivater i komb. |
| QG51AG | Antiinfektiva og/eller antiseptika, kombinationer til intrauterin brug |
| QG51AG01 | Procain benzylpenicillin, dihydrostreptomycin og sulfadimidin |
| QG51AG02 | Benzylpenicillin, dihydrostreptomycin og sulfadimidin |
| QG51AG03 | Tetracyclin, neomycin og sulfadimidin |
| QG51AG04 | Ampicillin og oxacillin |
| QG51AG05 | Ampicillin og cloxacillin |
| QG51AG06 | Oxytetracycline og neomycin |
| QG51AG07 | Ampicillin og colistin |
| QG51AX | Andre antiinfektiva og antiseptika til intrauterin anvendelse |
| QG51AX30 | Komb. af andre antiinfektiva og antiseptika til intrauterin anvendelse |
| QG51B | Antiinfektiva/antiseptika til intrauterint brug, komb. |
| QG51BA | Antibiotika, komb. med andre stoffer |
| QG51BC | Quinolin-derivater, komb. med andre stoffer |
| QG51BD | Antiseptika, komb. med andre stoffer |
| QG51BE | Sulfonamider, komb. med andre stoffer |
| QG51BF | Imidazol-derivater, komb. med andre stoffer |
| QG52 | Produkter til patter og yver |
| QG52A | Desinfektionsmidler |
| QG52B | Pattekanal-udstyr |
| QG52C | Blødgøringsmidler |
| QG52X | Diverse produkter til patter og yver |
| QH | Systemiske hormonpræparater, excl. kønshormoner |
| QH01 | Hypofyse- og hypothalamus-hormoner og analoger |
| QH01A | Hypofyseforlap-hormoner og analoger |
| QH01AA | Acth |
| QH01AA01 | Corticotropin |
| QH01AA02 | Tetracosactid |
| QH01AB | Thyrotropin |
| QH01AB01 | Thyrotropin |
| QH01AC | Somatropin og somatropin agonister |
| QH01AC01 | Somatropin |
| QH01AC02 | Somatrem |
| QH01AC03 | Mecasermin |
| QH01AC04 | Sermorelin |
| QH01AC05 | Mecaserminrinfabat |
| QH01AC06 | Tesamorelin |
| QH01AC07 | Somapacitan |
| QH01AC08 | Somatrogon |
| QH01AC09 | Lonapegsomatropin |
| QH01AX | Andre hypofyseforlap-hormoner og analoger |
| QH01AX01 | Pegvisomant |
| QH01AX90 | Capromorelin |
| QH01B | Hypofysebaglap-hormoner og analoger |
| QH01BA | Vasopressin og analoger |
| QH01BA01 | Vasopressin (argipressin) |
| QH01BA02 | Desmopressin |
| QH01BA03 | Lypressin |
| QH01BA04 | Terlipressin |
| QH01BA05 | Ornipressin |
| QH01BB | Oxytocin og derivater |
| QH01BB01 | Demoxytocin |
| QH01BB02 | Oxytocin |
| QH01BB03 | Carbetocin |
| QH01C | Hypothalamus-hormoner og analoger |
| QH01CA | Gonadotropin-releasing hormoner |
| QH01CA01 | Gonadorelin |
| QH01CA02 | Nafarelin |
| QH01CA90 | Buserelin |
| QH01CA91 | Fertirelin |
| QH01CA92 | Lecirelin |
| QH01CA93 | Deslorelin |
| QH01CA94 | Azagly-nafarelin |
| QH01CA95 | Peforelin |
| QH01CA96 | Laksegonadotropin-releasing hormonanalog |
| QH01CA97 | Triptorelin |
| QH01CA98 | Alarelin |
| QH01CB | Somatostatin og analoger |
| QH01CB01 | Somatostatin |
| QH01CB02 | Octreotid |
| QH01CB03 | Lanreotid |
| QH01CB04 | Vapreotid |
| QH01CB05 | Pasireotid |
| QH01CC | Anti-godadotropin releasing hormoner |
| QH01CC01 | Ganirelix |
| QH01CC02 | Cetrorelix |
| QH01CC03 | Elagolix |
| QH01CC04 | Linzagolix |
| QH01CC53 | Elagolix, estradiol og norethisteron |
| QH01CC54 | Relugolix, estradiol og norethisteron |
| QH02 | Kortikosteroider til systemisk brug |
| QH02A | Kortikosteroider til systemisk brug |
| QH02AA | Mineralcorticoider |
| QH02AA01 | Aldosteron |
| QH02AA02 | Fludrocortison |
| QH02AA03 | Desoxycorton |
| QH02AB | Glucocorticoider |
| QH02AB01 | Betamethason |
| QH02AB02 | Dexamethason |
| QH02AB03 | Fluocortolon |
| QH02AB04 | Methylprednisolon |
| QH02AB05 | Paramethason |
| QH02AB06 | Prednisolon |
| QH02AB07 | Prednison |
| QH02AB08 | Triamcinolon |
| QH02AB09 | Hydrocortison |
| QH02AB10 | Cortison |
| QH02AB11 | Prednyliden |
| QH02AB12 | Rimexolon |
| QH02AB13 | Deflaxacort |
| QH02AB14 | Cloprednol |
| QH02AB15 | Meprednison |
| QH02AB17 | Cortivazol |
| QH02AB18 | Vamorolon |
| QH02AB30 | Glucocorticoider i komb. |
| QH02AB56 | Prednisolon, kombinationer |
| QH02AB57 | Prednison, kombinationer |
| QH02AB90 | Flumetason |
| QH02B | Kortikosteroider til systemisk brug, komb. |
| QH02BX | Kortikosteroider til systemisk brug, komb. |
| QH02BX90 | Dexamethason, komb. |
| QH02C | Antiadrenale præparater |
| QH02CA | Antikortikosteroider |
| QH02CA01 | Trilostan |
| QH02CA02 | Osilodrostat |
| QH02CA03 | Ketoconazol |
| QH02CA04 | Levoketoconazol |
| QH03 | Thyroidea-terapi |
| QH03A | Thyroidea-præparater |
| QH03AA | Thyroidea-hormoner |
| QH03AA01 | Levothyroxinnatrium |
| QH03AA02 | Liothyroninnatrium |
| QH03AA03 | Levothyroxin og liothyronin i komb. |
| QH03AA04 | Tiratricol |
| QH03AA05 | Thyroidea-kirtel-præparater |
| QH03AA51 | Levothyroxinnatrium og iodforbindelser |
| QH03B | Antithyroide præparater |
| QH03BA | Thiouraciler |
| QH03BA01 | Methylthiouracil |
| QH03BA02 | Propylthiouracil |
| QH03BA03 | Benzylthiouracil |
| QH03BB | Svovlholdige imidazol-derivater |
| QH03BB01 | Carbimazol |
| QH03BB02 | Thiamazol |
| QH03BB52 | Thiamazol, komb. |
| QH03BC | Perchlorater |
| QH03BC01 | Kaliumperchlorat |
| QH03BX | Andre antithyroide præparater |
| QH03BX01 | Diiodtyrosin |
| QH03BX02 | Dibromtyrosin |
| QH03C | Iod-terapi |
| QH03CA | Iod-terapi |
| QH04 | Pancreas-hormoner |
| QH04A | Glycogenolytiske hormoner |
| QH04AA | Glycogenolytiske hormoner |
| QH04AA01 | Glucagon |
| QH04AA02 | Dasiglucagon |
| QH05 | Calcium-homeostase |
| QH05A | Parathyroidea-hormoner og analoger |
| QH05AA | Parathyroidea-hormoner og analoger |
| QH05AA01 | Parathyroidea-kirtel-ekstrakt |
| QH05AA02 | Teriparatid |
| QH05AA03 | Parathyroideahormon |
| QH05AA04 | Abaloparatid |
| QH05AA05 | Palopegteriparatid |
| QH05B | Anti-parathyroide midler |
| QH05BA | Calcitonin-præparater |
| QH05BA01 | Calcitonin (laks, syntetisk) |
| QH05BA02 | Calcitonin (svin, naturligt) |
| QH05BA03 | Calcitonin (humant, syntetisk) |
| QH05BA04 | Elcatonin |
| QH05BX | Andre anti-parathyroide midler |
| QH05BX01 | Cinacalcet |
| QH05BX02 | Paricalcitol |
| QH05BX03 | Doxercalciferol |
| QH05BX04 | Etelcalcetid |
| QH05BX05 | Calcifediol |
| QH05BX06 | Evocalcet |
| QI | Immunologica til veterinært brug |
| QI01 | Immunologiske midler til fugle |
| QI01A | Immunologica til hønsefugle |
| QI01AA | Inaktiverede virale vacciner |
| QI01AA01 | Smitsom bursal disease virus vaccine (gumboro) |
| QI01AA02 | Newcastle disease virus/paramyxovirus vaccine |
| QI01AA03 | Smitsom bronchitis virus vaccine |
| QI01AA04 | Reovirus vaccine |
| QI01AA05 | Adenovirus vaccine |
| QI01AA06 | Smitsom bronchitis+smitsom bursal disease+newcastle disease+rhinotrachei |
| QI01AA07 | Smitsom bronchitis+smitsom bursal disease+newcastle disease+rhinotrachei |
| QI01AA08 | Smitsom bronchitis+smitsom bursal disease+newcastle disease virus vaccin |
| QI01AA09 | Newcastle disease+smitsom bursal disease+adenovirus vaccine |
| QI01AA10 | Smitsom bronchitis+newcastle disease virus vaccine |
| QI01AA11 | Smitsom bursal disease+newcastle disease virus vaccine |
| QI01AA12 | Newcastle disease virus+adenovirus vaccine |
| QI01AA13 | Newcastle disease+smitsom bronchitis+adenovirus vaccine |
| QI01AA14 | Smitsom bronchitis virus+adenovirus vaccine |
| QI01AA15 | Smitsom bronchitis+smitsom bursal disease virus vaccine |
| QI01AA16 | Smitsom bronchitis+smitsom bursal disease+newcastle disease+reovirus vac |
| QI01AA17 | Rhinotracheitis virus vaccine |
| QI01AA18 | Smitsom bronchitis+newcastle disease+adenovirus+rhinotracheitis virus va |
| QI01AA19 | Smitsom bronchitis+smitsom bursal disease+newcastle disease+adenovirus v |
| QI01AA20 | Newcastle disease+rhinotracheitis virus vaccine |
| QI01AA21 | Smitsom bronchitis+newcastle disease+rhinotracheitis virus vaccine |
| QI01AA22 | Smitsom bursal disease+reovirus vaccine |
| QI01AA23 | Influenzavirus vaccine |
| QI01AA24 | Inf. bronc. virus+gumboro disease virus+newcastle disease virus+reovirus |
| QI01AA25 | Inf. bronc. virus+gumboro disease virus+newcastle disease virus+ reoviru |
| QI01AA26 | Inf. bronc. virus+gumboro disease virus+newcastle disease virus+reovirus |
| QI01AB | Inakt. bakterielle vacciner (inkl. mycoplasma, toxoid og chlamydia vacci |
| QI01AB01 | Salmonella vaccine |
| QI01AB02 | Pasteurella vaccine |
| QI01AB03 | Mycoplasma vaccine |
| QI01AB04 | Haemophilus vaccine |
| QI01AB05 | Escherichia vaccine |
| QI01AB06 | Erysipelothrix vaccine |
| QI01AB07 | Ornithobacterium vaccine |
| QI01AB08 | Clostridium |
| QI01AC | Inakt. bakterielle vacciner og antisera |
| QI01AD | Levende virale vacciner |
| QI01AD01 | Rhinotracheitis virus vaccine |
| QI01AD02 | Encephalomyelitis virus vaccine |
| QI01AD03 | Herpes virus vaccine (mareks disease) |
| QI01AD04 | Kyllingeanæmi vaccine |
| QI01AD05 | Adenovirus vaccine |
| QI01AD06 | Newcastle disease virus / paramyxovirus vaccine |
| QI01AD07 | Smitsom bronchitis virus vaccine |
| QI01AD08 | Smitsom laryngotracheitis virus vaccine |
| QI01AD09 | Smitsom bursal disease virus vaccine (gumboro disease) |
| QI01AD10 | Reovirus vaccine |
| QI01AD11 | Newcastle disease+smitsom bronchitis virus vaccine |
| QI01AD12 | Pox virus vaccine |
| QI01AD13 | Leucose virus vaccine |
| QI01AD14 | Reticuloendotheliose vaccine |
| QI01AD15 | Smitsom bursal disease (gumboro disease)+herpes virus vaccine (marek's d |
| QI01AD16 | Av.herpes v.(marek's d.)+av.ibd.v.(gumboro d.)+newcastle d.v./paramyxov |
| QI01AD17 | Av.herpesv.(marek's d.)+infec.laryngotracheitisv.+newcastle d.v./paramyx |
| QI01AD18 | Herpes virus (marek's disease)+laryngotracheitis virus+gumboro virus vac |
| QI01AD19 | Herpes virus (marek's disease)+laryngotracheitis virus vaccine |
| QI01AD20 | Av.herpes(marek?s)+infec.lar.trac.+ ibd.(gumboro)+newcastle d./paramyxov |
| QI01AE | Levende bakterielle vacciner |
| QI01AE01 | Salmonella vaccine |
| QI01AE02 | Pasteurella vaccine |
| QI01AE03 | Mycoplasma vaccine |
| QI01AE04 | Escherichia vaccine |
| QI01AE05 | Erysipelothrix vaccine |
| QI01AF | Levende bakterielle og virale vacciner |
| QI01AG | Levende og inaktiverede bakterielle vacciner |
| QI01AH | Levende og inaktiverede virale vacciner |
| QI01AI | Levende virale og inaktiverede bakterielle vacciner |
| QI01AJ | Levende virale og inakt. virale og bakterielle vacciner |
| QI01AK | Inaktiverede virale og levende bakterielle vacciner |
| QI01AL | Inaktiverede virale og bakterielle vacciner |
| QI01AL01 | Inakt. newcastle disease / paramyxovirus + escherichia + pasteurella vac |
| QI01AL02 | Inakt. newcastle disease / paramyxovirus + infektuøs bronchitis + haemop |
| QI01AL03 | Inakt. newcastle disease / paramyxovirus + haemophilus vaccine |
| QI01AL04 | Inakt. newcastle disease / paramyxovirus + pasteurella vaccine |
| QI01AL05 | Inakt. newcastle disease / paramyxovirus + infektuøs bronchitis + adenov |
| QI01AL06 | Inakt. newcastle disease / paramyxovirus + infektuøs bronchitis + escher |
| QI01AL07 | Newcastle disease virus/paramyxovirus + salmonella + pasteurella |
| QI01AM | Antisera, immunglobulin-præparater og antitoxiner |
| QI01AN | Levende parasitære vacciner |
| QI01AN01 | Coccidia vacciner |
| QI01AO | Inaktiverede parasitære vacciner |
| QI01AO01 | Coccidia vaccine |
| QI01AP | Levende fungale vacciner |
| QI01AQ | Inaktiverede fungale vacciner |
| QI01AR | In vivo diagnostiske præparater |
| QI01AS | Allergener |
| QI01AT | Colostrum præparater og substitutter |
| QI01AU | Andre levende vacciner |
| QI01AV | Andre inaktiverede vacciner |
| QI01AX | Andre immunologica |
| QI01B | Immunologica til ænder |
| QI01BA | Inaktiverede virale vacciner |
| QI01BA01 | Inakt. ande-parvovirus + inakt. gåse-parvovirus vaccine |
| QI01BB | Inakt. bakterielle vacciner (inkl. mycoplasma, toxoid og chlamydia vacci |
| QI01BB01 | Clostridium |
| QI01BC | Inaktiverede bakterielle vacciner og antisera |
| QI01BD | Levende virale vacciner |
| QI01BD01 | Enteritis virus vaccine |
| QI01BD02 | Hepatitis virus vaccine |
| QI01BD03 | Parvovirus vaccine |
| QI01BE | Levende bakterielle vacciner |
| QI01BF | Levende bakterielle og virale vacciner |
| QI01BG | Levende og inaktiverede bakterielle vacciner |
| QI01BH | Levende og inaktiverede virale vacciner |
| QI01BH01 | Lev. gåse-parvovirus + inakt. ande-parvovirus vaccine |
| QI01BI | Levende virale og inakt. bakterielle vacciner |
| QI01BJ | Levende virale og inakt. virale og bakterielle vacciner |
| QI01BK | Inaktiverede virale og levende bakterielle vacciner |
| QI01BL | Inaktiverede virale og bakterielle vacciner |
| QI01BM | Antisera, immunglobulin-præparater og antitoxiner |
| QI01BN | Levende parasitære vacciner |
| QI01BO | Inaktiverede parasitære vacciner |
| QI01BP | Levende fungale vacciner |
| QI01BQ | Inaktiverede fungale vacciner |
| QI01BR | In vivo diagnostiske præparater |
| QI01BS | Allergener |
| QI01BT | Colostrum præparater og substitutter |
| QI01BU | Andre levende vacciner |
| QI01BV | Andre inaktiverede vacciner |
| QI01BX | Andre immunologica |
| QI01C | Immunologica til kalkuner |
| QI01CA | Inaktiverede virale vacciner |
| QI01CA01 | Paramyxovirus vaccine |
| QI01CA02 | Paramyxovirus + rhinotracheitis virus vaccine |
| QI01CA03 | Newcastle disease/paramyxovirus + adenovirus vaccine |
| QI01CB | Inakt. bakterielle vacciner (inkl. mycoplasma, toxoid og chlamydia vacci |
| QI01CB01 | Pasteurella+erysipelothrix vaccine |
| QI01CB02 | Erysipelothrix vaccine |
| QI01CC | Inakt. bakterielle vacciner og antisera |
| QI01CD | Levende virale vacciner |
| QI01CD01 | Rhinotracheitis virus vaccine |
| QI01CD02 | Kalkunherpes virus vaccine |
| QI01CE | Levende bakterielle vacciner |
| QI01CF | Levende bakterielle og virale vacciner |
| QI01CG | Levende og inakt. bakterielle vacciner |
| QI01CH | Levende og inakt. virale vacciner |
| QI01CI | Lev. virale og inakt. bakterielle vacciner |
| QI01CJ | Lev. virale og inakt. virale og bakterielle vacciner |
| QI01CK | Inakt. virale og lev. bakterielle vacciner |
| QI01CL | Inakt. virale og bakterielle vacciner |
| QI01CL01 | Inakt. newcastle disease/paramyxovirus+adenovirus+influenzavirus+pasteur |
| QI01CM | Antisera, immunglobuliner og antitoxiner |
| QI01CN | Levende parasitære vacciner |
| QI01CO | Inaktiverede parasitære vacciner |
| QI01CP | Levende fungale vacciner |
| QI01CQ | Inaktiverede fungale vacciner |
| QI01CR | In-vivo diagnostiske præparater |
| QI01CS | Allergener |
| QI01CT | Colostrum præparater og substitutter |
| QI01CU | Andre levende vacciner |
| QI01CV | Andre inaktiverede vacciner |
| QI01CX | Andre immunologica til kalkuner |
| QI01D | Immunologica til gæs |
| QI01DA | Inaktiverede virale vacciner |
| QI01DB | Inakt. bakterielle vacciner (inkl. mycoplasma, toxoid og chlamydia vacci |
| QI01DC | Inakt. bakterielle vacciner og antisera |
| QI01DD | Levende virale vacciner |
| QI01DD01 | Parvovirus vaccine |
| QI01DE | Levende bakterielle vacciner |
| QI01DF | Levende bakterielle og virale vacciner |
| QI01DG | Levende og inakt. bakterielle vacciner |
| QI01DH | Levende ig inakt. virale vacciner |
| QI01DI | Levende virale og inakt. bakterielle vacciner |
| QI01DJ | Lev. virale og inakt. virale og bakterielle vacciner |
| QI01DK | Inakt. virale og levende bakterielle vacciner |
| QI01DL | Inakt. virale og bakterielle vacciner |
| QI01DM | Antisera, immunglobulin-præparater og antitoxiner |
| QI01DM01 | Parvovirus antiserum |
| QI01DN | Levende parasitære vacciner |
| QI01DO | Inaktiverede parasitære vacciner |
| QI01DP | Levende fungale vacciner |
| QI01DQ | Inaktiverede fungale vacciner |
| QI01DR | In-vivo diagnostiske præparater |
| QI01DS | Allergener |
| QI01DT | Colostrum præparater og substitutter |
| QI01DU | Andre levende vacciner |
| QI01DV | Andre inaktiverede vacciner |
| QI01DX | Andre immunologica til gæs |
| QI01E | Immunologica til duer |
| QI01EA | Inaktiverede virale vacciner |
| QI01EA01 | Paramyxovirus vaccine |
| QI01EB | Inakt. bakterielle vacciner (inkl. mycoplasma, toxoid og chlamydia vacci |
| QI01EC | Inakt. bakterielle vacciner og antisera |
| QI01ED | Levende virale vacciner |
| QI01ED01 | Due-pox virus vaccine |
| QI01EE | Levende bakterielle vacciner |
| QI01EE01 | Salmonella vaccine |
| QI01EF | Levende bakterielle og virale vacciner |
| QI01EG | Levende og inakt. bakterielle vacciner |
| QI01EH | Levende og inakt. virale vacciner |
| QI01EH01 | Lev. poxvirus + inakt. paramyxovirus vaccine |
| QI01EI | Lev. virale og inakt. bakterielle virus |
| QI01EJ | Lev. virale og inakt. virale og bakterielle vacciner |
| QI01EK | Inakt. virale og levende bakterielle vacciner |
| QI01EL | Inakt. virale og bakterielle vacciner |
| QI01EM | Antisera, immunglobulin-præparater og antitoxiner |
| QI01EN | Levende parasitære vacciner |
| QI01EO | Inaktiverede parasitære vacciner |
| QI01EP | Levende fungale vacciner |
| QI01EQ | Inaktiverede fungale vacciner |
| QI01ER | In-vivo diagnostiske præparater |
| QI01ES | Allergener |
| QI01ET | Colostrum præparater og substitutter |
| QI01EU | Andre levende vacciner |
| QI01EV | Andre inaktiverede vacciner |
| QI01EX | Andre immunologica til duer |
| QI01F | Immunologica til fasaner |
| QI01FA96 | Tildipirosin |
| QI01G | Immunologica til vagtler |
| QI01H | Immunologica til agerhøns |
| QI01I | Immunologica til strudse |
| QI01K | Immunologica til stuefugle |
| QI01KA | Inaktiverede virale vacciner |
| QI01KA01 | Pacheco's virus / herpesvirus vaccine |
| QI01KB | Inakt. bakterielle vacciner (inkl. mycoplasma, toxoid og chlamydia vacci |
| QI01KC | Inakt. bakterielle vacciner og antisera |
| QI01KD | Levende virale vacciner |
| QI01KD01 | Kanarie-pox virus vaccine |
| QI01KD02 | Pacheco's virus / herpesvirus vaccine |
| QI01KE | Levende bakterielle vacciner |
| QI01KF | Levende bakterielle og virale vacciner |
| QI01KG | Levende og inakt. bakterielle vacciner |
| QI01KH | Levende og inakt. virale vacciner |
| QI01KI | Lev. virale og inakt. bakterielle vacciner |
| QI01KJ | Lev. virale og inakt. virale og bakterielle vacciner |
| QI01KK | Inakt. virale og levende bakterielle vacciner |
| QI01KL | Inakt. virale og bakterielle vacciner |
| QI01KM | Antisera, immunglobulin-præparater og antitoxiner |
| QI01KN | Levende parasitære vacciner |
| QI01KO | Inaktiverede parasitære vacciner |
| QI01KP | Levende fungale vacciner |
| QI01KQ | Inaktiverede fungale vacciner |
| QI01KR | In-vivo diagnostiske præparater |
| QI01KS | Allergener |
| QI01KT | Colostrum præparater og substitutter |
| QI01KU | Andre levende vacciner |
| QI01KV | Andre inaktiverede vacciner |
| QI01KX | Andre immunologica til stuefugle |
| QI01X | Immunologica til andre fugle |
| QI02 | Immunologiske midler til kvæg |
| QI02A | Immunologica til kvæg |
| QI02AA | Inaktiverede virale vacciner |
| QI02AA01 | Bovin viral diarre vaccine (bvd) |
| QI02AA02 | Bovin respiratorisk syncytial virus vaccine (brsv) |
| QI02AA03 | Rhinotracheitis virus / herpesvirus vaccine (ibr) |
| QI02AA04 | Mund- og klovesyge virus vaccine |
| QI02AA05 | Parainfluenzavirus+adenovirus+reovirus vaccine |
| QI02AA06 | Parainfluenzavirus+adenovirus+reovirus+rhinotracheitis virus vaccine |
| QI02AA07 | Parainfluenzavirus+adenovirus+reovirus+respiratorisk syncytial virus vac |
| QI02AA08 | Bluetonguevirus |
| QI02AB | Inakt. bakterielle vacciner (inkl. mycoplasma, toxoid og chlamydia vacci |
| QI02AB01 | Clostridium vaccine |
| QI02AB02 | Mycobacterium vaccine |
| QI02AB03 | Leptospira vaccine |
| QI02AB04 | Pasteurella vaccine |
| QI02AB05 | Salmonella vaccine |
| QI02AB06 | Escherichia vaccine |
| QI02AB07 | Coxiella+chlamydia vaccine |
| QI02AB08 | Escherichia+salmonella+pasteurella+streptokok vaccine |
| QI02AB09 | Escherichia+salmonella vaccine |
| QI02AB10 | Escherichia+salmonella+pasteurella vaccine |
| QI02AB11 | Clostridium+pasteurella vaccine |
| QI02AB12 | Clostridium+salmonella vaccine |
| QI02AB13 | Escherichia+streptokok vaccine |
| QI02AB14 | Pasteurella+streptokok+corynebacterium vaccine |
| QI02AB15 | Chlamydia vaccine |
| QI02AB16 | Streptokok+stafylokok+pseudomonas+corynebacterium vaccine |
| QI02AB17 | Escherichia + stafylokokker |
| QI02AB18 | Streptococcus |
| QI02AC | Inaktiverede bakterielle vacciner og antisera |
| QI02AD | Levende virale vacciner |
| QI02AD01 | Rhinotracheitis virus / herpesvirus vaccine (ibr) |
| QI02AD02 | Bovin viral diarre vaccine (bvd) |
| QI02AD03 | Bovin viral diarre+bovin respiratorisk syncytial virus vaccine |
| QI02AD04 | Bovin respiratorisk syncytial virus vaccine (brsv) |
| QI02AD05 | Parainfluenzavirus vaccine |
| QI02AD06 | Rhinotracheitis virus+parainfluenzavirus vaccine |
| QI02AD07 | Bovin respiratorisk syncytial virus+parainfluenzavirus vaccine |
| QI02AD08 | Rotavirus+coronavirus vaccine |
| QI02AD09 | Rotavirus vaccine |
| QI02AD10 | Coronavirus vaccine |
| QI02AE | Levende bakterielle vacciner |
| QI02AE01 | Mycobacterium vaccine |
| QI02AE02 | Salmonella vaccine |
| QI02AE03 | Escherichia vaccine |
| QI02AE04 | Bacillus anthracis vaccine |
| QI02AE05 | Mycoplasma |
| QI02AF | Levende bakterielle og virale vacciner |
| QI02AG | Levende og inaktiverede bakterielle vacciner |
| QI02AH | Levende og inaktiverede virale vacciner |
| QI02AH01 | Rhinotrach.(ibr)+resp. sync.(brsv)+inakt.vir.diarre(bvd)+inakt.parainflu |
| QI02AI | Levende virale og inakt. bakterielle vacciner |
| QI02AI01 | Levende rotavirus+coronavirus+inakt. escherichia vaccine |
| QI02AJ | Levende virale 0g inakt. virale og bakterielle vacciner |
| QI02AK | Inakt. virale og levende bakterielle vacciner |
| QI02AL | Inakt. virale og bakterielle vacciner |
| QI02AL01 | Inakt. rotavirus+coronavirus+escherichia vaccine |
| QI02AL02 | Inakt. rotavirus+coronavirus+parvovirus+escherichia vaccine |
| QI02AL03 | Inakt. rotavirus+escherichia vaccine |
| QI02AL04 | Inakt. parainfluenzavirus+bovin respiratorisk syncytial virus+pasteurell |
| QI02AL05 | Inakt. rotavirus+coronavirus+clostridium+escherichia vaccine |
| QI02AM | Antisera, immunglobulin-præparater og antitoxiner |
| QI02AM01 | Escherichia antiserum |
| QI02AM02 | Salmonella antiserum |
| QI02AM03 | Pasteurella+salmonella+streptokok+escherichia antiserum |
| QI02AM04 | Escherichia+pneumokok antiserum |
| QI02AM05 | Rotavirus+coronavirus+escherichia antiserum |
| QI02AM06 | Salmonella+pasteurella+escherichia antiserum |
| QI02AM07 | Salmonella+ escherichia antiserum |
| QI02AM08 | Pasteurella antiserum |
| QI02AN | Levende parasitære vacciner |
| QI02AN01 | Dictyocaulus vaccine |
| QI02AO | Inaktiverede parasitære vacciner |
| QI02AO01 | Dictyocaulus vaccine |
| QI02AO02 | Cryptosporidium vaccine |
| QI02AP | Levende fungale vacciner |
| QI02AP01 | Trichophyton vaccine |
| QI02AQ | Inaktiverede fungale vacciner |
| QI02AQ01 | Trichophyton vaccine |
| QI02AR | In vivo diagnostiske præparater |
| QI02AR01 | Bovin tuberkulin ppd |
| QI02AR02 | Fugle tuberkulin ppd |
| QI02AS | Allergener |
| QI02AT | Colostrum præparater og substitutter |
| QI02AT01 | Escherichia |
| QI02AU | Andre levende vacciner |
| QI02AV | Andre inaktiverede vacciner |
| QI02AX | Andre immunologica |
| QI02B | Immunologica til bison |
| QI02X | Immunologica til andre kvægtyper |
| QI03 | Immunologica til capridae |
| QI03A | Immunologica til geder |
| QI03AA | Inaktiverede virale vacciner |
| QI03AB | Inakt. bakterielle vaciner (inkl. mycoplasma, toxoid og chlamydia vaccin |
| QI03AB01 | Mycobacterium vaccine |
| QI03AC | Inaktiverede bakterielle vacciner og antisera |
| QI03AD | Levende virale vacciner |
| QI03AD01 | Fåre- og gedepest (peste de petits ruminants, ppr) |
| QI03AE | Levende bakterielle vacciner |
| QI03AF | Levende bakterielle og virale vacciner |
| QI03AG | Levende og inakt. bakterielle vacciner |
| QI03AH | Levende og inakt. virale vacciner |
| QI03AI | Lev. virale og inakt. bakterielle vacciner |
| QI03AJ | Lev. virale og inakt. virale og bakterielle vacciner |
| QI03AK | Inakt. virale og lev. bakterielle vacciner |
| QI03AL | Inakt. virale og bakterielle vacciner |
| QI03AM | Antisera, immunglobulin-præparater og antitoxiner |
| QI03AN | Levende parasitære vacciner |
| QI03AO | Inaktiverede parasitære vacciner |
| QI03AP | Levende fungale vacciner |
| QI03AQ | Inaktiverede fungale vacciner |
| QI03AR | In-vivo diagnostiske præparater |
| QI03AS | Allergener |
| QI03AT | Colostrum præparater og substitutter |
| QI03AU | Andre levende vacciner |
| QI03AV | Andre inaktiverede vacciner |
| QI03AX | Andre immunologica til geder |
| QI03X | Immunologica til andre capridae |
| QI04 | Immunologiske midler til ovidae |
| QI04A | Immunologica til får |
| QI04AA | Inaktiverede virale vacciner |
| QI04AA01 | Louping ill virus vaccine |
| QI04AA02 | Bluetongue virus vaccine |
| QI04AB | Inakt. bakterielle vacciner (inkl. mycoplasma, toxoid og chlamydia vacci |
| QI04AB01 | Clostridium vaccine |
| QI04AB02 | Pasteurella vaccine |
| QI04AB03 | Bacteroides vaccine |
| QI04AB04 | Escherichia vaccine |
| QI04AB05 | Clostridium + pasteurella vaccine |
| QI04AB06 | Chlamydia vaccine |
| QI04AB08 | Erysipelothrix vaccine |
| QI04AB09 | Mycobacterium vaccine |
| QI04AB10 | Staphylococcus |
| QI04AC | Inakt. bakterielle vacciner og antisera |
| QI04AD | Levende virale vacciner |
| QI04AD01 | Orf virus+smitsom pustular dermatitis virus vaccine |
| QI04AE | Levende bakterielle vacciner |
| QI04AE01 | Chlamydia vaccine |
| QI04AE02 | Listeria vaccine |
| QI04AF | Levende bakterielle og virale vacciner |
| QI04AG | Lev. og inakt. bakterielle vacciner |
| QI04AH | Levende og inaktiverede virale vacciner |
| QI04AI | Lev. virale og inakt. bakterielle vacciner |
| QI04AJ | Lev. virale og inakt. virale og bakterielle vacciner |
| QI04AK | Inakt. virale og lev. bakterielle vacciner |
| QI04AL | Inakt. virale og bakterielle vacciner |
| QI04AM | Antisera, immunglobulin-præparater og antitoxiner |
| QI04AM01 | Pasteurella antiserum |
| QI04AM02 | Clostridium antiserum |
| QI04AN | Levende parasitære vacciner |
| QI04AN01 | Toxoplasma vaccine |
| QI04AO | Inaktiverede parasitære vacciner |
| QI04AP | Levende fungale vacciner |
| QI04AQ | Inaktiverede fungale vacciner |
| QI04AR | In vivo diagnostiske præparater |
| QI04AS | Allergener |
| QI04AT | Colostrum præparater og substitutter |
| QI04AU | Andre levende vacciner |
| QI04AV | Andre inaktiverede vacciner |
| QI04AX | Andre immunologica til får |
| QI04X | Andre immunologica til ovidae |
| QI05 | Immunologiske midler til hovdyr |
| QI05A | Immunologica til heste |
| QI05AA | Inaktiverede virale vacciner |
| QI05AA01 | Influenzavirus vaccine |
| QI05AA03 | Rhinopneumonitisvirus+reovirus+influenzavirus vaccine |
| QI05AA04 | Rhinopneumonitisvirus+influenzavirus vaccine |
| QI05AA05 | Rhinopneumonitisvirus/herpesvirus vaccine |
| QI05AA06 | Reovirus vaccine |
| QI05AA07 | Arteritisvirus vaccine |
| QI05AA08 | Parapox virus vaccine |
| QI05AA09 | Rotavirus vaccine |
| QI05AA10 | West nilevirus |
| QI05AA11 | Heste rhinopneumonitis virus + heste abort virus |
| QI05AB | Inakt. bakterielle vacciner (inkl. mycoplasma, toxoid og chlamydia vacci |
| QI05AB01 | Streptokok vaccine |
| QI05AB02 | Actinobacillus+escherichia+salmonella+streptokok vaccine |
| QI05AB03 | Clostridium vaccine |
| QI05AC | Inaktiverede bakterielle vacciner og antisera |
| QI05AD | Levende virale vacciner |
| QI05AD01 | Rhinopneumonitis virus/herpesvirus vaccine |
| QI05AD02 | Influenzavirus vaccine |
| QI05AE | Levende bakterielle vacciner |
| QI05AF | Levende bakterielle og virale vacciner |
| QI05AG | Levende og inakt. bakterielle vacciner |
| QI05AH | Levende og inaktiverede virale vacciner |
| QI05AI | Levende virale og inakt. bakterielle vacciner |
| QI05AI01 | Influenzavirus vaccine + clostridium vaccine |
| QI05AJ | Levende virale og inakt. virale og bakterielle vacciner |
| QI05AK | Inakt. virale og levende bakterielle vacciner |
| QI05AL | Inaktiverede virale og bakterielle vacciner |
| QI05AL01 | Inakt. influenzavirus+inakt. clostridium vaccine |
| QI05AM | Antisera, immunglobulin præparater og antitoxiner |
| QI05AM01 | Clostridium antiserum |
| QI05AM02 | Antilipopolysaccharid antiserum |
| QI05AM03 | Actinobacillus+escherichia+salmonella+streptokok antiserum |
| QI05AN | Levende parasitære vacciner |
| QI05AO | Inaktiverede parasitære vacciner |
| QI05AP | Levende fungale vacciner |
| QI05AP01 | Trichophyton vaccine |
| QI05AQ | Inaktiverede fungale vacciner |
| QI05AQ01 | Trichophyton vaccine |
| QI05AQ02 | Trichophyton+microsporum vaccine |
| QI05AR | In vivo diagnostiske præparater |
| QI05AS | Allergener |
| QI05AT | Colostrum præparater og substitutter |
| QI05AU | Andre levende vacciner |
| QI05AV | Andre inaktiverede vacciner |
| QI05AX | Andre immunologica til heste |
| QI05AX01 | Parapox ovis virus, inaktiveret |
| QI05AX02 | Propionibacterium acnes, inaktiveret |
| QI05B | Immunologica til æsler |
| QI05C | Immunologica til hovdyr-hybrider |
| QI05X | Immunologica til andre hovdyr |
| QI06 | Immunologica til felidae |
| QI06A | Immunologica til katte |
| QI06AA | Inaktiverede virale vacciner |
| QI06AA01 | Leukæmi-virus vaccine |
| QI06AA02 | Panleucopenivirus/parvovirus vaccine |
| QI06AA03 | Rabisevirus+rhinotracheitisvirus+calicivirus vaccine |
| QI06AA04 | Rhinotracheitisvirus+calicivirus+parvovirus+panleucopenivirus vaccine |
| QI06AA05 | Rhinotracheitisvirus+calicivirus vaccine |
| QI06AA06 | Infektuøs peritonitis virus vaccine |
| QI06AA07 | Calicivirus vaccine |
| QI06AA08 | Rhinotracheitisvirus vaccine |
| QI06AA09 | Panleucopenivirus+calicivirus+rhinotracheitisvirus+rabiesvirus vaccine |
| QI06AA10 | Immundefekt-virus vaccine |
| QI06AB | Inakt. bakterielle vacciner (inkl. mycoplasma, toxoid og chlamydia vacci |
| QI06AC | Inaktiverede bakterielle vacciner og antisera |
| QI06AC01 | Chlamydia vaccine |
| QI06AC02 | Bordetella vaccine |
| QI06AD | Levende virale vacciner |
| QI06AD01 | Panleucopenivirus vaccine |
| QI06AD02 | Infektuøs peritonitis virus vaccine |
| QI06AD03 | Rhinotracheitisvirus+calicivirus vaccine |
| QI06AD04 | Panleucopenivirus+rhinotracheitisvirus+calicivirus vaccine |
| QI06AD05 | Panleucopenivirus+rhinotracheitisvirus vaccine |
| QI06AD06 | Parapox virus vaccine |
| QI06AD07 | Katte-leukæmi rekobinant canarypoxvirus |
| QI06AD08 | Rabies, rekombinant canarypox virus, levende |
| QI06AE | Levende bakterielle vacciner |
| QI06AE01 | Chlamydia vaccine |
| QI06AE02 | Bordetella vaccine |
| QI06AF | Levende bakterielle og virale vacciner |
| QI06AF01 | Panleucopenivirus+rhinotracheitisvirus+calicivirus+chlamydia vaccine |
| QI06AG | Levende og inakt. bakterielle vacciner |
| QI06AH | Levende og inakt. virale vacciner |
| QI06AH01 | Lev. rhinotracheitisvirus+lev. calicivirus+inakt. panleucopenivirus vacc |
| QI06AH02 | Lev. panleucopenivirus+inakt. rabiesvirus vaccine |
| QI06AH03 | Lev. rhinotracheitisvirus+inakt. panleucopenivirus vaccine |
| QI06AH04 | Lev. panleucopenivirus+inakt. rabiesvirus+inakt. rhinotracheitisvirus+in |
| QI06AH05 | Lev. panleucopenivirus+lev. rhinotracheitisvirus+lev. calicivirus+inakt. |
| QI06AH06 | Lev. panleucopenivirus+lev. rhinotracheitisvirus+inakt. calicivirus vacc |
| QI06AH07 | Lev. panleucopenivirus+lev. rhinotracheitisvirus+lev. calicivirus+inakt. |
| QI06AH08 | Lev. rhinotracheitisvirus vaccine + inakt. calicivirus antigen |
| QI06AH09 | Lev. rhinotracheitisvirus+panleucopeni/parvovirus vaccine+inakt. caliciv |
| QI06AH10 | Levende katte rhinotracheitisvirus+panleucopeni/parvovirus+leukæmivirus+ |
| QI06AI | Levende virale og inakt. bakterielle vacciner |
| QI06AI01 | Lev. panleucopenivirus+lev. rhinotracheitisvirus+lev. calicivirus+inakt. |
| QI06AI02 | Lev. rhinotracheitisvirus+lev. calicivirus+inakt. chlamydia vaccine |
| QI06AI03 | Lev. panleucopenivirus+rhinotracheitisvirus+calicivirus+leukæmivirus+ina |
| QI06AJ | Levende virale og inakt. virale og bakterielle vacciner |
| QI06AJ01 | Lev. rhinotracheitisvirus+calicivirus+inakt. panleucopenivirus+lev. chla |
| QI06AJ02 | Lev. rhinotracheitisvirus vaccine+inakt. calicivirus-antigen+lev. chlamy |
| QI06AJ03 | Lev. rhinotracheitis+panleucopeni/parvovirusvaccine+inakt. calicivirus-a |
| QI06AJ04 | Katte-rhinotracheitis+katte-calicivirus+klamydia+katte-panleucopeni+katt |
| QI06AJ05 | Levende katte rhinotracheitisvirus+panleucopeni/parvovirus+leukæmivirus+ |
| QI06AK | Inakt. virale og levende balterielle vacciner |
| QI06AL | Inaktiverede virale og bakterielle vacciner |
| QI06AL01 | Inakt. panleucopeni/parvovirus+ rhinotracheitisvirus+ calicivirus+ leukæ |
| QI06AL02 | Inakt. panleucopenivirus+rhinotracheitisvirus+calicivirus+chlamydia vacc |
| QI06AL03 | Inakt. rhinotracheitisvirus+calicivirus+chlamydia vaccine |
| QI06AM | Antisera, immunglobulin-præparater og antitoxiner |
| QI06AM01 | Panleucopenivirus+rhinotracheitisvirus+calicivirus antiserum |
| QI06AN | Levende parasitære vacciner |
| QI06AO | Inaktiverede parasitære vacciner |
| QI06AP | Levende fungale vacciner |
| QI06AP01 | Trichophyton vaccine |
| QI06AP02 | Trichophyton+microsporum vaccine |
| QI06AQ | Inaktiverede fungale vacciner |
| QI06AQ01 | Trichophyton+microsporum vaccine |
| QI06AQ02 | Microsporum vaccine |
| QI06AR | In vivo diagnostiske præparater |
| QI06AS | Allergener |
| QI06AT | Colostrum præparater og substitutter |
| QI06AU | Andre levende vacciner |
| QI06AV | Andre inaktiverede vacciner |
| QI06AX | Andre immunologica til katte |
| QI06X | Andre felidae |
| QI07 | Immunologica til canidae |
| QI07A | Immunologica til hunde |
| QI07AA | Inaktiverede virale vacciner |
| QI07AA01 | Parvovirus vaccine |
| QI07AA02 | Rabiesvirus vaccine |
| QI07AA03 | Parainfluenzavirus+reovirus+influenzavirus vaccine |
| QI07AA04 | Parainfluenzavirus vaccine |
| QI07AA05 | Adenovirus vaccine |
| QI07AA06 | Herpesvirus vaccine |
| QI07AA07 | Influenzavirus vaccine |
| QI07AB | Inakt. bakterielle vacciner (inkl. mycoplasma, toxoid og chlamydia vacci |
| QI07AB01 | Leptospira vaccine |
| QI07AB02 | Stafylokok vaccine |
| QI07AB03 | Bordetella vaccine |
| QI07AB04 | Borrelia vaccine |
| QI07AC | Inaktiverede bakterielle vacciner og antisera |
| QI07AD | Levende virale vacciner |
| QI07AD01 | Parvovirus vaccine |
| QI07AD02 | Distemper virus+adenovirus+parvovirus vaccine |
| QI07AD03 | Distemper virus+parvovirus vaccine |
| QI07AD04 | Distemper virus+adenovirus+parvovirus+parainfluenzavirus vaccine |
| QI07AD05 | Distemper virus vaccine |
| QI07AD06 | Distemper virus+adenovirus vaccine |
| QI07AD07 | Distemper virus+parainfluenzavirus vaccine |
| QI07AD08 | Parainfluenzavirus vaccine |
| QI07AD09 | Parvovirus+parainfluenzavirus vaccine |
| QI07AD10 | Distemper virus+adenovirus+parainfluenzavirus vaccine |
| QI07AD11 | Coronavirus vaccine |
| QI07AD12 | Coronavirus+parvovirus vaccine |
| QI07AD13 | Parapox virus vaccine |
| QI07AD14 | Distemper virus vaccine baseret på mæslingevirus |
| QI07AE | Levende bakterielle vacciner |
| QI07AE01 | Bordetella vaccine |
| QI07AF | Levende bakterielle og virale vacciner |
| QI07AF01 | Bordetella + parainfluenza virus |
| QI07AF02 | Bordetella + adenovirus + parainfluenza virus |
| QI07AG | Levende og inaktiverede bakterielle vacciner |
| QI07AH | Levende og inaktiverede virale vacciner |
| QI07AH01 | Lev. distemper virus+inakt. adenovirus+parvovirus vaccine |
| QI07AH02 | Lev. parainfluenzavirus+inakt. parvovirus vaccine |
| QI07AH03 | Lev. distemper virus+parainfluenzavirus+inakt. adenovirus+parvovirus vac |
| QI07AH04 | Lev. distemper virus + parvovirus + inakt. coronavirus vaccine |
| QI07AH05 | Levende (distempervirus+adenovirus+parvovirus+parainfluenzavirus) + inak |
| QI07AH06 | Levende parainfluenza virus + inaktiveret katte coronavirus |
| QI07AI | Levende virale og inakt. bakterielle vacciner |
| QI07AI01 | Lev. distemper virus+adenovirus+inakt. leptospira vaccine |
| QI07AI02 | Lev. distemper virus+adenovirus+parainfluenzavirus+parvovirus+inakt. lep |
| QI07AI03 | Lev. distemper virus+adenovirus+parvovirus+inakt. leptospira vaccine |
| QI07AI04 | Lev. distemper virus+inakt. leptospira vaccine |
| QI07AI05 | Lev. parvovirus+inakt. leptospira vaccine |
| QI07AI06 | Lev. distemper virus+parvovirus+inakt. leptospira vaccine |
| QI07AI07 | Lev. parvovirus+parainfluenzavirus vaccine+inakt. leptospira vaccine |
| QI07AI08 | Lev. parainfluenzavirus vaccine + inakt. leptospira vaccine |
| QI07AJ | Levende virale og inakt. virale og bakterielle vacciner |
| QI07AJ01 | Lev. distemper virus+inakt. adenovirus+rabiesvirus+leptospira vaccine |
| QI07AJ02 | Lev. distemper virus+inakt. adenovirus+leptospira vaccine |
| QI07AJ03 | Lev. distemper virus+inakt. adenovirus+parvovirus+leptospira vaccine |
| QI07AJ04 | Lev. distemper virus+inakt. adenovirus+parvovirus+rabiesvirus+leptospira |
| QI07AJ05 | Lev. distemper virus+adenovirus+parvovirus+inakt. rabiesvirus+leptospira |
| QI07AJ06 | Lev. distemper virus+adenovirus+parainfluenzavirus parvovirus+inakt. rab |
| QI07AJ07 | Lev. distemper virus+adenovirus+inakt. rabiesvirus+leptospira vaccine |
| QI07AJ08 | Lev. distemper virus+adenovirus+inakt. parvovirus+leptospira vaccine |
| QI07AJ09 | Lev. distemper virus+adenovirus+parvovirus+inakt. leptospira vaccine |
| QI07AJ10 | Lev. distempervirus+adenovirus+parainfluenzavirus+parvovirus+inakt. coro |
| QI07AJ11 | Lev. parvovirus+parainfluenzavirus vaccine+inakt. leptospira+coronavirus |
| QI07AJ12 | Lev. parainfluenzavirus vaccine+inakt. leptospira+coronavirus vaccine |
| QI07AK | Inakt. virale og levende bakterielle vacciner |
| QI07AL | Inaktiverede virale og bakterielle vacciner |
| QI07AL01 | Inakt. rabiesvirus+leptospira vaccine |
| QI07AL02 | Inakt. rabiesvirus+parvovirus+leptospira vaccine |
| QI07AL03 | Inakt. distemper virus+adenovirus+parvovirus+rabiesvirus+leptospira vacc |
| QI07AL04 | Inakt. parvovirus+leptospira vaccine |
| QI07AL05 | Inakt. parainfluenzavirus+bordetella vaccine |
| QI07AM | Antisera, immunglobulin-præparater og antitoxiner |
| QI07AM01 | Distemper virus+adenovirus+parvovirus+leptospira antiserum |
| QI07AM02 | Anti-lipopolysaccharid antiserum |
| QI07AM03 | Distemper virus+adenovirus+parvovirus antiserum |
| QI07AM04 | Slangegift antiserum |
| QI07AN | Levende parasitære vacciner |
| QI07AO | Inaktiverede parasitære vacciner |
| QI07AO01 | Leishmania |
| QI07AP | Levende fungale vacciner |
| QI07AQ | Inaktiverede fungale vacciner |
| QI07AQ01 | Trichophyton+microsporum vaccine |
| QI07AQ02 | Microsporum vaccine |
| QI07AR | In vivo diagnostiske præparater |
| QI07AS | Allergener |
| QI07AT | Colostrum præparater og substitutter |
| QI07AU | Andre levende vacciner |
| QI07AV | Andre inaktiverede vacciner |
| QI07AV01 | Stafylokok + bacteriofag vaccine |
| QI07AX | Andre immunologica til hunde |
| QI07B | Immunologica til ræve |
| QI07BA | Inaktiverede virale vacciner |
| QI07BB | Inaktiverede bakterielle vacciner |
| QI07BC | Inaktiverede bakterielle vacciner og antisera |
| QI07BD | Levende virale vacciner |
| QI07BE | Levende bakterielle vacciner |
| QI07BF | Levende bakterielle og virale vacciner |
| QI07BG | Levende og inakt. bakterielle vacciner |
| QI07BH | Levende og inakt. virale vacciner |
| QI07BI | Levende virale og inakt. bakterielle vacciner |
| QI07BJ | Levende virale og inakt. virale og bakterielle vacciner |
| QI07BK | Inaktiverede virale og levende bakterielle vacciner |
| QI07BL | Inaktiverede virale og bakterielle vacciner |
| QI07BM | Antisera, immunglobulin-præparater og antitoxiner |
| QI07BN | Levende parasitære vacciner |
| QI07BO | Inaktiverede parasitære vacciner |
| QI07BP | Levende fungale vacciner |
| QI07BQ | Inaktiverede fungale vacciner |
| QI07BR | In vivo diagnostiske præparater |
| QI07BS | Allergener |
| QI07BT | Colostrum præparater og substitutter |
| QI07BU | Andre levende vacciner |
| QI07BV | Andre inaktiverede vacciner |
| QI07BX | Andre immunologica til ræve |
| QI07X | Andre canidae |
| QI07XA | Inaktiverede virale vacciner |
| QI07XB | Inaktiverede bakterielle vacciner |
| QI07XC | Inaktiverede bakterielle vacciner og antisera |
| QI07XD | Levende virale vacciner |
| QI07XE | Levende bakterielle vacciner |
| QI07XF | Levende bakterielle og virale vacciner |
| QI07XG | Levende og inaktiverede bakterielle vacciner |
| QI07XH | Levende og inaktiverede virale vacciner |
| QI07XI | Lev. virale og inakt. bakterielle vacciner |
| QI07XJ | Lev. virale og inakt. virale og bakterielle vacciner |
| QI07XK | Inakt. virale og lev. bakterielle vacciner |
| QI07XL | Inakt. virale og bakterielle vacciner |
| QI07XM | Antisera, immunglobulin-præparater og antitoxiner |
| QI07XN | Levende parasitære vacciner |
| QI07XO | Inaktiverede parasitære vacciner |
| QI07XP | Levende fungale vacciner |
| QI07XQ | Inaktiverede fungale vacciner |
| QI07XR | In vivo diagnostiske præparater |
| QI07XS | Allergener |
| QI07XT | Colostrum præparater og substitutter |
| QI07XU | Andre levende vacciner |
| QI07XV | Andre inaktiverede vacciner |
| QI07XX | Andre immunologiske præparater til canidae |
| QI08 | Immunologica til leporidae |
| QI08A | Immunologica til kaniner |
| QI08AA | Inaktiverede virale vacciner |
| QI08AA01 | Rabbit hemmorhagic disease virus vaccine |
| QI08AA02 | Distemper virus vaccine |
| QI08AB | Inakt. bakterielle vacciner (inkl. mycoplasma, toxoid og chlamydia vacci |
| QI08AB01 | Pasteurella + bordetella vaccine |
| QI08AB02 | Pasteurella vaccine |
| QI08AB03 | Clostridium |
| QI08AC | Inakt. bakterielle vacciner og antisera |
| QI08AD | Levende virale vacciner |
| QI08AD01 | Shope fibroma virus vaccine |
| QI08AD02 | Myxomatosevirus vaccine |
| QI08AE | Levende bakterielle vacciner |
| QI08AF | Levende bakterielle og virale vacciner |
| QI08AG | Levende og inakt. bakterielle vacciner |
| QI08AH | Levende og inakt. virale vacciner |
| QI08AH01 | Lev. myxomatosevirus + inakt. rabbit haemorrhagic disease virus vaccine |
| QI08AI | Lev. virale og inakt. bakterielle vacciner |
| QI08AJ | Lev. virale og inakt. virale og bakterielle vacciner |
| QI08AK | Inakt. virale og lev. bakterielle vacciner |
| QI08AL | Inakt. virale og bakterielle vacciner |
| QI08AM | Antisera, immunglobulin-præparater og antitoxiner |
| QI08AN | Levende parasitære vacciner |
| QI08AO | Inaktiverede parasitære vacciner |
| QI08AP | Levende fungale vacciner |
| QI08AQ | Inaktiverede fungale vacciner |
| QI08AQ01 | Trichophyton + microsporum vaccine |
| QI08AR | In-vivo diagnostiske præparater |
| QI08AS | Allergener |
| QI08AT | Colostrum præparater og substitutter |
| QI08AU | Andre levende vacciner |
| QI08AV | Andre inaktiverede vacciner |
| QI08AX | Andre immunologica til kaniner |
| QI08B | Immunologica til harer |
| QI08X | Immunologica til andre leporidae |
| QI09 | Immunologiske midler til svin |
| QI09A | Immunologica til svin |
| QI09AA | Inaktiverede virale vacciner |
| QI09AA01 | Aujeszkys syge virus vaccine |
| QI09AA02 | Parvovirus vaccine |
| QI09AA03 | Influenzavirus vaccine |
| QI09AA04 | Aujeszkys syge+influenzavirus vaccine |
| QI09AA05 | Prrs-virus vaccine |
| QI09AA06 | Klassisk svinefeber-virus vaccine |
| QI09AA07 | Circovirus vaccine |
| QI09AB | Inakt. bakterielle vacciner (inkl. mycoplasma, toxoid og chlamydia vacci |
| QI09AB01 | Treponema vaccine |
| QI09AB02 | Escherichia vaccine |
| QI09AB03 | Erysipelothrix vaccine |
| QI09AB04 | Bordetella + pasteurella vaccine |
| QI09AB05 | Pasteurella vaccine |
| QI09AB06 | Actinobacillus/haemophilus + pasteurella vaccine |
| QI09AB07 | Actinobacillus/haemophilus vaccine |
| QI09AB08 | Escherichia + clostridium vaccine |
| QI09AB09 | Escherichia + erysipelothrix vaccine |
| QI09AB10 | Pasteurella + stafylokok + corynebacterium vaccine |
| QI09AB11 | Escherichia + pasteurella + salmonella + streptokok vaccine |
| QI09AB12 | Clostridium vaccine |
| QI09AB13 | Mycoplasma vaccine |
| QI09AB14 | Salmonella vaccine |
| QI09AB15 | Escherichia + erysipelothrix + clostridium vaccine |
| QI09AB16 | Bordetella + pasteurella + mycoplasma vaccine |
| QI09AB17 | Mycoplasma + haemophilus vaccine |
| QI09AB18 | Lawsonia |
| QI09AC | Inaktiverede bakterielle vacciner og antisera |
| QI09AD | Levende virale vacciner |
| QI09AD01 | Aujeszkys syge virus vaccine |
| QI09AD02 | Overførbar gastroenteritis (tge) virus vaccine |
| QI09AD03 | Porcint reproduktions- og respirationssyndrom (prrs) virus vaccine |
| QI09AD04 | Klassisk svinefeber-virus vaccine |
| QI09AE | Levende bakterielle vacciner |
| QI09AE01 | Erysipelothrix vaccine |
| QI09AE02 | Salmonella vaccine |
| QI09AE03 | Escherichia vaccine |
| QI09AE04 | Lawsonia vaccine |
| QI09AF | Levende bakterielle og virale vacciner |
| QI09AG | Levende og inaktiverede bakterielle vacciner |
| QI09AH | Levende og inaktiverede virale vacciner |
| QI09AH01 | Levende aujeszkys syge og inaktiveret influenzavirus vaccine |
| QI09AI | Levende virale og inaktiverede bakterielle vacciner |
| QI09AJ | Levende virale og inaktiverede virale og bakterielle vacciner |
| QI09AK | Inaktiverede virale og levende bakterielle vacciner |
| QI09AL | Inaktiverede virale og bakterielle vacciner |
| QI09AL01 | Inaktiveret parvovirus+erysipelothrix vaccine |
| QI09AL02 | Inaktiveret rotavirus+escherichia vaccine |
| QI09AL03 | Inaktiveret parvovirus+escherichia+erysipelothrix vaccine |
| QI09AL04 | Inaktiveret influenzavirus+erysipelothrix vaccine |
| QI09AL05 | Inakt. overførbar gastroenteritis+escherichia+clostridium vaccine |
| QI09AL06 | Inaktiveret parvovirus+influenzavirus+erysipelothrix vaccine |
| QI09AL07 | Inakt. parvovirus+erysipelothrix+leptospira vaccine |
| QI09AL08 | Porcint circovirus + mycoplasma |
| QI09AL09 | Porcint rotavirus + escherichia + clostridium |
| QI09AM | Antisera, immunglobuliner og antitoxiner |
| QI09AM01 | Escherichia antiserum |
| QI09AM02 | Pasteurella antiserum |
| QI09AM03 | Erysipelothrix antiserum |
| QI09AM04 | Clostridium antiserum |
| QI09AN | Levende parasitære vacciner |
| QI09AO | Inaktiverede parasitære vacciner |
| QI09AP | Levende fungale vacciner |
| QI09AQ | Inaktiverede fungale vacciner |
| QI09AR | In vivo diagnostiske præparater |
| QI09AS | Allergener |
| QI09AT | Colostrum præparater og substitutter |
| QI09AU | Andre levende vacciner |
| QI09AV | Andre inaktiverede vacciner |
| QI09AX | Andre immunologiske midler |
| QI09X | Andre suidae |
| QI10 | Immunologica til fisk |
| QI10A | Immunologica til atlanterhavslaks |
| QI10AA | Inaktiverede virale vacciner |
| QI10AA01 | Salmon pancreas disease virus vaccine |
| QI10AA02 | Salmon pancreas disease (spd), proteinkodende plasmid |
| QI10AB | Inakt. bakterielle vacciner (inkl. mycoplasma, toxoid og chlamydia vacci |
| QI10AB01 | Aeromonas vaccine |
| QI10AB02 | Aeromonas + vibrio vaccine |
| QI10AB03 | Aeromonas + moritella + vibrio vaccine |
| QI10AB04 | Yersinia |
| QI10AB05 | Moritella |
| QI10AC | Inakt. bakterielle vacciner og antisera |
| QI10AD | Levende virale vacciner |
| QI10AE | Levende bakterielle vacciner |
| QI10AF | Levende bakterielle og virale vacciner |
| QI10AG | Levende og inakt. bakterielle vacciner |
| QI10AH | Levende og inakt. virale vacciner |
| QI10AI | Lev. virale og inakt. bakterielle vacciner |
| QI10AJ | Lev. virale og inakt. virale og bakterielle vacciner |
| QI10AK | Inakt. virale og lev. bakterielle vacciner |
| QI10AL | Inakt. virale og bakterielle vacciner |
| QI10AL01 | Inakt. ipn-virus+aeromonas+vibrio vaccine |
| QI10AL02 | Ipn virus + aeromonas + moritella + vibrio |
| QI10AL03 | Infektiøs pankreasenekrosevirus (ipn) + aeromona |
| QI10AL04 | Infektiøs pankreasnekrosevirus+infek. lakseanæmivirus+aeromonas+moritell |
| QI10AL05 | Ipn nec. virus+pancreatic disease (spd) virus+aeromonas+moritella+vibrio |
| QI10AM | Antisera, immunglobuliner og antitoxiner |
| QI10AN | Levende parasitære vacciner |
| QI10AO | Inakt. parasitære vacciner |
| QI10AP | Levende fungale vacciner |
| QI10AQ | Inaktiverede fungale vacciner |
| QI10AR | In-vivo diagnostiske præparater |
| QI10AS | Allergener |
| QI10AT | Colostrum præparater og substitutter |
| QI10AU | Andre levende vacciner |
| QI10AV | Andre inaktiverede vacciner |
| QI10AX | Andre immunologica til atlanterhavslaks |
| QI10B | Immunologica til regnbueørreder |
| QI10BA | Inaktiverede virale vacciner |
| QI10BB | Inakt. bakt. vacciner (inkl. mycoplasma, toxoid og chlamydia vacciner) |
| QI10BB01 | Vibrio vaccine |
| QI10BB02 | Aeromonas+vibrio vaccine |
| QI10BB03 | Yersinia vaccine |
| QI10BB04 | Aeromonas + moritella + vibrio + flavobacterium |
| QI10BC | Inakt. bakterielle vacciner og antisera |
| QI10BD | Levende virale vacciner |
| QI10BE | Levende bakterielle vacciner |
| QI10BF | Levende bakterielle og virale vacciner |
| QI10BG | Levende og inakt. bakterielle vacciner |
| QI10BH | Levende og inakt. virale vacciner |
| QI10BI | Lev. virale og inakt. bakterielle vacciner |
| QI10BJ | Lev. virale og inakt. virale og bakterielle vacciner |
| QI10BK | Inakt. virale og lev. bakterielle vacciner |
| QI10BL | Inakt. virale og bakterielle vacciner |
| QI10BM | Antisera, immunglobulin-præparater og antitoxiner |
| QI10BN | Levende parasitære vacciner |
| QI10BO | Inakt. parasitære vacciner |
| QI10BP | Levende fungale vacciner |
| QI10BQ | Inakt. fungale vacciner |
| QI10BR | In-vivo diagnostiske præparater |
| QI10BS | Allergener |
| QI10BT | Colostrum præparater og substitutter |
| QI10BU | Andre levende vacciner |
| QI10BV | Andre inaktiverede vacciner |
| QI10BX | Andre immunologica til regnbueørreder |
| QI10C | Immunologica til karper |
| QI10D | Immunologica til pighvar |
| QI10E | Immunologica til akvariefisk |
| QI10F | Atlantisk torsk |
| QI10FB | Inaktiverede bakterievacciner (inkl. mycoplasma, anatoksin og klamydia) |
| QI10FB01 | Vibrio |
| QI10FB02 | Aeromonas+vibrio |
| QI10X | Immunologica til andre fisk |
| QI11 | Immunologiske midler til gnavere |
| QI11A | Immunologica til rotter |
| QI11B | Immunologica til mus |
| QI11C | Immunologica til marsvin |
| QI11X | Immunologica til andre gnavere |
| QI20 | Immunologica, andre dyrearter |
| QI20A | Immunologica til kronhjorte |
| QI20AA | Inaktiverede virale vacciner |
| QI20AB | Inakt. bakterielle vacciner (inkl. mycoplasma, toxoid og chlamydia vacci |
| QI20AB01 | Mycobakteria vaccine |
| QI20AC | Inakt. bakterielle vacciner og antisera |
| QI20AD | Levende virale vacciner |
| QI20AE | Levende bakterielle vacciner |
| QI20AF | Levende bakterielle og virale vacciner |
| QI20AG | Levende og inakt. bakterielle vacciner |
| QI20AH | Levende og inakt. virale vacciner |
| QI20AI | Levende virale og inakt. bakterielle vacciner |
| QI20AJ | Lev. virale og inakt. virale og bakterielle vacciner |
| QI20AK | Inakt. virale og levende bakterielle vacciner |
| QI20AL | Inakt. virale og bakterielle vacciner |
| QI20AM | Antisera, immunglobulin-præparater og antitoxiner |
| QI20AN | Levende parasitære vacciner |
| QI20AO | Inaktiverede parasitære vacciner |
| QI20AP | Levende fungale vacciner |
| QI20AQ | Inaktiverede fungale vacciner |
| QI20AR | In-vivo diagnostiske præparater |
| QI20AS | Allergener |
| QI20AT | Colostrum præparater og substitutter |
| QI20AU | Andre levende vacciner |
| QI20AV | Andre inaktiverede vacciner |
| QI20AX | Andre immunologica til kronhjorte |
| QI20B | Immunologica til rensdyr |
| QI20C | Immunologica til mink |
| QI20CA | Inaktiverede virale vacciner |
| QI20CA01 | Mink enteritis virus vaccine |
| QI20CB | Inakt. bakterielle vacciner (inkl. mycoplasma, toxoid og chlamydia vacci |
| QI20CB01 | Clostridium |
| QI20CC | Inakt. bakterielle vacciner og antisera |
| QI20CD | Levende virale vacciner |
| QI20CD01 | Distemper virus vaccine |
| QI20CE | Levende bakterielle vacciner |
| QI20CF | Levende bakterielle og virale vacciner |
| QI20CG | Levende og inakt. bakterielle vacciner |
| QI20CH | Levende og inakt. virale vacciner |
| QI20CH01 | Levende mink distemper virus + inaktiveret mink enteritis virus |
| QI20CI | Lev. virale og inakt. bakterielle vacciner |
| QI20CJ | Lev. virale og inakt. virale og bakterielle vacciner |
| QI20CJ01 | Lev. distemper virus+inakt. parvovirus/minkenteritisvirus+clostridium+ps |
| QI20CK | Inakt. virale og lev. bakterielle virus |
| QI20CL | Inakt. virale og bakterielle vacciner |
| QI20CL01 | Inakt. parvovirus/minkenteritisvirus+clostridium+pseudomonas vaccine |
| QI20CL02 | Inakt. parvovirus+clostridium vaccine |
| QI20CM | Antisera, immunglobulin-præparater og antitoxiner |
| QI20CN | Levende parasitære vacciner |
| QI20CO | Inaktiverede parasitære vacciner |
| QI20CP | Levende fungale vacciner |
| QI20CQ | Inaktiverede fungale vacciner |
| QI20CR | In-vivo diagnostiske præparater |
| QI20CS | Allergener |
| QI20CT | Colostrum præparater og substitutter |
| QI20CU | Andre levende vacciner |
| QI20CV | Andre inaktiverede vacciner |
| QI20CX | Andre immunologica til mink |
| QI20D | Immunologica til fritter |
| QI20DA | Inaktiverede virale vacciner |
| QI20DB | Inakt. bakterielle vacciner (inkl. mycoplasma, toxoid og chlamydia vacci |
| QI20DC | Inakt. bakterielle vacciner og antisera |
| QI20DD | Levende virale vacciner |
| QI20DD01 | Ferret distempervirus |
| QI20DE | Levende bakterielle vacciner |
| QI20DF | Levende bakterielle og virale vacciner |
| QI20DG | Levende og inakt. bakterielle vacciner |
| QI20DH | Levende og inakt. virale vacciner |
| QI20DI | Levende virale og inakt. bakterielle vacciner |
| QI20DJ | Lev. virale og inakt. virale og bakterielle vacciner |
| QI20DK | Inakt. virale og lev. bakterielle vacciner |
| QI20DL | Inakt. virale og bakterielle vacciner |
| QI20DM | Antisera, immunglobulin-præparater og antitoxiner |
| QI20DN | Levende parasitære vacciner |
| QI20DO | Inaktiverede parasitære vacciner |
| QI20DP | Levende fungale vacciner |
| QI20DQ | Inaktiverede fungale vacciner |
| QI20DR | In-vivo diagnostiske præparater |
| QI20DS | Allergener |
| QI20DT | Colostrum præparater og substitutter |
| QI20DU | Andre levende vacciner |
| QI20DV | Andre inaktiverede vacciner |
| QI20DX | Andre immunologica til fritter |
| QI20E | Immunologica til slanger |
| QI20F | Immunologica til bier |
| QI20X | Immunologica, andre dyrearter |
| QI20XE | Levende bakterievacciner |
| QI20XE01 | Mycobakterie |
| QJ | Generelle antiinfektiva til systemisk brug |
| QJ01 | Antibakterika til systemisk brug |
| QJ01A | Tetracycliner |
| QJ01AA | Tetracycliner |
| QJ01AA01 | Demeclocyclin |
| QJ01AA02 | Doxycyclin |
| QJ01AA03 | Chlortetracyclin |
| QJ01AA04 | Lymecyclin |
| QJ01AA05 | Metacyclin |
| QJ01AA06 | Oxytetracyclin |
| QJ01AA07 | Tetracyclin |
| QJ01AA08 | Minocyclin |
| QJ01AA09 | Rolitetracyclin |
| QJ01AA10 | Penimepicyclin |
| QJ01AA11 | Clomocyclin |
| QJ01AA12 | Tigecyclin |
| QJ01AA13 | Eravacyclin |
| QJ01AA14 | Sarecyclin |
| QJ01AA15 | Omadacyclin |
| QJ01AA20 | Tetracycliner i komb. |
| QJ01AA53 | Chlortetracyclin, komb. |
| QJ01AA56 | Oxytetracyclin, kombinationer |
| QJ01B | Amphenicoler |
| QJ01BA | Amphenicoler |
| QJ01BA01 | Chloramphenicol |
| QJ01BA02 | Thiamphenicol |
| QJ01BA52 | Thiamphenicol, komb. |
| QJ01BA90 | Florfenicol |
| QJ01BA99 | Amphenicoler, komb. |
| QJ01C | Beta-lactam antibakterika, penicilliner |
| QJ01CA | Penicilliner med udvidet spektrum |
| QJ01CA01 | Ampicillin |
| QJ01CA02 | Pivampicillin |
| QJ01CA03 | Carbenicillin |
| QJ01CA04 | Amoxicillin |
| QJ01CA05 | Carindacillin |
| QJ01CA06 | Bacampicillin |
| QJ01CA07 | Epicillin |
| QJ01CA08 | Pivmecillinam |
| QJ01CA09 | Azlocillin |
| QJ01CA10 | Mezlocillin |
| QJ01CA11 | Mecillinam |
| QJ01CA12 | Piperacillin |
| QJ01CA13 | Ticarcillin |
| QJ01CA14 | Metampicillin |
| QJ01CA15 | Talampicillin |
| QJ01CA16 | Sulbenicillin |
| QJ01CA17 | Temocillin |
| QJ01CA18 | Hetacillin |
| QJ01CA19 | Aspoxicillin |
| QJ01CA20 | Komb. penicilliner m. udvidet spektrum |
| QJ01CA51 | Ampicillin, komb. |
| QJ01CE | Beta-lactamase-følsomme penicilliner |
| QJ01CE01 | Benzylpenicillin (penicillin g) |
| QJ01CE02 | Phenoxymethylpenicillin (penicillin v) |
| QJ01CE03 | Propicillin |
| QJ01CE04 | Azidocillin |
| QJ01CE05 | Pheneticillin |
| QJ01CE06 | Penamecillin |
| QJ01CE07 | Clometocillin |
| QJ01CE08 | Benzathinbenzylpenicillin |
| QJ01CE09 | Procainpenicillin (ban) |
| QJ01CE10 | Benzathinphenoxymethylpenicillin |
| QJ01CE30 | Komb. af beta-lactamase-følsomme penicilliner |
| QJ01CE90 | Penethamathydroiodid (ban) |
| QJ01CE91 | Benethaminpenicillin |
| QJ01CF | Beta-lactamase-resistente penicilliner |
| QJ01CF01 | Dicloxacillin |
| QJ01CF02 | Cloxacillin |
| QJ01CF03 | Methicillin |
| QJ01CF04 | Oxacillin |
| QJ01CF05 | Flucloxacillin |
| QJ01CF06 | Nafcillin |
| QJ01CG | Beta-lactamase-hæmmere |
| QJ01CG01 | Sulbactam |
| QJ01CG02 | Tazobactam |
| QJ01CR | Komb. af penicilliner, incl. beta-lactamase-hæmmere |
| QJ01CR01 | Ampicillin og beta-lactamaseinhibitor |
| QJ01CR02 | Amoxicillin og beta-lactamaseinhibitor |
| QJ01CR03 | Ticarcillin og beta-lactamaseinhibitor |
| QJ01CR04 | Sultamicillin |
| QJ01CR05 | Piperacillin og beta-lactamaseinhibitor |
| QJ01CR50 | Kombinationer af penicilliner |
| QJ01D | Andre beta-lactam antibakterika |
| QJ01DB | Cephalosporiner, 1. generation |
| QJ01DB01 | Cefalexin |
| QJ01DB02 | Cefaloridin |
| QJ01DB03 | Cefalotin |
| QJ01DB04 | Cefazolin |
| QJ01DB05 | Cefadroxil |
| QJ01DB06 | Cefazedon |
| QJ01DB07 | Cefatrizin |
| QJ01DB08 | Cefapirin |
| QJ01DB09 | Cefradin |
| QJ01DB10 | Cefacetril |
| QJ01DB11 | Cefroxadin |
| QJ01DB12 | Ceftezol |
| QJ01DC | Cephalosporiner, 2. generation |
| QJ01DC01 | Cefoxitin |
| QJ01DC02 | Cefuroxim |
| QJ01DC03 | Cefamandol |
| QJ01DC04 | Cefaclor |
| QJ01DC05 | Cefotetan |
| QJ01DC06 | Cefonicid |
| QJ01DC07 | Cefotiam |
| QJ01DC08 | Loracarbef |
| QJ01DC09 | Cefmetazol |
| QJ01DC10 | Cefprozil |
| QJ01DC11 | Ceforanid |
| QJ01DC12 | Cefminox |
| QJ01DC13 | Cefbuperazon |
| QJ01DC14 | Flomoxef |
| QJ01DC52 | Cefuroxim og beta-lactamasehæmmer |
| QJ01DD | Cephalosporiner, 3. generation |
| QJ01DD01 | Cefotaxim |
| QJ01DD02 | Ceftazidim |
| QJ01DD03 | Cefsulodin |
| QJ01DD04 | Ceftriaxon |
| QJ01DD05 | Cefmenoxim |
| QJ01DD06 | Latamoxef |
| QJ01DD07 | Ceftizoxim |
| QJ01DD08 | Cefixim |
| QJ01DD09 | Cefodizim |
| QJ01DD10 | Cefetamet |
| QJ01DD11 | Cefpiramid |
| QJ01DD12 | Cefoperazon |
| QJ01DD13 | Cefpodoxim |
| QJ01DD14 | Ceftibuten |
| QJ01DD15 | Cefdinir |
| QJ01DD16 | Cefditoren |
| QJ01DD17 | Cefcapen |
| QJ01DD18 | Cefteram |
| QJ01DD51 | Cefotaxim og beta-lactamaseinhibitor |
| QJ01DD52 | Ceftazidim og beta-lactamaseinhibitor |
| QJ01DD58 | Cefixim og beta-lactamasehæmmer |
| QJ01DD62 | Cefoperazon og beta-lactamaseinhibitor |
| QJ01DD63 | Ceftriaxon og beta-lactamaseinhibitor |
| QJ01DD64 | Cefpodoxim og beta-lactamaseinhibitor |
| QJ01DD90 | Ceftiofur |
| QJ01DD91 | Cefovecin |
| QJ01DD99 | Ceftiofur, kombinationer |
| QJ01DE | Cephalosporiner, 4. generation |
| QJ01DE01 | Cefepim |
| QJ01DE02 | Cefpirom |
| QJ01DE03 | Cefozopran |
| QJ01DE51 | Cefepim og beta-lactamasehæmmer |
| QJ01DE90 | Cefquinom |
| QJ01DF | Monobactamer |
| QJ01DF01 | Aztreonam |
| QJ01DF02 | Carumonam |
| QJ01DF51 | Aztreonam og beta-lactamase hæmmer |
| QJ01DH | Carbapenemer |
| QJ01DH02 | Meropenem |
| QJ01DH03 | Ertapenem |
| QJ01DH04 | Doripenem |
| QJ01DH05 | Biapenem |
| QJ01DH06 | Tebipenem-pivoxil |
| QJ01DH51 | Imipenem og cilastatin |
| QJ01DH52 | Meropenem og vaborbactam |
| QJ01DH55 | Panipenem og betamipron |
| QJ01DH56 | Imipenem, cilastatin og relebactam |
| QJ01DI | Andre cephalosporiner og penemer |
| QJ01DI01 | Ceftobiprolmedocaril |
| QJ01DI02 | Ceftarolin fosamil |
| QJ01DI03 | Faropenem |
| QJ01DI04 | Cefiderocol |
| QJ01DI54 | Ceftolozan og beta-lactamaseinhibitor |
| QJ01E | Sulfonamider og trimethoprim |
| QJ01EA | Trimethoprim og derivater |
| QJ01EA01 | Trimethoprim |
| QJ01EA02 | Brodimoprim |
| QJ01EA03 | Iclaprim |
| QJ01EQ | Sulfonamider |
| QJ01EQ01 | Sulfapyrazol |
| QJ01EQ02 | Sulfamethizol |
| QJ01EQ03 | Sulfadimidin |
| QJ01EQ04 | Sulfapyridin |
| QJ01EQ05 | Sulfafurazol |
| QJ01EQ06 | Sulfanilamid |
| QJ01EQ07 | Sulfathiazol |
| QJ01EQ08 | Sulfaphenazol |
| QJ01EQ10 | Sulfadiazin |
| QJ01EQ11 | Sulfamethoxazol |
| QJ01EQ12 | Sulfachlorpyridazin |
| QJ01EQ13 | Sulfadoxin |
| QJ01EQ14 | Sulfatroxazol |
| QJ01EQ15 | Sulfamethoxypyridazin |
| QJ01EQ16 | Sulfazuinoxalin |
| QJ01EQ17 | Sulfamerazin |
| QJ01EQ18 | Sulfamonomethoxin |
| QJ01EQ19 | Sulfalen |
| QJ01EQ21 | Sulfacetamid |
| QJ01EQ30 | Sulfonamider, komb. |
| QJ01EQ59 | Sulfadimethoxin, komb. |
| QJ01EW | Komb. af sulfonamid og trimethoprim, incl. derivater |
| QJ01EW03 | Sulfadimidin og trimethoprim, incl. derivater |
| QJ01EW09 | Sulfadimethoxin og trimethoprim, incl. derivater |
| QJ01EW10 | Sulfadiazin og trimethoprim |
| QJ01EW11 | Sulfamethoxazol og trimethoprim, incl. derivater |
| QJ01EW12 | Sulfachlorpyridazin og trimethoprim, incl. derivater |
| QJ01EW13 | Sulfadoxin og trimethoprim, incl. derivater |
| QJ01EW14 | Sulfatroxazol og trimethoprim, incl. derivater |
| QJ01EW15 | Sulfamethoxypyridazin og trimethoprim, incl. derivater |
| QJ01EW16 | Sulfaquinoxalin og trimethoprim, incl. derivater |
| QJ01EW17 | Sulfamonomethoxin og trimethoprim, inkl. derivater |
| QJ01EW18 | Sulfamerazin og trimethoprim |
| QJ01EW19 | Sulfadimethoxin og ormetoprim |
| QJ01EW30 | Komb. af sulfonamider og trimethoprim, incl. derivater |
| QJ01F | Macrolider, lincosamider og streptograminer |
| QJ01FA | Macrolider |
| QJ01FA01 | Erythromycin |
| QJ01FA02 | Spiramycin |
| QJ01FA03 | Midecamycin |
| QJ01FA05 | Oleandomycin |
| QJ01FA06 | Roxithromycin |
| QJ01FA07 | Josamycin |
| QJ01FA08 | Troleandomycin |
| QJ01FA09 | Clarithromycin |
| QJ01FA10 | Azithromycin |
| QJ01FA11 | Miocamycin |
| QJ01FA12 | Rokitamycin |
| QJ01FA13 | Dirithromycin |
| QJ01FA14 | Flurithromycin |
| QJ01FA15 | Telithromycin |
| QJ01FA16 | Solithromycin |
| QJ01FA90 | Tylosin |
| QJ01FA91 | Tilmicosin |
| QJ01FA92 | Tylvalosin |
| QJ01FA93 | Kitasamycin |
| QJ01FA94 | Tulathromycin |
| QJ01FA95 | Gamithromycin |
| QJ01FA96 | Tildipirosin |
| QJ01FA99 | Macrolider, kombinationer med andre stoffer |
| QJ01FF | Lincosamider |
| QJ01FF01 | Clindamycin |
| QJ01FF02 | Lincomycin |
| QJ01FF52 | Lincomycin, kombinationer |
| QJ01FG | Streptograminer |
| QJ01FG01 | Pristinamycin |
| QJ01FG02 | Quinupristin/dalfopristin |
| QJ01FG90 | Virginiamycin |
| QJ01G | Aminoglycosid-antibakterika |
| QJ01GA | Streptomyciner |
| QJ01GA01 | Streptomycin |
| QJ01GA02 | Streptoduocin |
| QJ01GA90 | Dihydrostreptomycin |
| QJ01GA99 | Kombinationer af streptomyciner |
| QJ01GB | Andre aminoglycosider |
| QJ01GB01 | Tobramycin |
| QJ01GB03 | Gentamicin |
| QJ01GB04 | Kanamycin |
| QJ01GB05 | Neomycin |
| QJ01GB06 | Amikacin |
| QJ01GB07 | Netilmicin |
| QJ01GB08 | Sisomicin |
| QJ01GB09 | Dibekacin |
| QJ01GB10 | Ribostamycin |
| QJ01GB11 | Isepamicin |
| QJ01GB12 | Arbekacin |
| QJ01GB13 | Bekanamycin |
| QJ01GB14 | Plazomicin |
| QJ01GB90 | Apramycin |
| QJ01GB91 | Framycetin |
| QJ01GB92 | Paromomycin |
| QJ01M | Antibakterielle quinoloner og quinoxaliner |
| QJ01MA | Fluoroquinoloner |
| QJ01MA01 | Ofloxacin |
| QJ01MA02 | Ciprofloxacin |
| QJ01MA03 | Pefloxacin |
| QJ01MA04 | Enoxacin |
| QJ01MA05 | Temafloxacin |
| QJ01MA06 | Norfloxacin |
| QJ01MA07 | Lomefloxacin |
| QJ01MA08 | Fleroxacin |
| QJ01MA09 | Sparfloxacin |
| QJ01MA10 | Rufloxacin |
| QJ01MA11 | Grepafloxacin |
| QJ01MA12 | Levofloxacin |
| QJ01MA13 | Trovafloxacin |
| QJ01MA14 | Moxifloxacin |
| QJ01MA15 | Gemifloxacin |
| QJ01MA16 | Gatifloxacin |
| QJ01MA17 | Prulifloxacin |
| QJ01MA18 | Pazufloxacin |
| QJ01MA19 | Garenoxacin |
| QJ01MA21 | Sitafloxacin |
| QJ01MA22 | Tosufloxacin |
| QJ01MA23 | Delafloxacin |
| QJ01MA24 | Levonadifloxacin |
| QJ01MA25 | Lascufloxacin |
| QJ01MA90 | Enrofloxacin |
| QJ01MA92 | Danofloxacin |
| QJ01MA93 | Marbofloxacin |
| QJ01MA94 | Difloxacin |
| QJ01MA95 | Orbifloxacin |
| QJ01MA96 | Ibafloxacin |
| QJ01MA97 | Pradofloxacin |
| QJ01MA98 | Sarafloxacin |
| QJ01MB | Andre quinoloner |
| QJ01MB01 | Rosoxacin |
| QJ01MB02 | Nalidixinsyre |
| QJ01MB03 | Piromidinsyre |
| QJ01MB04 | Pipemidinsyre |
| QJ01MB05 | Oxolinsyre |
| QJ01MB06 | Cinoxacin |
| QJ01MB07 | Flumequin |
| QJ01MB08 | Nemonoxacin |
| QJ01MQ | Quinoxaliner |
| QJ01MQ01 | Olaquindox |
| QJ01R | Kombinationer af antibakterika |
| QJ01RA | Kombinationer af antibakterika |
| QJ01RA01 | Penicilliner, komb. m. andre antibakterika |
| QJ01RA02 | Sulfonamider, komb. m. andre antibakterika, excl. trimethoprim |
| QJ01RA03 | Cefuroxim og metronidazol |
| QJ01RA04 | Spiramycin og metronidazol |
| QJ01RA05 | Levofloxacin og ornidazol |
| QJ01RA06 | Cefepim og amikacin |
| QJ01RA07 | Azithromycin, fluconazol og secnidazol |
| QJ01RA08 | Tetracyclin og oleandomycin |
| QJ01RA09 | Ofloxacin og ornidazol |
| QJ01RA10 | Ciprofloxacin og metronidazol |
| QJ01RA11 | Ciprofloxacin og tinidazol |
| QJ01RA12 | Ciprofloxacin og ornidazol |
| QJ01RA13 | Norfloxacin og tinidazol |
| QJ01RA14 | Norfloxacin og metronidazol |
| QJ01RA15 | Cefixim og ornidazol |
| QJ01RA16 | Cefixim og azithromycin |
| QJ01RA17 | Ofloxacin og nitazoxanid |
| QJ01RA18 | Ofloxacin og tinidazol |
| QJ01RA19 | Tetracyclin og nystatin |
| QJ01RA80 | Nitrofuran-derivater, kombinationer med andre antibakterika |
| QJ01RA90 | Tetracycliner, komb. m. andre antibakterika |
| QJ01RA91 | Macrolider, kombinationer med andre antibakterika |
| QJ01RA92 | Amphenicoler, komb. m. andre antibakterika |
| QJ01RA93 | Cefalosporiner, komb. m. andre antibakterika |
| QJ01RA94 | Lincosamider, komb. med andre antibakterika |
| QJ01RA95 | Polymyxiner, komb. med andre antibakterika |
| QJ01RA96 | Quinoloner, komb. med andre antibakterika |
| QJ01RA97 | Aminoglycosider, komb. med andre antibakterielle midler |
| QJ01RV | Kombinationer af antibakterika og andre stoffer |
| QJ01RV01 | Antibakterika og kortikosteroider |
| QJ01X | Andre antibakterika |
| QJ01XA | Glycopeptid antibakterika |
| QJ01XA01 | Vancomycin |
| QJ01XA02 | Teicoplanin |
| QJ01XA03 | Telavancin |
| QJ01XA04 | Dalbavancin |
| QJ01XA05 | Oritavancin |
| QJ01XB | Polymyxiner |
| QJ01XB01 | Colistin |
| QJ01XB02 | Polymyxin |
| QJ01XC | Steroid-antibakterika |
| QJ01XC01 | Fusidinsyre |
| QJ01XD | Imidazol-derivater |
| QJ01XD01 | Metronidazol |
| QJ01XD02 | Tinidazol |
| QJ01XD03 | Ornidazol |
| QJ01XE | Nitrofuran-derivater |
| QJ01XE01 | Nitrofurantoin |
| QJ01XE02 | Nifurtoinol |
| QJ01XE03 | Furazidin |
| QJ01XE51 | Nitrofurantoin, kombinationer |
| QJ01XE90 | Furazolidin |
| QJ01XE91 | Nifurpirinol |
| QJ01XQ | Pleuromutiliner |
| QJ01XQ01 | Tiamulin |
| QJ01XQ02 | Valnemulin |
| QJ01XX | Andre antibakterika |
| QJ01XX01 | Fosfomycin |
| QJ01XX02 | Xibornol |
| QJ01XX03 | Clofoctol |
| QJ01XX04 | Spectinomycin |
| QJ01XX05 | Methenamin |
| QJ01XX06 | Mandelsyre |
| QJ01XX07 | Nitroxolin |
| QJ01XX08 | Linezolid |
| QJ01XX09 | Daptomycin |
| QJ01XX10 | Bacitracin |
| QJ01XX11 | Tedizolid |
| QJ01XX12 | Lefamulin |
| QJ01XX13 | Gepotidacin |
| QJ01XX55 | Methenamin, komb. |
| QJ01XX93 | Furaltadon |
| QJ01XX95 | Novobiocin |
| QJ02 | Antimykotika til systemisk brug |
| QJ02A | Antimykotika til systemisk brug |
| QJ02AA | Antibiotika |
| QJ02AA01 | Amphotericin |
| QJ02AA02 | Hachimycin |
| QJ02AB | Imidazol-derivater |
| QJ02AB01 | Miconazol |
| QJ02AB02 | Ketoconazol |
| QJ02AB90 | Clotrimazol |
| QJ02AC | Triazol- og tetrazolderivater |
| QJ02AC01 | Fluconazol |
| QJ02AC02 | Itraconazol |
| QJ02AC03 | Voriconazol |
| QJ02AC04 | Posaconazol |
| QJ02AC05 | Isavuconazol |
| QJ02AC06 | Oteseconazol |
| QJ02AX | Andre antimykotika til systemisk brug |
| QJ02AX01 | Flucytosin |
| QJ02AX04 | Caspofungin |
| QJ02AX05 | Micafungin |
| QJ02AX06 | Anidulafungin |
| QJ02AX07 | Ibrexafungerp |
| QJ02AX08 | Rezafunginacetat |
| QJ04 | Antimycobakterica |
| QJ04A | Midler til behandling af tuberculose |
| QJ04AA | Aminosalicylsyre og derivater |
| QJ04AA01 | Aminosalicylsyre |
| QJ04AA02 | Natriumaminosalicylat |
| QJ04AA03 | Calciumaminosalicylat |
| QJ04AB | Antibiotika |
| QJ04AB01 | Cycloserin |
| QJ04AB02 | Rifampicin |
| QJ04AB03 | Rifamycin |
| QJ04AB04 | Rifabutin |
| QJ04AB05 | Rifapentin |
| QJ04AB06 | Enviomycin |
| QJ04AB30 | Capreomycin |
| QJ04AC | Hydrazider |
| QJ04AC01 | Isoniazid |
| QJ04AC02 | Ftivazid |
| QJ04AC51 | Isoniazid, komb. |
| QJ04AD | Thiocarbamid-derivater |
| QJ04AD01 | Protionamid |
| QJ04AD02 | Tiocarlid |
| QJ04AD03 | Ethionamid |
| QJ04AK | Andre midler til behandling af tuberculose |
| QJ04AK01 | Pyrazinamid |
| QJ04AK02 | Ethambutol |
| QJ04AK03 | Terizidon |
| QJ04AK04 | Morinamid |
| QJ04AK05 | Bedaquilin |
| QJ04AK06 | Delamanid |
| QJ04AK07 | Thioacetazon |
| QJ04AK08 | Pretomanid |
| QJ04AM | Komb. af midler til behandling af tuberkulose |
| QJ04AM01 | Streptomycin og isoniazid |
| QJ04AM02 | Rifampicin og isoniazid |
| QJ04AM03 | Ethambutol og isoniazid |
| QJ04AM04 | Thioacetazon og isoniazid |
| QJ04AM05 | Rifampicin, pyrazinamid og isoniazid |
| QJ04AM06 | Rifampicin, pyrazinamid, ethambutol og isoniazid |
| QJ04AM07 | Rifampicin, ethambutol og isoniazid |
| QJ04AM08 | Isoniazid, sulfamethoxazol og trimethoprim |
| QJ04AM09 | Pyrazinamid, ethambutol, isoniazid og lomefloxacin |
| QJ04AM10 | Pyrazinamid, ethambutol, protionamid og lomefloxacin |
| QJ04AM11 | Rifabutin, pyrazinamid og protionamid |
| QJ04AM12 | Rifampicin, pyrazinamid, isoniazid og levofloxacin |
| QJ04B | Midler til behandling af lepra |
| QJ04BA | Midler til behandling af lepra |
| QJ04BA01 | Clofazimin |
| QJ04BA02 | Dapson |
| QJ04BA03 | Aldesulfonnatrium |
| QJ04BA50 | Dapson og rifampicin |
| QJ04BA51 | Dapson, rifampicin og clofazimin |
| QJ05 | Antivirale midler til systemisk brug |
| QJ05A | Direkte virkende antivirale midler |
| QJ05AA | Thiosemicarbazoner |
| QJ05AA01 | Metisazon |
| QJ05AB | Nucleosider og nucleotider exkl. revers transcriptase-hæmmere |
| QJ05AB01 | Aciclovir |
| QJ05AB02 | Idoxuridin |
| QJ05AB03 | Vidarabin |
| QJ05AB06 | Ganciclovir |
| QJ05AB09 | Famciclovir |
| QJ05AB11 | Valaciclovir |
| QJ05AB12 | Cidofovir |
| QJ05AB13 | Penciclovir |
| QJ05AB14 | Valganciclovir |
| QJ05AB15 | Brivudin |
| QJ05AB16 | Remdesivir |
| QJ05AB17 | Brincidofovir |
| QJ05AB18 | Molnupiravir |
| QJ05AC | Cykliske aminer |
| QJ05AC02 | Rimantadin |
| QJ05AC03 | Tromantadin |
| QJ05AD | Phosphonsyre-derivater |
| QJ05AD01 | Foscarnet |
| QJ05AD02 | Fosfonet |
| QJ05AE | Protease-hæmmere |
| QJ05AE01 | Saquinavir |
| QJ05AE02 | Indinavir |
| QJ05AE03 | Ritonavir |
| QJ05AE04 | Nelfinavir |
| QJ05AE05 | Amprenavir |
| QJ05AE07 | Fosamprenavir |
| QJ05AE08 | Atazanavir |
| QJ05AE09 | Tipranavir |
| QJ05AE10 | Darunavir |
| QJ05AE16 | Ensitrelvir |
| QJ05AE30 | Nirmatrelvir og ritonavir |
| QJ05AF | Nucleosid og nucleotid revers transcriptase-hæmmere |
| QJ05AF01 | Zidovudin |
| QJ05AF02 | Didanosin |
| QJ05AF03 | Zalcitabin |
| QJ05AF04 | Stavudin |
| QJ05AF05 | Lamivudin |
| QJ05AF06 | Abacavir |
| QJ05AF07 | Tenofovirdisoproxil |
| QJ05AF08 | Adefovirdipivoxil |
| QJ05AF09 | Emtricitabin |
| QJ05AF10 | Entecavir |
| QJ05AF11 | Darunavir |
| QJ05AF12 | Clevudin |
| QJ05AF13 | Tenofovir alafenamid |
| QJ05AG | Non-nucleosid revers transcriptase-hæmmere |
| QJ05AG01 | Nevirapin |
| QJ05AG02 | Delavirdin |
| QJ05AG03 | Efavirenz |
| QJ05AG04 | Etravirin |
| QJ05AG05 | Rilpivirin |
| QJ05AG06 | Doravirin |
| QJ05AG07 | Elsulfavirin |
| QJ05AH | Neuraminidase-hæmmere |
| QJ05AH01 | Zanamivir |
| QJ05AH02 | Oseltamivir |
| QJ05AH03 | Peramivir |
| QJ05AH04 | Laninamivir |
| QJ05AJ | Integrasehæmmere |
| QJ05AJ01 | Raltegravir |
| QJ05AJ02 | Elvitegravir |
| QJ05AJ03 | Dolutegravir |
| QJ05AJ04 | Cabotegravir |
| QJ05AP | Antivirale midler til behandling af hcv-infektioner |
| QJ05AP01 | Ribavirin |
| QJ05AP02 | Telaprevir |
| QJ05AP03 | Boceprevir |
| QJ05AP04 | Faldaprevir |
| QJ05AP05 | Simeprevir |
| QJ05AP06 | Asunaprevir |
| QJ05AP07 | Daclatasvir |
| QJ05AP08 | Sofosbuvir |
| QJ05AP09 | Dasabuvir |
| QJ05AP10 | Elbasvir |
| QJ05AP11 | Grazoprevir |
| QJ05AP12 | Coblopasvir |
| QJ05AP13 | Ravidasvir |
| QJ05AP14 | Narlaprevir |
| QJ05AP51 | Sofosbuvir og ledipasvir |
| QJ05AP52 | Dasabuvir, ombitasvir, paritaprevir og ritonavir |
| QJ05AP53 | Ombitasvir, paritaprevir og ritonavir |
| QJ05AP54 | Elbasvir og grazoprevir |
| QJ05AP55 | Sofosbuvir og velpatasvir |
| QJ05AP56 | Sofosbuvir, velpatasvir og voxilaprevir |
| QJ05AP57 | Glecaprevir og pibrentasvir |
| QJ05AP58 | Daclatasvir, asunaprevir og beclabuvir |
| QJ05AR | Antivirale midler til behandling af hiv-infektioner, komb. |
| QJ05AR01 | Zidovudin og lamivudin |
| QJ05AR02 | Lamivudin og abacavir |
| QJ05AR03 | Tenofovirdisoproxil og emtricitabin |
| QJ05AR04 | Zidovudin, lamivudin og abacavir |
| QJ05AR05 | Zidovudin, lamivudin og nevirapin |
| QJ05AR06 | Emtricitabin, tenofovirdisoproxil og efavirenz |
| QJ05AR07 | Stavudin, lamivudin og nevirapin |
| QJ05AR08 | Emtricitabin, tenofovirdisoproxil og rilpivirin |
| QJ05AR09 | Emtricitabin, tenofovirdisoproxil, elvitegravir og cobicistat |
| QJ05AR10 | Lopinavir og ritonavir |
| QJ05AR11 | Lamivudin, tenofovir-disoproxil og efavirenz |
| QJ05AR12 | Lamivudin og tenofovirdisoproxil |
| QJ05AR13 | Lamivudin, abacavir og dolutegravir |
| QJ05AR14 | Darunavir og cobicistat |
| QJ05AR15 | Atazanavir og cobicistat |
| QJ05AR16 | Lamivudin og raltegravir |
| QJ05AR17 | Emtricitabin og tenofovir alafenamid |
| QJ05AR18 | Emtricitabin, tenofovir alafenamid, elvitegravir og cobicistat |
| QJ05AR19 | Emtricitabin, tenofovir alafenamid og rilpivirin |
| QJ05AR20 | Emtricitabin, tenofovir alafenamid og bictegravir |
| QJ05AR21 | Dolutegravir og rilpivirin |
| QJ05AR22 | Emtricitabin, tenofovir alafenamid, darunavir og cobicistat |
| QJ05AR23 | Atazanavir og ritonavir |
| QJ05AR24 | Lamivudin, tenofovirdisoproxil og doravirin |
| QJ05AR25 | Lamivudin og dolutegravir |
| QJ05AR26 | Darunavir og ritonavir |
| QJ05AR27 | Lamivudin, tenofovirdisoproxil og dolutegravir |
| QJ05AR28 | Stavudin og lamivudin |
| QJ05AR29 | Emtricitabin, tenofovir alafenamid og dolutegravir |
| QJ05AX | Andre antivirale midler |
| QJ05AX01 | Moroxydin |
| QJ05AX02 | Lysozym |
| QJ05AX05 | Inosin pranobex |
| QJ05AX06 | Pleconaril |
| QJ05AX07 | Enfuvirtid |
| QJ05AX09 | Maraviroc |
| QJ05AX10 | Maribavir |
| QJ05AX13 | Umifenovir |
| QJ05AX17 | Enisamiumiodid |
| QJ05AX18 | Letermovir |
| QJ05AX19 | Tiloron |
| QJ05AX21 | Pentandisyreimidazolylethanamid |
| QJ05AX23 | Ibalizumab |
| QJ05AX24 | Tecovirimat |
| QJ05AX25 | Baloxavirmarboxil |
| QJ05AX26 | Amenamevir |
| QJ05AX27 | Favipiravir |
| QJ05AX28 | Bulevirtid |
| QJ05AX29 | Fostemsavir |
| QJ05AX31 | Lenacapavir |
| QJ05AX32 | Riamilovir |
| QJ05AX33 | Labuvirtid |
| QJ51 | Antibakterika til intramammært brug |
| QJ51A | Tetracycliner til intramammært brug |
| QJ51AA | Tetracycliner |
| QJ51AA03 | Chlortetracyclin |
| QJ51AA06 | Oxytetracyclin |
| QJ51AA07 | Tetracyclin |
| QJ51AA53 | Chlortetracyclin, kombinationer |
| QJ51B | Amphenicoler til intramammært brug |
| QJ51BA | Amphenicoler |
| QJ51BA01 | Chloramphenicol |
| QJ51BA02 | Thiamphenicol |
| QJ51BA90 | Florfenicol |
| QJ51C | Beta-lactam antibakterika, penicilliner, t. intramammært brug |
| QJ51CA | Penicilliner med udvidet spektrum |
| QJ51CA01 | Ampicillin |
| QJ51CA51 | Ampicillin, kombinationer |
| QJ51CE | Beta-lactamase-følsomme penicilliner |
| QJ51CE01 | Benzylpenicillin |
| QJ51CE09 | Procainpenicillin (ban) |
| QJ51CE59 | Procainpenicillin, kombinationer |
| QJ51CE90 | Phenetamat (ban) |
| QJ51CF | Beta-lactamase-resistente penicilliner |
| QJ51CF01 | Dicloxacillin |
| QJ51CF02 | Cloxacillin |
| QJ51CF03 | Methicillin |
| QJ51CF04 | Oxacillin |
| QJ51CF05 | Flucloxacillin |
| QJ51CR | Komb. af penicilliner og/eller beta-lactamase-inhibitorer |
| QJ51CR01 | Ampicillin og enzym-inhibitor |
| QJ51CR02 | Amoxicillin og enzym-inhibitor |
| QJ51CR50 | Kombinationer af penicilliner |
| QJ51D | Andre beta-lactam antibakterika til intramammært brug |
| QJ51DA | Cephalosporiner og beslægtede stoffer |
| QJ51DA01 | Cefalexin |
| QJ51DA04 | Cefazolin |
| QJ51DA06 | Cefuroxim |
| QJ51DA30 | Cefapirin |
| QJ51DA32 | Cefoperazon |
| QJ51DA34 | Cefacetril |
| QJ51DA90 | Cefalonium |
| QJ51DA91 | Ceftiofur |
| QJ51DA92 | Cefquinom |
| QJ51DB | Første generations cefalosporiner |
| QJ51DB01 | Cefalexin |
| QJ51DB04 | Cefazolin |
| QJ51DB08 | Cefapirin |
| QJ51DB10 | Cefacetril |
| QJ51DB90 | Cefalonium |
| QJ51DC | Anden generations cefalosporiner |
| QJ51DC02 | Cefuroxim |
| QJ51DD | Tredje generations cefalosporiner |
| QJ51DD12 | Cefoperazon |
| QJ51DD90 | Ceftiofur |
| QJ51DE | Fjerde generations cefalosporiner |
| QJ51DE90 | Cefquinom |
| QJ51E | Sulfonamider og trimethoprim |
| QJ51EA | Trimethoprim og derivater |
| QJ51EA01 | Trimethoprim |
| QJ51F | Macrolider og lincosamider til intramammært brug |
| QJ51FA | Macrolider |
| QJ51FA01 | Erythromycin |
| QJ51FA02 | Spiramycin |
| QJ51FA90 | Tylosin |
| QJ51FF | Lincosamider |
| QJ51FF02 | Lincomycin |
| QJ51FF90 | Pirlimycin |
| QJ51G | Aminoglycosid antibakterika til intramammært brug |
| QJ51GA | Streptomyciner |
| QJ51GA90 | Dihydrostreptomycin |
| QJ51GB | Andre aminoglycosider |
| QJ51GB03 | Gentamicin |
| QJ51GB90 | Apramycin |
| QJ51R | Komb. af antibakterika til intramammært brug |
| QJ51RA | Tetracycliner, komb. med andre antibakterika |
| QJ51RA01 | Chlortetracyclin, komb. med andre antibakterika |
| QJ51RB | Amphenicoler, komb. med andre antibakterika |
| QJ51RB01 | Chloramphenicol, komb. med andre antibakterika |
| QJ51RC | Beta-lactam antibiotika,penicillin, komb. med andre antibakterika |
| QJ51RC01 | Ampicillin + cloxacillin |
| QJ51RC03 | Procainpenicillin + dihydrostreptomycin |
| QJ51RC04 | Procainpenicillin+dihydrostreptomycin+sulfadimidin |
| QJ51RC05 | Procainpenicillin + neomycin |
| QJ51RC06 | Procainpenicillin + novobiocin |
| QJ51RC07 | Benzylpenicillin + neomycin + bacitracin |
| QJ51RC08 | Benzathin benzylpenicillin + dihydrostreptomycin |
| QJ51RC09 | Penethamathydroiodid + dihydrostreptomycin |
| QJ51RC10 | Penethamathydroiodid+benethaminpenicillin+framycetin (=neomycin b) |
| QJ51RC11 | Ampicillin + oxacillin |
| QJ51RC20 | Ampicillin, komb. med andre antibakterika |
| QJ51RC21 | Pivampicillin, komb. med andre antibakterika |
| QJ51RC22 | Benzylpenicillin, komb. med andre antibakterika |
| QJ51RC23 | Procainpenicillin, komb. med andre antibakterika |
| QJ51RC24 | Benzathinbenzylpenicillin, komb. med andre antibakterika |
| QJ51RC25 | Penethamathydroiodid, komb. med andre antibakterika |
| QJ51RC26 | Cloxacillin, komb. med andre antibakterika |
| QJ51RD | Andre beta-lactam antibakterika, komb. med andre antibakterika |
| QJ51RD01 | Cefalexin, komb. med andre antibakterika |
| QJ51RD34 | Cefacetril, komb. med andre antibakterika |
| QJ51RE | Sulfonamider og trimethoprim inkl. derivater |
| QJ51RE01 | Sulfadiazin og trimethoprim |
| QJ51RF | Macrolider, komb. med andre antibakterika |
| QJ51RF01 | Spiramycin, komb. med andre antibakterika |
| QJ51RF02 | Erythromycin, komb. med andre antibakterika |
| QJ51RF03 | Lincomycin, komb. med andre antibakterika |
| QJ51RG | Aminoglycosid antibakterika, kombinationer |
| QJ51RG01 | Neomycin, komb. med andre antibakterika |
| QJ51RV | Kombinationer af antibakterika og andre stoffer |
| QJ51RV01 | Antibakterika og kortikosteroider |
| QJ51RV02 | Antibakterika, antimykotika og kortikosteroider |
| QJ51X | Andre antibakterika til intramammær brug |
| QJ51XB | Polymyxiner |
| QJ51XB01 | Colistin |
| QJ51XB02 | Polymyxin b |
| QJ51XX | Andre antibakterika til intramammær brug |
| QJ51XX01 | Rifaximin |
| QJ54 | Antimycobakterica til intramammært brug |
| QJ54A | Midler til behandling af tuberculose |
| QJ54AB | Antibiotika |
| QJ54AB02 | Rifampicin |
| QJ54AB03 | Rifamycin |
| QL | Antineoplastiske og immunomodulerende stoffer |
| QL01 | Antineoplastiske stoffer |
| QL01A | Alkylerende midler |
| QL01AA | Kvælstofsennepsgas-analoger |
| QL01AA01 | Cyclophosphamid |
| QL01AA02 | Chlorambucil |
| QL01AA03 | Melphalan |
| QL01AA05 | Chlormethin |
| QL01AA06 | Ifosfamid |
| QL01AA07 | Trofosfamid |
| QL01AA08 | Prednimustin |
| QL01AA09 | Bendamustin |
| QL01AA10 | Melphalanflufenamid |
| QL01AB | Alkylsulfonater |
| QL01AB01 | Busulfan |
| QL01AB02 | Treosulfan |
| QL01AB03 | Mannosulfan |
| QL01AC | Ethyleniminer |
| QL01AC01 | Thiotepa |
| QL01AC02 | Triaziquon |
| QL01AC03 | Carboquon |
| QL01AD | Nitroso-urinstoffer |
| QL01AD01 | Carmustin |
| QL01AD02 | Lomustin |
| QL01AD03 | Semustin |
| QL01AD04 | Streptozocin |
| QL01AD05 | Fotemustin |
| QL01AD06 | Nimustin |
| QL01AD07 | Ranimustin |
| QL01AD08 | Uramustin |
| QL01AG | Epoxider |
| QL01AG01 | Etoglucid |
| QL01AX | Andre alkylerende midler |
| QL01AX01 | Mitobronitol |
| QL01AX02 | Pipobroman |
| QL01AX03 | Temozolomid |
| QL01AX04 | Dacarbazin |
| QL01B | Antimetabolitter |
| QL01BA | Folsyreanaloger |
| QL01BA01 | Methotrexat |
| QL01BA02 | Paltitrexid |
| QL01BA03 | Raltitrexid |
| QL01BA04 | Pemetrexed |
| QL01BA05 | Pralatrexat |
| QL01BB | Purin-analoger |
| QL01BB02 | Mercaptopurin |
| QL01BB03 | Tioguanin |
| QL01BB04 | Cladribin |
| QL01BB05 | Fludarabin |
| QL01BB06 | Clofarabin |
| QL01BB07 | Nelarabin |
| QL01BB90 | Rabacfosadin |
| QL01BC | Pyrimidin-analoger |
| QL01BC01 | Cytarabin |
| QL01BC02 | Fluoruracil |
| QL01BC03 | Tegafur |
| QL01BC04 | Carmofur |
| QL01BC05 | Gemcitabin |
| QL01BC06 | Capecitabin |
| QL01BC07 | Azacitidin |
| QL01BC08 | Decitabin |
| QL01BC09 | Floxuridin |
| QL01BC52 | Fluoruracil, komb. |
| QL01BC53 | Tegafur, komb. |
| QL01BC58 | Decitabin, kombinationer |
| QL01BC59 | Trifluridin, kombinationer |
| QL01C | Plantealkaloider og andre naturprodukter |
| QL01CA | Vinca-alkaloider og analoger |
| QL01CA01 | Vinblastin |
| QL01CA02 | Vincristin |
| QL01CA03 | Vindesin |
| QL01CA04 | Vinorelbin |
| QL01CA05 | Vinflunin |
| QL01CA06 | Vintafolid |
| QL01CB | Podophyllotoxin-derivater |
| QL01CB01 | Etoposid |
| QL01CB02 | Teniposid |
| QL01CC | Colchicin-derivater |
| QL01CC01 | Demecolcin |
| QL01CD | Taxaner |
| QL01CD01 | Paclitaxel |
| QL01CD02 | Docetaxel |
| QL01CD03 | Paclitaxel poliglumex |
| QL01CD04 | Cabazitaxel |
| QL01CD51 | Paclitaxel og encequidar |
| QL01CE | Topoisomerase 1 hæmmere |
| QL01CE01 | Topotecan |
| QL01CE02 | Irinotecan |
| QL01CE03 | Etirinotecan pegol |
| QL01CE04 | Belotecan |
| QL01CX | Andre plantealkaloider og naturprodukter |
| QL01CX01 | Trabectedin |
| QL01D | Cytotoksiske antibiotika og beslægtede stoffer |
| QL01DA | Actinomyciner |
| QL01DA01 | Dactinomycin |
| QL01DB | Anthracycliner og beslægtede stoffer |
| QL01DB01 | Doxorubicin |
| QL01DB02 | Daunorubicin |
| QL01DB03 | Epirubicin |
| QL01DB04 | Aclarubicin |
| QL01DB05 | Zorubicin |
| QL01DB06 | Idarubicin |
| QL01DB07 | Mitoxanthron |
| QL01DB08 | Pirarubicin |
| QL01DB09 | Valrubicin |
| QL01DB10 | Amrubicin |
| QL01DB11 | Pixantron |
| QL01DC | Andre cytotoksiske antibiotika |
| QL01DC01 | Bleomycin |
| QL01DC02 | Plicamycin |
| QL01DC03 | Mitomycin |
| QL01DC04 | Ixabepilon |
| QL01DC05 | Utidelon |
| QL01E | Proteinkinasehæmmere |
| QL01EA | Bcr-abl tyrosinkinasehæmmere |
| QL01EA01 | Imatinib |
| QL01EA02 | Dasatinib |
| QL01EA03 | Nilotinib |
| QL01EA04 | Bosutinib |
| QL01EA05 | Ponatinib |
| QL01EA06 | Asciminib |
| QL01EB | Epidermal vækstfaktor receptor (egfr)-tyrosinkinasehæmmere |
| QL01EB01 | Gefitinib |
| QL01EB02 | Erlotinib |
| QL01EB03 | Afatinib |
| QL01EB04 | Osimertinib |
| QL01EB05 | Rociletinib |
| QL01EB06 | Olmutinib |
| QL01EB07 | Dacomitinib |
| QL01EB08 | Icotinib |
| QL01EB09 | Lazertinib |
| QL01EB10 | Mobocertinib |
| QL01EB11 | Aumolertinib |
| QL01EC | B-raf serin-threoninkinase (braf) hæmmere |
| QL01EC01 | Vemurafenib |
| QL01EC02 | Dabrafenib |
| QL01EC03 | Encorafenib |
| QL01ED | Anaplastisk lymfom kinase (alk) hæmmere |
| QL01ED01 | Crizotinib |
| QL01ED02 | Ceritinib |
| QL01ED03 | Alectinib |
| QL01ED04 | Brigatinib |
| QL01ED05 | Lorlatinib |
| QL01EE | Mitogen-aktiverede proteinkinase (mek) hæmmere |
| QL01EE01 | Trametinib |
| QL01EE02 | Cobimetinib |
| QL01EE03 | Binimetinib |
| QL01EE04 | Selumetinib |
| QL01EE05 | Mirdametinib |
| QL01EF | Cyclin-afhængig kinase (cdk) hæmmere |
| QL01EF01 | Palbociclib |
| QL01EF02 | Ribociclib |
| QL01EF03 | Abemaciclib |
| QL01EG | Mammalian target of rapamycin (mtor) kinase hæmmere |
| QL01EG01 | Temsirolimus |
| QL01EG02 | Everolimus |
| QL01EG03 | Ridaforolimus |
| QL01EG04 | Sirolimus |
| QL01EH | Human epidermal vækstfaktor receptor 2 (her2) tyrosinkinase hæmmere |
| QL01EH01 | Lapatinib |
| QL01EH02 | Neratinib |
| QL01EH03 | Tucatinib |
| QL01EJ | Janus associerede kinase (jak) hæmmere |
| QL01EJ01 | Ruxolitinib |
| QL01EJ02 | Fedratinib |
| QL01EJ03 | Pacritinib |
| QL01EJ04 | Momelotinib |
| QL01EK | Vaskulær endotelial vækstfaktor receptor (vegfr)-tyrosinkinase hæmmere |
| QL01EK01 | Axitinib |
| QL01EK02 | Cediranib |
| QL01EK03 | Tivozanib |
| QL01EK04 | Fruquintinib |
| QL01EL | Bruton's tyrosinkinase (btk) hæmmere |
| QL01EL01 | Ibrutinib |
| QL01EL02 | Acalabrutinib |
| QL01EL03 | Zanubrutinib |
| QL01EL04 | Orelabrutinib |
| QL01EL05 | Pirtobrutinib |
| QL01EL06 | Tirabrutinib |
| QL01EM | Phosphatidylinositol-3-kinase (pi3k) hæmmere |
| QL01EM01 | Idelalisib |
| QL01EM02 | Copanlisib |
| QL01EM03 | Alpelisib |
| QL01EM04 | Duvelisib |
| QL01EM05 | Parsaclisib |
| QL01EN | Fibroblast vækstfaktor receptor (fgfr) tyrosinkinasehæmmere |
| QL01EN01 | Erdafitinib |
| QL01EN02 | Pemigatinib |
| QL01EN03 | Infigratinib |
| QL01EN04 | Futibatinib |
| QL01EX | Andre proteinkinasehæmmere |
| QL01EX01 | Sunitinib |
| QL01EX02 | Sorafenib |
| QL01EX03 | Pazopanib |
| QL01EX04 | Vandetanib |
| QL01EX05 | Regorafenib |
| QL01EX06 | Masitinib |
| QL01EX07 | Cabozantinib |
| QL01EX08 | Lenvatinib |
| QL01EX09 | Nintedanib |
| QL01EX10 | Midostaurin |
| QL01EX11 | Quizartinib |
| QL01EX12 | Larotrectinib |
| QL01EX13 | Gilteritinib |
| QL01EX14 | Entrectinib |
| QL01EX15 | Pexidartinib |
| QL01EX17 | Capmatinib |
| QL01EX18 | Avapritinib |
| QL01EX19 | Ripretinib |
| QL01EX21 | Tepotinib |
| QL01EX22 | Selpercatinib |
| QL01EX23 | Pralsetinib |
| QL01EX24 | Surufatinib |
| QL01EX25 | Umbralisib |
| QL01EX26 | Sitravatinib |
| QL01EX27 | Capivasertib |
| QL01EX28 | Repotrectinib |
| QL01EX90 | Toceranib |
| QL01F | Monoklonale antistoffer og antistof-lægemiddel-konjugater |
| QL01FA | Anti-cd20 monoklonale antistoffer |
| QL01FA01 | Rituximab |
| QL01FA02 | Ofatumumab |
| QL01FA03 | Obinutuzumab |
| QL01FB | Anti-cd22 monoklonale antistoffer |
| QL01FB01 | Inotuzumab ozogamicin |
| QL01FB02 | Moxetumomab pasudotox |
| QL01FC | Anti-cd38 monoklonale antistoffer |
| QL01FC01 | Daratumumab |
| QL01FC02 | Isatuximab |
| QL01FD | Human epidermal vækstfaktor receptor 2 (her2) hæmmere |
| QL01FD01 | Trastuzumab |
| QL01FD02 | Pertuzumab |
| QL01FD03 | Trastuzumab emtansin |
| QL01FD04 | Trastuzumab deruxtecan |
| QL01FD05 | Trastuzumab duocarmazin |
| QL01FD06 | Margetuximab |
| QL01FD07 | Zanidatamab |
| QL01FE | Epidermal vækstfaktor receptor (egfr) hæmmere |
| QL01FE01 | Cetuximab |
| QL01FE02 | Panitumumab |
| QL01FE03 | Necitumumab |
| QL01FF | Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) hæmmere |
| QL01FF01 | Nivolumab |
| QL01FF02 | Pembrolizumab |
| QL01FF03 | Durvalumab |
| QL01FF04 | Avelumab |
| QL01FF05 | Atezolizumab |
| QL01FF06 | Cemiplimab |
| QL01FF07 | Dostarlimab |
| QL01FF08 | Prolgolimab |
| QL01FF09 | Tislelizumab |
| QL01FF10 | Retifanlimab |
| QL01FF11 | Sugemalimab |
| QL01FF12 | Serplulimab |
| QL01FF13 | Toripalimab |
| QL01FG | Vaskulær endotelial vækstfaktor (vegf/vegfr) hæmmere |
| QL01FG01 | Bevacizumab |
| QL01FG02 | Ramucirumab |
| QL01FX | Andre monoklonale antistoffer og antistof-lægemiddel-konjugater |
| QL01FX01 | Edrecolomab |
| QL01FX02 | Gemtuzumab ozogamicin |
| QL01FX03 | Catumaxomab |
| QL01FX04 | Ipilimumab |
| QL01FX05 | Brentuximab vedotin |
| QL01FX06 | Dinutuximab beta |
| QL01FX07 | Blinatumomab |
| QL01FX08 | Elotuzumab |
| QL01FX09 | Mogamulizumab |
| QL01FX10 | Olaratumab |
| QL01FX11 | Bermekimab |
| QL01FX12 | Tafasitamab |
| QL01FX13 | Enfortumab vedotin |
| QL01FX14 | Polatuzumab vedotin |
| QL01FX15 | Belantamab mafodotin |
| QL01FX16 | Oportuzumab monatox |
| QL01FX17 | Sacituzumab govitecan |
| QL01FX18 | Amivantamab |
| QL01FX19 | Sabatolimab |
| QL01FX20 | Tremelimumab |
| QL01FX21 | Naxitamab |
| QL01FX22 | Loncastuximab tesirin |
| QL01FX23 | Tisotumab vedotin |
| QL01FX24 | Teclistamab |
| QL01FX25 | Mosunetuzumab |
| QL01FX26 | Mirvetuximab soravtansin |
| QL01FX27 | Epcoritamab |
| QL01FX28 | Glofitamab |
| QL01FX29 | Talquetamab |
| QL01FX31 | Zolbetuximab |
| QL01FX32 | Elranatamab |
| QL01FX33 | Tarlatamab |
| QL01FX34 | Odronextamab |
| QL01FX35 | Datopotamab deruxtecan |
| QL01FX36 | Patritumab deruxtecan |
| QL01FY | Kombinationer af monoklonale antistoffer og antistof-lægemiddel-konjugat |
| QL01FY01 | Pertuzumab og trastuzumab |
| QL01FY02 | Nivolumab og relatlimab |
| QL01FY03 | Prolgolimab og nurulimab |
| QL01X | Andre neoplastiske stoffer |
| QL01XA | Platin-forbindelser |
| QL01XA01 | Cisplatin |
| QL01XA02 | Carboplatin |
| QL01XA03 | Oxaliplatin |
| QL01XA04 | Satraplatin |
| QL01XA05 | Polyplatillen |
| QL01XB | Methylhydraziner |
| QL01XB01 | Procarbazin |
| QL01XD | Sensibilatorer anvendt til fotodynamisk/stråle- terapi |
| QL01XD01 | Profimernatrium |
| QL01XD03 | Methylaminolevolinat |
| QL01XD04 | Aminolevulinsyre |
| QL01XD05 | Temoporfin |
| QL01XD06 | Efaproxiral |
| QL01XD07 | Padeliporfin |
| QL01XF | Retinoider til cancerbehandling |
| QL01XF01 | Tretinoin |
| QL01XF02 | Alitretinoin |
| QL01XF03 | Bexaroten |
| QL01XG | Proteasomhæmmere |
| QL01XG01 | Bortezomib |
| QL01XG02 | Carfilzomib |
| QL01XG03 | Ixazomib |
| QL01XH | Histondeacetylase (hdac) hæmmere |
| QL01XH01 | Vorinostat |
| QL01XH02 | Romidepsin |
| QL01XH03 | Panobinostat |
| QL01XH04 | Belinostat |
| QL01XH05 | Entinostat |
| QL01XH06 | Tucidinostat |
| QL01XH07 | Resminostat |
| QL01XJ | Hedgehog pathway hæmmere |
| QL01XJ01 | Vismodegib |
| QL01XJ02 | Sonidegib |
| QL01XJ03 | Glasdegib |
| QL01XK | Poly (adp-ribose) polymerase (parp) hæmmere |
| QL01XK01 | Olaparib |
| QL01XK02 | Niraparib |
| QL01XK03 | Rucaparib |
| QL01XK04 | Talazoparib |
| QL01XK05 | Veliparib |
| QL01XK06 | Pamiparib |
| QL01XK52 | Niraparib og abirateron |
| QL01XL | Antineoplastisk celle- og genterapi |
| QL01XL01 | Sitimagen ceradenovec |
| QL01XL02 | Talimogen laherparepvec |
| QL01XL03 | Axicabtagen ciloleucel |
| QL01XL04 | Tisagenlecleucel |
| QL01XL05 | Ciltacabtagen autoleucel |
| QL01XL06 | Brexucabtagen autoleucel |
| QL01XL07 | Idecabtagen vicleucel |
| QL01XL08 | Lisocabtagene maraleucel |
| QL01XL09 | Tabelecleucel |
| QL01XL10 | Nadofaragen firadenovec |
| QL01XL11 | Lifileucel |
| QL01XL12 | Obecabtagen autoleucel |
| QL01XM | Isocitrat dehydrogenase (idh) hæmmere |
| QL01XM01 | Enasidenib |
| QL01XM02 | Ivosidenib |
| QL01XM03 | Olutasidenib |
| QL01XM04 | Vorasidenib |
| QL01XU | Andre antineoplastiske stoffer (fortsat) |
| QL01XX | Andre antineoplastiske stoffer |
| QL01XX01 | Amsacrin |
| QL01XX02 | Asparaginase |
| QL01XX03 | Altretamin |
| QL01XX05 | Hydroxycarbamid |
| QL01XX07 | Lonidamin |
| QL01XX08 | Pentostatin |
| QL01XX10 | Masoprocol |
| QL01XX11 | Estramustin |
| QL01XX16 | Mitoguazon |
| QL01XX18 | Tiazofurin |
| QL01XX23 | Mitotan |
| QL01XX24 | Pegaspargase |
| QL01XX27 | Arsentrioxid |
| QL01XX29 | Denileukin diftitox |
| QL01XX33 | Celecoxib |
| QL01XX35 | Anagrelid |
| QL01XX36 | Oblimersen |
| QL01XX40 | Omacetaxin mepesuccinat |
| QL01XX41 | Eribulin |
| QL01XX44 | Aflibercept |
| QL01XX52 | Venetoclax |
| QL01XX53 | Vosaroxin |
| QL01XX57 | Plitidepsin |
| QL01XX58 | Epacadostat |
| QL01XX66 | Selinexor |
| QL01XX67 | Tagraxofusp |
| QL01XX69 | Lurbinectedin |
| QL01XX72 | Tazemetostat |
| QL01XX73 | Sotorasib |
| QL01XX74 | Belzutifan |
| QL01XX75 | Tebentafusp |
| QL01XX77 | Adagrasib |
| QL01XX78 | Navitoclax |
| QL01XX79 | Eflornithin |
| QL01XX80 | Imetelstat |
| QL01XX81 | Nirogacestat |
| QL01XX82 | Darinaparsin |
| QL01XX83 | Paratoluenesulfonamid |
| QL01XX84 | Pelabresib |
| QL01XX85 | Idroxioliesyre |
| QL01XX86 | Calaspargase pegol |
| QL01XX91 | Tigilanoltiglat |
| QL01XX92 | Verdinexor |
| QL01XY | Antineoplastiske stoffer i komb. |
| QL01XY01 | Cytarabin og daunorubicin |
| QL01XY04 | Bifikafusp alfa og onfekafusp alfa |
| QL02 | Endocrin terapi |
| QL02A | Hormoner og beslægtede stoffer |
| QL02AA | Østrogener |
| QL02AA01 | Diethylstilbestrol |
| QL02AA02 | Polyestradiolphosphat |
| QL02AA03 | Ethinylestradiol |
| QL02AA04 | Fosfestrol |
| QL02AB | Gestagener |
| QL02AB01 | Megestrol |
| QL02AB02 | Medroxyprogesteron |
| QL02AB03 | Gestonoron |
| QL02AE | Gonadotropin-releasing hormon-analoger |
| QL02AE01 | Buserelin |
| QL02AE02 | Leuprorelin |
| QL02AE03 | Goserelin |
| QL02AE04 | Triptorelin |
| QL02AE05 | Histrelin |
| QL02AE51 | Leuprorelin og bicalutamid |
| QL02AX | Andre hormoner |
| QL02B | Hormon-antagonister og beslægtede stoffer |
| QL02BA | Anti-østrogener |
| QL02BA01 | Tamoxifen |
| QL02BA02 | Toremifen |
| QL02BA03 | Fulvestrant |
| QL02BA04 | Elacestrant |
| QL02BB | Anti-androgener |
| QL02BB01 | Flutamid |
| QL02BB02 | Nilutamid |
| QL02BB03 | Bicalutamid |
| QL02BB04 | Enzalutamid |
| QL02BB05 | Apalutamid |
| QL02BB06 | Darolutamid |
| QL02BG | Aromatase-inhibitorer |
| QL02BG01 | Aminogluthetimid |
| QL02BG02 | Formestan |
| QL02BG03 | Anastrozol |
| QL02BG04 | Letrozol |
| QL02BG05 | Vorozol |
| QL02BG06 | Exemestan |
| QL02BX | Andre hormon-antagonister og beslægtede stoffer |
| QL02BX01 | Abarelix |
| QL02BX02 | Degarelix |
| QL02BX03 | Abirateron |
| QL02BX04 | Relugolix |
| QL02BX53 | Abirateron og kortikosteroider |
| QL03 | Immunstimulerende midler |
| QL03A | Immunstimulerende midler |
| QL03AA | Kolonistimulerende faktorer |
| QL03AA02 | Filgrastim |
| QL03AA03 | Molgramostim |
| QL03AA09 | Sargramostim |
| QL03AA10 | Lenograstim |
| QL03AA12 | Ancestim |
| QL03AA13 | Pegfilgrastim |
| QL03AA14 | Lipegfilgrastim |
| QL03AA15 | Balugrastim |
| QL03AA16 | Empegfilgrastim |
| QL03AA17 | Pegteograstim |
| QL03AA18 | Efbemalenograstim alfa |
| QL03AA19 | Eflapegrastim |
| QL03AA90 | Pegbovigrastim |
| QL03AB | Interferoner |
| QL03AB01 | Interferon alfa naturligt |
| QL03AB02 | Interferon beta naturligt |
| QL03AB03 | Interferon gamma |
| QL03AB04 | Interferon alfa-2a |
| QL03AB05 | Interferon alfa-2b |
| QL03AB06 | Interferon alfa-n1 |
| QL03AB07 | Interferon beta-1a |
| QL03AB08 | Interferon beta-1b |
| QL03AB09 | Interferon alfacon-1 |
| QL03AB10 | Peginterferon alfa-2b |
| QL03AB11 | Peginterferon alfa-2a |
| QL03AB12 | Albinterferon alfa-2b |
| QL03AB13 | Peginterferon beta-1a |
| QL03AB14 | Cepeginterferon alfa-2b |
| QL03AB15 | Ropeginterferon alfa-2b |
| QL03AB16 | Peginterferon alfacon-2 |
| QL03AB17 | Sampeginterferon beta-1a |
| QL03AB60 | Peginterferon-alfa-2b, komb. |
| QL03AB61 | Peginterferon alfa-2a, kombinationer |
| QL03AB90 | Interferon omega, feline oprindelse |
| QL03AC | Interleukiner |
| QL03AC01 | Aldesleukin |
| QL03AC02 | Oprelvekin |
| QL03AX | Andre immunstimulerende midler |
| QL03AX01 | Lentinan |
| QL03AX02 | Roquinimex |
| QL03AX03 | Bcg-vaccine |
| QL03AX04 | Pegademase |
| QL03AX05 | Pidotimod |
| QL03AX07 | Poly i:c |
| QL03AX08 | Poly iclc |
| QL03AX09 | Thymopentin |
| QL03AX10 | Immunocyanin |
| QL03AX11 | Tasonermin |
| QL03AX12 | Melanoma vaccine |
| QL03AX13 | Glatirameracetat |
| QL03AX14 | Histaminhydrochlorid |
| QL03AX15 | Mifamurtid |
| QL03AX16 | Plerixafor |
| QL03AX17 | Sipuleucel-t |
| QL03AX18 | Cridanimod |
| QL03AX19 | Dasiprotimut-t |
| QL03AX21 | Elapegademase |
| QL03AX22 | Leniolisib |
| QL03AX23 | Motixafortid |
| QL03AX24 | Mavorixafor |
| QL03AX90 | Felint interleukin-2 recombinant canarypoxvirus |
| QL04 | Immunsuppressiva |
| QL04A | Immunsuppressiva |
| QL04AA | Selektive immunsuppressiva |
| QL04AA01 | Ciclosporin |
| QL04AA03 | Antilymfocyt-immunoglobulin (hest) |
| QL04AA04 | Antithymocyt-immunoglobulin (kanin) |
| QL04AA05 | Tacrolimus |
| QL04AA06 | Mycophenolsyre |
| QL04AA08 | Daclizumab |
| QL04AA09 | Basiliximab |
| QL04AA11 | Etanercept |
| QL04AA12 | Infliximab |
| QL04AA14 | Anakinra |
| QL04AA15 | Alefacept |
| QL04AA16 | Afelimomab |
| QL04AA17 | Adalimumab |
| QL04AA19 | Gusperimus |
| QL04AA22 | Abetimus |
| QL04AA24 | Abatacept |
| QL04AA28 | Belatacept |
| QL04AA32 | Apremilast |
| QL04AA40 | Cladribin |
| QL04AA41 | Imlifidase |
| QL04AA48 | Belumosudil |
| QL04AA58 | Efgartigimod alfa |
| QL04AA60 | Remibrutinib |
| QL04AA90 | Fuzapladib |
| QL04AB | Tumornekrosefaktor alfa (tnf-alfa)-hæmmere |
| QL04AB01 | Etanercept |
| QL04AB02 | Infliximab |
| QL04AB03 | Afelimomab |
| QL04AB04 | Adalimumab |
| QL04AB05 | Certolizumab pegol |
| QL04AB06 | Golimumab |
| QL04AB07 | Opinercept |
| QL04AC | Interleukinhæmmere |
| QL04AC01 | Daclizumab |
| QL04AC02 | Basiliximab |
| QL04AC03 | Anakinra |
| QL04AC04 | Rilonacept |
| QL04AC05 | Ustekinumab |
| QL04AC07 | Tocilizumab |
| QL04AC08 | Canakinumab |
| QL04AC09 | Briakinumab |
| QL04AC10 | Secukinumab |
| QL04AC11 | Siltuximab |
| QL04AC12 | Brodalumab |
| QL04AC13 | Ixekizumab |
| QL04AC14 | Sarilumab |
| QL04AC15 | Sirukumab |
| QL04AC16 | Guselkumab |
| QL04AC17 | Tildrakizumab |
| QL04AC18 | Risankizumab |
| QL04AC19 | Satralizumab |
| QL04AC20 | Netakimab |
| QL04AC21 | Bimekizumab |
| QL04AC22 | Spesolimab |
| QL04AC23 | Olokizumab |
| QL04AC24 | Mirikizumab |
| QL04AC25 | Levilimab |
| QL04AC26 | Goflikicept |
| QL04AD | Calcineurinhæmmere |
| QL04AD01 | Ciclosporin |
| QL04AD02 | Tacrolimus |
| QL04AD03 | Voclosporin |
| QL04AE | Sphingosin 1-phosphat (s1p) receptormodulatorer |
| QL04AE01 | Fingolimod |
| QL04AE02 | Ozanimod |
| QL04AE03 | Siponimod |
| QL04AE04 | Ponesimod |
| QL04AE05 | Etrasimod |
| QL04AF | Janus associerede kinase (jak) hæmmere |
| QL04AF01 | Tofacitinib |
| QL04AF02 | Baricitinib |
| QL04AF03 | Upadacitinib |
| QL04AF04 | Filgotinib |
| QL04AF05 | Itacitinib |
| QL04AF06 | Peficitinib |
| QL04AF07 | Deucravacitinib |
| QL04AF08 | Ritlecitinib |
| QL04AG | Monoklonale antistoffer |
| QL04AG01 | Muromonab-cd3 |
| QL04AG02 | Efalizumab |
| QL04AG03 | Natalizumab |
| QL04AG04 | Belimumab |
| QL04AG05 | Vedolizumab |
| QL04AG06 | Alemtuzumab |
| QL04AG07 | Begelomab |
| QL04AG08 | Ocrelizumab |
| QL04AG09 | Emapalumab |
| QL04AG10 | Inebilizumab |
| QL04AG11 | Anifrolumab |
| QL04AG12 | Ofatumumab |
| QL04AG13 | Teprotumumab |
| QL04AG14 | Ublituximab |
| QL04AG15 | Divozilimab |
| QL04AG16 | Rozanolixizumab |
| QL04AG17 | Seniprutug |
| QL04AG90 | Cirevetmab |
| QL04AH | Mammalian target of rapamycin (mtor) kinasehæmmere |
| QL04AH01 | Sirolimus |
| QL04AH02 | Everolimus |
| QL04AJ | Komplementhæmmere |
| QL04AJ01 | Eculizumab |
| QL04AJ02 | Ravulizumab |
| QL04AJ03 | Pegcetacoplan |
| QL04AJ04 | Sutimlimab |
| QL04AJ05 | Avacopan |
| QL04AJ06 | Zilucoplan |
| QL04AJ07 | Crovalimab |
| QL04AJ08 | Iptacopan |
| QL04AJ09 | Danicopan |
| QL04AJ10 | Vilobelimab |
| QL04AJ11 | Pozelimab |
| QL04AK | Dihydroorotat dehydrogenase (dhodh) hæmmere |
| QL04AK01 | Leflunomid |
| QL04AK02 | Teriflunomid |
| QL04AX | Andre immunosuppressiva |
| QL04AX01 | Azathioprin |
| QL04AX02 | Thalidomid |
| QL04AX03 | Methotrexat |
| QL04AX04 | Lenalidomid |
| QL04AX05 | Pirfenidon |
| QL04AX06 | Pomalidomid |
| QL04AX07 | Dimethylfumarat |
| QL04AX08 | Darvadstrocel |
| QL04AX09 | Diroximelfumarat |
| QL04AX10 | Tegomilfumarat |
| QM | Muskulo-skeletale system |
| QM01 | Antiinflammatorika og antireumatika |
| QM01A | Antiinflammatorika og antireumatika,non-steroid |
| QM01AA | Butylpyrazolidiner |
| QM01AA01 | Phenylbutazon |
| QM01AA02 | Mofebutazon |
| QM01AA03 | Oxyphenbutazon |
| QM01AA05 | Clofezon |
| QM01AA06 | Kebuzon |
| QM01AA90 | Suxibuzon |
| QM01AA99 | Kombinationer |
| QM01AB | Eddikesyre-derivater og beslægtede stoffer |
| QM01AB01 | Indometacin |
| QM01AB02 | Sulindac |
| QM01AB03 | Tolmetin |
| QM01AB04 | Zomepirac |
| QM01AB05 | Diclofenac |
| QM01AB06 | Alclofenac |
| QM01AB07 | Bumadizon |
| QM01AB08 | Etodolac |
| QM01AB09 | Lonazolac |
| QM01AB10 | Fentiazac |
| QM01AB11 | Acemetacin |
| QM01AB12 | Difenpiramid |
| QM01AB13 | Oxametacin |
| QM01AB14 | Proglumetacin |
| QM01AB15 | Ketorolac |
| QM01AB16 | Aceclofenac |
| QM01AB17 | Bufexamac |
| QM01AB51 | Indometacin, komb. |
| QM01AB55 | Diclofenac, komb. |
| QM01AC | Oxicamer |
| QM01AC01 | Piroxicam |
| QM01AC02 | Tenoxicam |
| QM01AC04 | Droxicam |
| QM01AC05 | Lornoxicam |
| QM01AC06 | Meloxicam |
| QM01AC56 | Meloxicam, kombinationer |
| QM01AE | Propionsyre-derivater |
| QM01AE01 | Ibuprofen |
| QM01AE02 | Naproxen |
| QM01AE03 | Ketoprofen |
| QM01AE04 | Fenoprofen |
| QM01AE05 | Fenbufen |
| QM01AE06 | Benoxaprofen |
| QM01AE07 | Suprofen |
| QM01AE08 | Pirprofen |
| QM01AE09 | Flurbiprofen |
| QM01AE10 | Indoprofen |
| QM01AE11 | Tiaprofensyre |
| QM01AE12 | Oxaprozin |
| QM01AE13 | Ibuproxam |
| QM01AE14 | Dexibuprofen |
| QM01AE15 | Flunoxaprofen |
| QM01AE16 | Alminoprofen |
| QM01AE17 | Dexketoprofen |
| QM01AE18 | Naproxcinod |
| QM01AE19 | Loxoprofen |
| QM01AE20 | Pelubiprofen |
| QM01AE52 | Naproxen og esomeprazol |
| QM01AE53 | Ketoprofen, komb. |
| QM01AE56 | Naproxen og misoprostol |
| QM01AE57 | Naproxen og diphenhydramin |
| QM01AE90 | Vedaprofen |
| QM01AE91 | Carprofen |
| QM01AE92 | Tepoxalin |
| QM01AG | Fenamater |
| QM01AG01 | Mefenamsyre |
| QM01AG02 | Tolfenamsyre |
| QM01AG03 | Flufenamsyre |
| QM01AG04 | Meclofenamsyre |
| QM01AG90 | Flunixin |
| QM01AH | Coxibs |
| QM01AH01 | Oxaceprol |
| QM01AH02 | Rofecoxib |
| QM01AH03 | Valdecoxib |
| QM01AH04 | Parecoxib |
| QM01AH05 | Etoricoxib |
| QM01AH06 | Lumiracoxib |
| QM01AH07 | Polmacoxib |
| QM01AH90 | Firocoxib |
| QM01AH91 | Robenacoxib |
| QM01AH92 | Mavacoxib |
| QM01AH93 | Cimicoxib |
| QM01AH94 | Deracoxib |
| QM01AH95 | Enflicoxib |
| QM01AX | Andre antiinflammatoriske stoffer, non-steroide |
| QM01AX01 | Nabumeton |
| QM01AX02 | Niflumsyre |
| QM01AX04 | Azapropazon |
| QM01AX05 | Glucosamin |
| QM01AX07 | Glucosaminglycan-polysulfat |
| QM01AX12 | Glucosamin-polyglucansulfat |
| QM01AX13 | Proquazon |
| QM01AX14 | Orgotein |
| QM01AX17 | Nimesulid |
| QM01AX18 | Feprazon |
| QM01AX21 | Diacerein |
| QM01AX22 | Morniflumat |
| QM01AX23 | Tenidap |
| QM01AX25 | Chondroitinsulfat |
| QM01AX26 | Avocado og soyabønneolie, uforsæbelige stoffer |
| QM01AX52 | Nifluminsyre, kombinationer |
| QM01AX68 | Feprazon, komb. |
| QM01AX90 | Pentosanpolysulfat |
| QM01AX91 | Aminopropionitril |
| QM01AX92 | Grapiprant |
| QM01AX99 | Kombinationer af andre nsaid |
| QM01B | Antiinflammatoriske midler i komb. |
| QM01BA | Antiinflammatoriske midler i komb. med kortikosteroider |
| QM01BA01 | Phenylbutazon og kortikosteroid |
| QM01BA02 | Dipyrocetyl og kortikosteroid |
| QM01BA03 | Acetylsalicylsyre og kortikosteroid |
| QM01BA99 | Kombinationer |
| QM01BX | Andre anti-inflammatoriske midler i komb. |
| QM01C | Specifikke antireumatika |
| QM01CA | Quinoliner |
| QM01CB | Guldholdige midler |
| QM01CC | Penicillamin og lignende stoffer |
| QM01CC01 | Penicillamin |
| QM01CC02 | Bucillamin |
| QM01CX | Andre specifikke antirheumatiske midler |
| QM02 | Midler mod led- og muskelsmerter til udvortes brug |
| QM02A | Midler mod led- og muskelsmerter til udvortes brug |
| QM02AA | Antiinflammatorika, non-steroide, t. udvortes brug |
| QM02AA01 | Phenylbutazon |
| QM02AA02 | Mofebutazon |
| QM02AA03 | Clofezon |
| QM02AA04 | Oxyphenbutazon |
| QM02AA05 | Benzydamin |
| QM02AA06 | Etofenamat |
| QM02AA07 | Piroxicam |
| QM02AA08 | Felbinac |
| QM02AA09 | Bufexamac |
| QM02AA10 | Ketoprofen |
| QM02AA11 | Bendazac |
| QM02AA12 | Naproxen |
| QM02AA13 | Ibuprofen |
| QM02AA14 | Fentiazac |
| QM02AA15 | Diclofenac |
| QM02AA16 | Feprazon |
| QM02AA17 | Niflumsyre |
| QM02AA18 | Meclofenamsyre |
| QM02AA19 | Flurbiprofen |
| QM02AA21 | Tolmetin |
| QM02AA22 | Suxibuzon |
| QM02AA23 | Indometacin |
| QM02AA24 | Nifenazon |
| QM02AA25 | Aceclofenac |
| QM02AA26 | Nimesulid |
| QM02AA27 | Dexketoprofen |
| QM02AA28 | Piketoprofen |
| QM02AA29 | Esflurbiprofen |
| QM02AA99 | Antiinflammatorika, non-steroide, t. udvortes brug, komb. |
| QM02AB | Capsaicin og lignende præparater |
| QM02AB01 | Capsaicin |
| QM02AB02 | Zucapsaicin |
| QM02AC | Midler med salicylsyre-derivater |
| QM02AC99 | Midler med salicylsyre-derivater, kombinationer |
| QM02AQ | Blister-midler |
| QM02AX | Andre midler mod led- og muskelsmerter til udvortes brug |
| QM02AX02 | Tolazolin |
| QM02AX03 | Dimethylsulfoxid |
| QM02AX05 | Idrocilamid |
| QM02AX06 | Tolperison |
| QM02AX10 | Diverse |
| QM02AX99 | Kombinationer |
| QM03 | Muskel-relaxanter |
| QM03A | Muskel-relaxanter, perifert virkende midler |
| QM03AA | Curare-alkaloider |
| QM03AA01 | Alcuronium |
| QM03AA02 | Tubocurarin |
| QM03AA04 | Dimethyltubocurarin |
| QM03AB | Cholin-derivater |
| QM03AB01 | Suxamethon |
| QM03AC | Andre kvarternære ammoniumforbindelser |
| QM03AC01 | Pancuronium |
| QM03AC02 | Gallamin |
| QM03AC03 | Vecuronium |
| QM03AC04 | Atracurium |
| QM03AC05 | Hexafluronium |
| QM03AC06 | Pipecuroniumbromid |
| QM03AC07 | Doxacuriumchlorid |
| QM03AC08 | Fazadiniumbromid |
| QM03AC09 | Rocuroniumbromid |
| QM03AC10 | Mivacuriumchlorid |
| QM03AC11 | Cisatracuricum |
| QM03AX | Andre muskel-relaxanter, perifert virkende |
| QM03AX01 | Botulinum-toxin |
| QM03B | Muskel-relaxanter, centralt virkende midler |
| QM03BA | Carbaminsyre-estere |
| QM03BA01 | Phenprobamat |
| QM03BA02 | Carisoprodol |
| QM03BA03 | Methocarbamol |
| QM03BA04 | Styramat |
| QM03BA05 | Fecarbamat |
| QM03BA51 | Phenprobamat, komb. excl. psykoleptika |
| QM03BA52 | Carisoprodol, komb. excl. psykoleptika |
| QM03BA53 | Methocarbamol, komb. excl. psykoleptika |
| QM03BA71 | Phenprobamat, komb. med psykoleptika |
| QM03BA72 | Carisoprodol, komb. med psykoleptika |
| QM03BA73 | Methocarbamol, komb. med psykoleptika |
| QM03BA99 | Kombinationer |
| QM03BB | Oxazol-, thiazin-, triazin-derivater |
| QM03BB02 | Chlormezanon |
| QM03BB03 | Chlorzoxazon |
| QM03BB52 | Chlormezanon, komb. excl. psykoleptika |
| QM03BB53 | Chlorzoxazon, komb. excl. psykoleptika |
| QM03BB72 | Chlormezanon, komb. med psykoleptika |
| QM03BB73 | Chlorzoxazon, komb. med psykoleptika |
| QM03BC | Ethere, kemisk beslægtet med antihistaminer |
| QM03BC01 | Orphenadrin (citrat) |
| QM03BC51 | Orphenadrin, komb. |
| QM03BX | Andre centralt virkende midler |
| QM03BX01 | Baclofen |
| QM03BX02 | Tizanidin |
| QM03BX03 | Pridinol |
| QM03BX04 | Tolperison |
| QM03BX05 | Thiocolchicosid |
| QM03BX06 | Mephenesin |
| QM03BX07 | Tetrazepam |
| QM03BX08 | Cyclobenzaprin |
| QM03BX09 | Eperison |
| QM03BX30 | Phenyramidol |
| QM03BX53 | Pridinol, kombinationer |
| QM03BX55 | Thiocolchicosid, kombinationer |
| QM03BX90 | Guaifenesin |
| QM03C | Muskel-relaxanter, direkte virkende |
| QM04 | Midler mod arthritis urica |
| QM04A | Midler mod arthritis urica |
| QM04AA | Midler, der hæmmer urinsyreproduktionen |
| QM04AA01 | Allopurinol |
| QM04AA02 | Tisopurin |
| QM04AA03 | Febuxostat |
| QM04AA51 | Allopurinol, kombinationer |
| QM04AB | Midler, der hæmmer urinsyreproduktionen |
| QM04AB01 | Probenecid |
| QM04AB02 | Sulfinpyrazon |
| QM04AB03 | Benzpromaron |
| QM04AB04 | Isobromindion |
| QM04AB05 | Lesinurad |
| QM04AC | Midler uden virkning på urinsyre-metabolismen |
| QM04AC01 | Colchicin |
| QM04AC02 | Cinchophen |
| QM04AC51 | Colchicin og probenecid |
| QM04AX | Andre midler mod arthritis urica |
| QM04AX01 | Uratoxidase |
| QM04AX02 | Pegloticase |
| QM05 | Midler til behandling af knoglesygdomme |
| QM05B | Midler med virkning på knoglestruktur og mineralisering |
| QM05BA | Biphosphonater |
| QM05BA01 | Etidronsyre |
| QM05BA02 | Clodronsyre |
| QM05BA03 | Pamidronsyre |
| QM05BA04 | Alendronsyre |
| QM05BA05 | Tiludronsyre |
| QM05BA06 | Ibandronsyre |
| QM05BA07 | Risedronsyre |
| QM05BA08 | Zoledronsyre |
| QM05BB | Biphosphonater, komb. |
| QM05BB01 | Etidronsyre og calcium, sekvenspræparater |
| QM05BB02 | Risedronsyre og calcium, sekvenspræparater |
| QM05BB03 | Alendronsyre og colecalciferol |
| QM05BB04 | Risendronsyre, calcium og colecalciferol, sekvenspræparater |
| QM05BB05 | Alendronsyre, calcium og colecalciferol, sekvenspræparater |
| QM05BB06 | Alendronsyre og alfacalcidol, sekvenspræparater |
| QM05BB07 | Risedronsyre og colecalciferol |
| QM05BB08 | Zoledronsyre, calcium og cholecalciferol, sekvenspræparater |
| QM05BB09 | Ibandronsyre og colecalciferol |
| QM05BC | Knoglemorphogene proteiner |
| QM05BC01 | Dibotermin alfa |
| QM05BC02 | Eptotermin alfa |
| QM05BX | Andre midler med virkning på knoglestruktur og mineralisering |
| QM05BX01 | Ipriflavon |
| QM05BX02 | Aluminiumchlorhydrat |
| QM05BX03 | Strontiumranelat |
| QM05BX04 | Denosumab |
| QM05BX05 | Burosumab |
| QM05BX06 | Romosozumab |
| QM05BX07 | Vosoritid |
| QM05BX08 | Menatetrenon |
| QM05BX53 | Strontiumranelat og colecalciferol |
| QM09 | Andre midler mod forstyrrelser i det muskulo-skeletale system |
| QM09A | Andre midler mod forstyrrelser i det muskulo-skeletale system |
| QM09AA | Quinin og derivater |
| QM09AA01 | Hydroquinin |
| QM09AA72 | Quinin, komb. med psykoleptika |
| QM09AB | Enzymer |
| QM09AB01 | Chymopapain |
| QM09AB02 | Collagenase clostridium histolytikum |
| QM09AB03 | Bromelainer |
| QM09AB52 | Trypsin, komb. |
| QM09AX | Andre midler mod forstyrrelser i det muskulo-skeletale system |
| QM09AX01 | Hyaluronsyre |
| QM09AX02 | Chondrocytter, autologe |
| QM09AX03 | Ataluren |
| QM09AX04 | Drisapersen |
| QM09AX05 | Aceneuramsyre |
| QM09AX06 | Eteplirsen |
| QM09AX07 | Nusinersen |
| QM09AX08 | Golodirsen |
| QM09AX09 | Onasemnogenabeparvovec |
| QM09AX10 | Risdiplam |
| QM09AX11 | Palovaroten |
| QM09AX12 | Viltolarsen |
| QM09AX13 | Casimersen |
| QM09AX14 | Givinostat |
| QM09AX15 | Delandistrogen moxeparvovec |
| QM09AX90 | Hestestamceller |
| QM09AX91 | Polyacrylamid |
| QM09AX92 | Hundestamceller |
| QM09AX99 | Kombinationer |
| QN | Centralnervesystemet |
| QN01 | Anæstetika |
| QN01A | Anæstetika, generelle |
| QN01AA | Ethere |
| QN01AA01 | Anæstetisk ether (diethylether) |
| QN01AA02 | Vinylether |
| QN01AB | Halogenerede kulbrinter |
| QN01AB01 | Halothan |
| QN01AB02 | Chloroform |
| QN01AB04 | Enfluran |
| QN01AB05 | Trichlorethylen |
| QN01AB06 | Isofluran |
| QN01AB07 | Desfluran |
| QN01AB08 | Sevofluran |
| QN01AF | Barbiturater, usammensatte |
| QN01AF01 | Methohexital |
| QN01AF02 | Hexobarbital |
| QN01AF03 | Thiopental |
| QN01AF90 | Thiamylal |
| QN01AG | Barbiturater i komb. med andre stoffer |
| QN01AG01 | Narcobarbital |
| QN01AH | Opioid-anæstetika |
| QN01AH01 | Fentanyl |
| QN01AH02 | Alfentanil |
| QN01AH03 | Sufentanil |
| QN01AH04 | Phenoperidin |
| QN01AH05 | Anileridin |
| QN01AH06 | Remifentanil |
| QN01AH51 | Fentanyl, komb. |
| QN01AX | Andre generelle anæstetika |
| QN01AX03 | Ketamin |
| QN01AX04 | Propanidid |
| QN01AX05 | Alfaxalon |
| QN01AX07 | Etomidat |
| QN01AX10 | Propofol |
| QN01AX11 | Natriumoxybat |
| QN01AX13 | Dinitrogenoxid |
| QN01AX14 | Esketamin |
| QN01AX15 | Xenon |
| QN01AX63 | Dinitrogenoxid, komb. |
| QN01AX91 | Azaperon |
| QN01AX92 | Benzocain |
| QN01AX93 | Tricainmesilat |
| QN01AX94 | Isoeugenol |
| QN01AX95 | Levomenthol |
| QN01AX99 | Andre generelle anæstetika, kombinationer |
| QN01B | Lokalanæstetika |
| QN01BA | Aminobenzoesyre-estere |
| QN01BA01 | Metabutethamin |
| QN01BA02 | Procain |
| QN01BA03 | Tetracain |
| QN01BA04 | Chlorprocain |
| QN01BA05 | Benzocain |
| QN01BA52 | Procain, komb. |
| QN01BA53 | Tetracain, kombinationer |
| QN01BB | Amider |
| QN01BB01 | Bupivacain |
| QN01BB02 | Lidocain |
| QN01BB03 | Mepivacain |
| QN01BB04 | Prilocain |
| QN01BB05 | Butanilicain |
| QN01BB06 | Cinchocain |
| QN01BB07 | Etidocain |
| QN01BB08 | Articain |
| QN01BB09 | Ropivacain |
| QN01BB10 | Levobupivacain |
| QN01BB20 | Amider i komb. |
| QN01BB51 | Bupivacain, komb. |
| QN01BB52 | Lidocain, komb. |
| QN01BB53 | Mepivacain, komb. |
| QN01BB54 | Prilocain, komb. |
| QN01BB57 | Etidocain, komb. |
| QN01BB58 | Articain, komb. |
| QN01BB59 | Bupivacain og meloxicam |
| QN01BC | Benzoesyre-estere |
| QN01BC01 | Cocain |
| QN01BX | Andre lokalanæstetika |
| QN01BX01 | Ethylchlorid |
| QN01BX02 | Dyclonin |
| QN01BX03 | Phenol |
| QN01BX04 | Capsaicin |
| QN02 | Analgetika |
| QN02A | Opioider |
| QN02AA | Naturlige opiumalkaloider |
| QN02AA01 | Morphin |
| QN02AA02 | Opium |
| QN02AA03 | Hydromorphon |
| QN02AA04 | Nicomorphin |
| QN02AA05 | Oxycodon |
| QN02AA08 | Dihydrocodein |
| QN02AA10 | Papaveretum |
| QN02AA11 | Oxymorphon |
| QN02AA51 | Morphin, komb. excl. psykoleptika |
| QN02AA53 | Hydromorphon og naloxon |
| QN02AA55 | Oxycodon og naloxon |
| QN02AA56 | Oxycodon og naltrexon |
| QN02AA79 | Codein, komb. med psykoleptika |
| QN02AB | Phenylpiperidin-derivater |
| QN02AB01 | Ketobemidon |
| QN02AB02 | Pethidin |
| QN02AB03 | Fentanyl |
| QN02AB52 | Pethidin, komb. excl. psykoleptika |
| QN02AB53 | Fentanyl, komb. excl. psykoleptika |
| QN02AB72 | Pethidin, komb. med psykoleptika |
| QN02AB73 | Fentanyl, komb. med psykoleptika |
| QN02AC | Diphenylpropylamin-derivater |
| QN02AC01 | Dextromoramid |
| QN02AC03 | Piritramid |
| QN02AC04 | Dextropropoxyphen |
| QN02AC05 | Bezitramid |
| QN02AC52 | Methadon, kombinationer excl. psykoleptika |
| QN02AC54 | Dextropropoxyphen, komb. excl. psykoleptika |
| QN02AC74 | Dextropropoxyphen, komb. med psykoleptika |
| QN02AC90 | Methadon |
| QN02AD | Benzomorphan-derivater |
| QN02AD01 | Pentazocin |
| QN02AD02 | Phenazocin |
| QN02AD51 | Pentazocin og naloxon |
| QN02AE | Oripavin-derivater |
| QN02AE01 | Buprenorphin |
| QN02AE90 | Etorphin |
| QN02AE99 | Oripavin-derivater, kombinationer |
| QN02AF | Morphinan-derivater |
| QN02AF01 | Butorphanol |
| QN02AF02 | Nalbufin |
| QN02AG | Opioider i komb. med antispasmodika |
| QN02AG01 | Morphin og antispasmodika |
| QN02AG02 | Ketobemidon og antispasmodika |
| QN02AG03 | Pethidin og antispasmodika |
| QN02AG04 | Hydromorphon og antispasmodika |
| QN02AJ | Opioider i kombination med non-opioide analgetika |
| QN02AJ01 | Dihydrocodein og paracetamol |
| QN02AJ02 | Dihydrocodein og acetylsalicylsyre |
| QN02AJ03 | Dihydrocodein og andre non-opioide analgetika |
| QN02AJ06 | Codein og paracetamol |
| QN02AJ07 | Codein og acetylsalicylsyre |
| QN02AJ08 | Codein og ibuprofen |
| QN02AJ09 | Codein og andre non-opioide analgetika |
| QN02AJ13 | Tramadol og paracetamol |
| QN02AJ14 | Tramadol og dexketoprofen |
| QN02AJ15 | Tramadol og andre non-opioide analgetika |
| QN02AJ16 | Tramadol og celecoxib |
| QN02AJ17 | Oxycodon og paracetamol |
| QN02AJ18 | Oxycodon og acetylsalicylsyre |
| QN02AJ19 | Oxycodon og ibuprofen |
| QN02AJ22 | Hydrocodon og paracetamol |
| QN02AJ23 | Hydrocodon og ibuprofen |
| QN02AX | Andre opioider |
| QN02AX01 | Tilidin |
| QN02AX02 | Tramadol |
| QN02AX03 | Dezocin |
| QN02AX05 | Meptazinol |
| QN02AX06 | Tapentadol |
| QN02AX07 | Oliceridin |
| QN02AX51 | Tilidin og naloxon |
| QN02B | Andre analgetika og antipyretica |
| QN02BA | Salicylsyre og derivater |
| QN02BA01 | Acetylsalicylsyre |
| QN02BA02 | Aloxiprin |
| QN02BA03 | Cholinsalicylat |
| QN02BA04 | Natriumsalicylat |
| QN02BA05 | Salicylamid |
| QN02BA06 | Salicyloylsalicylsyre |
| QN02BA07 | Ethenzamid |
| QN02BA08 | Morpholinsalicylat |
| QN02BA09 | Dipyrocetyl |
| QN02BA10 | Benorilat |
| QN02BA11 | Diflunisal |
| QN02BA12 | Kaliumsalicylat |
| QN02BA14 | Guacetisal |
| QN02BA15 | Carbasalatcalcium |
| QN02BA16 | Imidazolsalicylat |
| QN02BA55 | Salicylamid, komb. excl. psykoleptika |
| QN02BA57 | Ethenzamid, komb. excl. psykoleptika |
| QN02BA59 | Dipyrocetyl, komb. excl. psykoleptika |
| QN02BA65 | Carbasalatcalcium, komb. excl. psykoleptika |
| QN02BA67 | Magnesiumsalicylat, kombinationer excl. psykoleptika |
| QN02BA71 | Acetylsalicylsyre, komb. med psykoleptika |
| QN02BA75 | Salicylamid, komb. med psykoleptika |
| QN02BA77 | Ethenzamid, komb. med psykoleptika |
| QN02BA79 | Dipyrocetyl, komb. med psykoleptika |
| QN02BB | Pyrazoloner |
| QN02BB01 | Phenazon |
| QN02BB02 | Metamizolnatrium |
| QN02BB03 | Aminophenazon |
| QN02BB04 | Propyphenazon |
| QN02BB05 | Nifenazon |
| QN02BB51 | Phenazon, komb. excl. psykoleptika |
| QN02BB52 | Metamizolnatrium, komb. excl. psykoleptika |
| QN02BB53 | Aminophenazon, komb. excl. psykoleptika |
| QN02BB54 | Propyphenazon, komb. excl. psykoleptika |
| QN02BB71 | Phenazon, komb. med psykoleptika |
| QN02BB72 | Metamizolnatrium, komb. med psykoleptika |
| QN02BB73 | Aminophenazon, komb. med psykoleptika |
| QN02BB74 | Propyphenazon, komb. med psykoleptika |
| QN02BE | Anilider |
| QN02BE01 | Paracetamol |
| QN02BE03 | Phenacetin |
| QN02BE04 | Bucetin |
| QN02BE05 | Propacetamol |
| QN02BE53 | Phenacetin, komb. excl. psykoleptika |
| QN02BE54 | Bucetin, komb. excl. psykoleptika |
| QN02BE71 | Paracetamol, komb. med psykoleptika |
| QN02BE73 | Phenacetin, komb. med psykoleptika |
| QN02BE74 | Bucetin, komb. med psykoleptika |
| QN02BF | Gabapentinoider |
| QN02BF01 | Gabapentin |
| QN02BF02 | Pregabalin |
| QN02BF03 | Mirogabalin |
| QN02BG | Andre analgetika og antipyretica |
| QN02BG02 | Rimazolium |
| QN02BG03 | Glafenin |
| QN02BG04 | Floctafenin |
| QN02BG05 | Viminol |
| QN02BG06 | Nefopam |
| QN02BG07 | Flupirtin |
| QN02BG08 | Ziconotid |
| QN02BG09 | Methoxyfluran |
| QN02BG10 | Nabiximols |
| QN02BG12 | Tanezumab |
| QN02BG90 | Frunevetmab |
| QN02BG91 | Bedinvetmab |
| QN02BG92 | Relfovetmab |
| QN02BG93 | Izenivetmab |
| QN02C | Midler mod migræne |
| QN02CA | Ergot-alkaloider |
| QN02CA01 | Dihydroergotamin |
| QN02CA02 | Ergotamin |
| QN02CA04 | Methysergid |
| QN02CA07 | Lisurid |
| QN02CA51 | Dihydroergotamin, kombinationer |
| QN02CA52 | Ergotamin, kombinationer uden psykoleptika |
| QN02CA72 | Ergotamin, kombinationer med psykoleptika |
| QN02CB | Kortikosteroid-derivater |
| QN02CB01 | Flumedroxon |
| QN02CC | Selektive 5ht(1)-receptor-agonister |
| QN02CC01 | Sumatrptan |
| QN02CC02 | Naratriptan |
| QN02CC03 | Zolmitriptan |
| QN02CC04 | Rizatriptan |
| QN02CC05 | Almotriptan |
| QN02CC06 | Eletriptan |
| QN02CC07 | Frovatriptan |
| QN02CC08 | Lasmiditan |
| QN02CC51 | Sumatriptan og naproxen |
| QN02CD | Calcitoningenrelaterede peptid (cgrp) -antagonister |
| QN02CD01 | Erenumab |
| QN02CD02 | Galcanezumab |
| QN02CD03 | Fremanezumab |
| QN02CD04 | Ubrogepant |
| QN02CD05 | Eptinezumab |
| QN02CD06 | Rimegepant |
| QN02CD07 | Atogepant |
| QN02CD08 | Zavegepant |
| QN02CX | Andre midler mod mirgæne |
| QN02CX01 | Pizotifen |
| QN02CX02 | Clonidin |
| QN02CX03 | Iprazochrom |
| QN02CX05 | Dimetotiazin |
| QN02CX06 | Oxetoron |
| QN03 | Antiepileptika |
| QN03A | Antiepileptika |
| QN03AA | Barbiturater og derivater |
| QN03AA01 | Methylphenobarbital |
| QN03AA02 | Phenobarbital |
| QN03AA03 | Primidon |
| QN03AA04 | Barbexaclon |
| QN03AA30 | Metharbital |
| QN03AB | Hydantoin-derivater |
| QN03AB01 | Ethotoin |
| QN03AB02 | Phenytoin |
| QN03AB03 | Amino(diphenylhydantoin)valersyre |
| QN03AB04 | Mephenytoin |
| QN03AB05 | Fosphenytoin |
| QN03AB52 | Phenytoin, komb. |
| QN03AB54 | Mephenytoin, komb. |
| QN03AC | Oxazolidin-derivater |
| QN03AC01 | Paramethadion |
| QN03AC02 | Trimethadion |
| QN03AC03 | Ethadion |
| QN03AD | Succinimid-derivater |
| QN03AD01 | Ethosuximid |
| QN03AD02 | Phensuximid |
| QN03AD03 | Mesuximid |
| QN03AD51 | Ethosuximid, komb. |
| QN03AE | Benzodiazepin-derivater |
| QN03AE01 | Clonazepam |
| QN03AF | Carboxamid-derivater |
| QN03AF01 | Carbamazepin |
| QN03AF02 | Oxcarbazepin |
| QN03AF03 | Rufinamid |
| QN03AF04 | Eslicarbazepin |
| QN03AG | Fedtsyre-derivater |
| QN03AG01 | Valproinsyre |
| QN03AG02 | Valpromid |
| QN03AG03 | Aminobutyrsyre |
| QN03AG04 | Vigabatrin |
| QN03AG05 | Progabid |
| QN03AG06 | Tiagabin |
| QN03AX | Andre antiepileptika |
| QN03AX03 | Sultiam |
| QN03AX07 | Phenacemid |
| QN03AX09 | Lamotrigin |
| QN03AX10 | Felbamat |
| QN03AX11 | Topiramat |
| QN03AX13 | Pheneturid |
| QN03AX14 | Levetiracetam |
| QN03AX15 | Zonisamid |
| QN03AX17 | Stiripentol |
| QN03AX18 | Lacosamid |
| QN03AX19 | Carisbamat |
| QN03AX21 | Retigabin |
| QN03AX22 | Perampanel |
| QN03AX23 | Brivaracetam |
| QN03AX24 | Cannabidiol |
| QN03AX25 | Cenobamat |
| QN03AX26 | Fenfluramin |
| QN03AX27 | Ganaxolon |
| QN03AX30 | Beclamid |
| QN03AX90 | Imepitoin |
| QN03AX91 | Kaliumbromid |
| QN04 | Anti-parkinson-midler |
| QN04B | Dopaminerge stoffer |
| QN04BA | Dopa og dopa-derivater |
| QN04BA01 | Levodopa |
| QN04BA02 | Levodopa og decarboxylase-hæmmer |
| QN04BA03 | Levodopa, decarboxylase-hæmmer og comt-hæmmer |
| QN04BA04 | Melevodopa |
| QN04BA05 | Melevodopa og decarboxylase-hæmmer |
| QN04BA06 | Etilevodopa og decarboxylase-hæmmer |
| QN04BA07 | Foslevodopa og decarboxylasehæmmer |
| QN04BB | Adamantan-derivater |
| QN04BB01 | Amantadin |
| QN04BC | Dopamin-agonister |
| QN04BC01 | Bromocriptin |
| QN04BC02 | Pergolid |
| QN04BC03 | Dihydroergocryptinmesylat |
| QN04BC04 | Ropinirol |
| QN04BC05 | Pramipexol |
| QN04BC06 | Cabergolin |
| QN04BC07 | Apomorphin |
| QN04BC08 | Piribedil |
| QN04BC09 | Rotigotin |
| QN04BD | Monoamin-oxidase type b hæmmere |
| QN04BD01 | Selegilin |
| QN04BD02 | Rasagilin |
| QN04BD03 | Safinamid |
| QN04BX | Andre dopaminerge stoffer |
| QN04BX01 | Tolcapon |
| QN04BX02 | Entacapon |
| QN04BX03 | Budipin |
| QN04BX04 | Opicapon |
| QN04C | Andre antiparkinsonmidler |
| QN04CX | Andre antiparkinsonmidler |
| QN04CX01 | Istradefyllin |
| QN05 | Psykoleptika |
| QN05A | Antipsykotika |
| QN05AA | Phenothiazin med alifatisk sidekæde |
| QN05AA01 | Chlorpromazin |
| QN05AA02 | Levopromazin |
| QN05AA03 | Promazin |
| QN05AA04 | Acepromazin |
| QN05AA05 | Triflupromazin |
| QN05AA06 | Cyamemazin |
| QN05AA07 | Chlorproethazin |
| QN05AB | Phenothiazin med piperazinstruktur |
| QN05AB01 | Dixyrazin |
| QN05AB02 | Fluphenazin |
| QN05AB03 | Perphenazin |
| QN05AB04 | Prochlorperazin |
| QN05AB05 | Thiopropazat |
| QN05AB06 | Trifluoperazin |
| QN05AB07 | Acetophenazin |
| QN05AB08 | Thioproperazin |
| QN05AB09 | Butaperazin |
| QN05AB10 | Perazin |
| QN05AC | Phenothiazin med piperidinstruktur |
| QN05AC01 | Periciazin |
| QN05AC02 | Thioridazin |
| QN05AC03 | Mesoridazin |
| QN05AC04 | Pipotiazin |
| QN05AD | Butyrophenon-derivater |
| QN05AD01 | Haloperidol |
| QN05AD02 | Trifluperidol |
| QN05AD03 | Melperon |
| QN05AD04 | Moperon |
| QN05AD05 | Pipamperon |
| QN05AD06 | Bromperidol |
| QN05AD07 | Benperidol |
| QN05AD08 | Droperidol |
| QN05AD09 | Fluanisol |
| QN05AD10 | Lumateperon |
| QN05AD90 | Azaperon |
| QN05AE | Indol-derivater |
| QN05AE01 | Oxypertin |
| QN05AE02 | Molindon |
| QN05AE03 | Sertindol |
| QN05AE04 | Ziprasidon |
| QN05AE05 | Lurasidon |
| QN05AF | Thioxanthen-derivater |
| QN05AF01 | Flupentixol |
| QN05AF02 | Clopenthixol |
| QN05AF03 | Chlorprothixen |
| QN05AF04 | Tiotixen |
| QN05AF05 | Zuclopenthixol |
| QN05AG | Diphenylbutylpiperidin-derivater |
| QN05AG01 | Fluspirilen |
| QN05AG02 | Pimozid |
| QN05AG03 | Penfluridol |
| QN05AH | Diazepiner, oxazepiner, thiazepiner og oxepiner |
| QN05AH01 | Loxapin |
| QN05AH02 | Clozapin |
| QN05AH03 | Olanzapin |
| QN05AH04 | Quetiapin |
| QN05AH05 | Asenapin |
| QN05AH06 | Clotiapin |
| QN05AH53 | Olanzapin og samidorphan |
| QN05AK | Neuroleptika i tardiv dyskinesi |
| QN05AK01 | Tetrabenazin |
| QN05AL | Benzamider |
| QN05AL01 | Sulpirid |
| QN05AL02 | Sultoprid |
| QN05AL03 | Tiaprid |
| QN05AL04 | Remoxiprid |
| QN05AL05 | Amisulprid |
| QN05AL06 | Veralaprid |
| QN05AL07 | Levosulpirid |
| QN05AN | Lithium |
| QN05AN01 | Lithium |
| QN05AX | Andre antipsykotika |
| QN05AX07 | Prothipendyl |
| QN05AX08 | Risperidon |
| QN05AX09 | Clotiapin |
| QN05AX10 | Mosapramin |
| QN05AX11 | Zotepin |
| QN05AX12 | Aripiprazol |
| QN05AX13 | Paliperidon |
| QN05AX14 | Iloperidon |
| QN05AX15 | Cariprazin |
| QN05AX16 | Brexpiprazol |
| QN05AX17 | Pimavanserin |
| QN05AX90 | Amperozid |
| QN05B | Anxiolytika |
| QN05BA | Benzodiazepin-derivater |
| QN05BA01 | Diazepam |
| QN05BA02 | Chlordiazepoxid |
| QN05BA03 | Medazepam |
| QN05BA04 | Oxazepam |
| QN05BA05 | Kaliumclorazepat |
| QN05BA06 | Lorazepam |
| QN05BA07 | Adinazolam |
| QN05BA08 | Bromazepam |
| QN05BA09 | Clobazam |
| QN05BA10 | Ketazolam |
| QN05BA11 | Prazepam |
| QN05BA12 | Alprazolam |
| QN05BA13 | Halazepam |
| QN05BA14 | Pinazepam |
| QN05BA15 | Camazepam |
| QN05BA16 | Nordazepam |
| QN05BA17 | Fludiazepam |
| QN05BA18 | Ethylloflazepat |
| QN05BA19 | Etizolam |
| QN05BA21 | Clotiazepam |
| QN05BA22 | Cloxazolam |
| QN05BA23 | Tofisopam |
| QN05BA24 | Bentazepam |
| QN05BA25 | Mexazolam |
| QN05BA56 | Lorazepam, komb. |
| QN05BB | Diphenylmethan-derivater |
| QN05BB01 | Hydroxyzin |
| QN05BB02 | Captodiam |
| QN05BB51 | Hydoxyzin, komb. |
| QN05BC | Carbamater |
| QN05BC01 | Meprobamat |
| QN05BC03 | Emylcamat |
| QN05BC04 | Mebutamat |
| QN05BC51 | Meprobamat, komb. |
| QN05BD | Dibenzo-bicyclo-octadien-derivater |
| QN05BD01 | Benzoctamin |
| QN05BE | Azaspirodecandion-derivater |
| QN05BE01 | Buspiron |
| QN05BX | Andre anxiolytika |
| QN05BX01 | Mefenoxalon |
| QN05BX02 | Gedocarnil |
| QN05BX03 | Etifoxin |
| QN05BX04 | Fabomotizol |
| QN05BX05 | Lavendelolie |
| QN05BX90 | Clomipramin |
| QN05C | Hypnotika og sedativa |
| QN05CA | Barbiturater, usammensatte |
| QN05CA01 | Pentobarbital |
| QN05CA02 | Amobarbital |
| QN05CA03 | Butobarbital |
| QN05CA04 | Barbital |
| QN05CA05 | Aprobarbital |
| QN05CA06 | Secobarbital |
| QN05CA07 | Talbutal |
| QN05CA08 | Vinylbital |
| QN05CA09 | Vinbarbital |
| QN05CA10 | Cyclobarbital |
| QN05CA11 | Heptabarbital |
| QN05CA12 | Reposal |
| QN05CA15 | Methohexital |
| QN05CA16 | Hexobarbital |
| QN05CA19 | Thiopental |
| QN05CA20 | Etallobarbital |
| QN05CA21 | Allobarbital |
| QN05CA22 | Proxibarbal |
| QN05CB | Barbiturater, komb. |
| QN05CB01 | Barbiturater i komb. |
| QN05CB02 | Barbiturater i komb. med andre stoffer |
| QN05CC | Aldehyder og derivater |
| QN05CC01 | Chloralhydrat |
| QN05CC02 | Chloralodol |
| QN05CC03 | Acetylglycinamid-chloralhydrat |
| QN05CC04 | Dichloralphenazon |
| QN05CC05 | Paraldehyd |
| QN05CD | Benzodiazepin-derivater |
| QN05CD01 | Flurazepam |
| QN05CD02 | Nitrazepam |
| QN05CD03 | Flunitrazepam |
| QN05CD04 | Estazolam |
| QN05CD05 | Triazolam |
| QN05CD06 | Lormetazepam |
| QN05CD07 | Temazepam |
| QN05CD08 | Midazolam |
| QN05CD09 | Brotizolam |
| QN05CD10 | Quazepam |
| QN05CD11 | Loprazolam |
| QN05CD12 | Doxefazepam |
| QN05CD13 | Cinolazepam |
| QN05CD14 | Remimazolam |
| QN05CD15 | Nimetazepam |
| QN05CD90 | Climazolam |
| QN05CE | Piperidindion-derivater |
| QN05CE01 | Glutethimid |
| QN05CE02 | Methyprylon |
| QN05CE03 | Pyrithyldion |
| QN05CF | Benzodiazepin-relaterede stoffer |
| QN05CF01 | Zopiclon |
| QN05CF02 | Zolpidem |
| QN05CF03 | Zaleplon |
| QN05CF04 | Eszopiclon |
| QN05CH | Melatoninreceptoragonister |
| QN05CH01 | Melatonin |
| QN05CH02 | Ramelteon |
| QN05CH03 | Tasimelteon |
| QN05CJ | Orexinreceptor antagonister |
| QN05CJ01 | Suvorexant |
| QN05CJ02 | Lemborexant |
| QN05CJ03 | Daridorexant |
| QN05CM | Andre hypnotika og sedativa |
| QN05CM01 | Methaqualon |
| QN05CM02 | Clomethiazol |
| QN05CM03 | Bromisoval |
| QN05CM04 | Carbromal |
| QN05CM05 | Scopolamin |
| QN05CM06 | Propiomazin |
| QN05CM07 | Triclofos |
| QN05CM08 | Ethchlorvynol |
| QN05CM09 | Baldrianrod |
| QN05CM10 | Hexapropymat |
| QN05CM11 | Bromider |
| QN05CM12 | Apronal |
| QN05CM13 | Valnoctamid |
| QN05CM15 | Methylpentynol |
| QN05CM16 | Niaprazin |
| QN05CM17 | Melatonin |
| QN05CM18 | Dexmedetomidin |
| QN05CM90 | Detomidin |
| QN05CM91 | Medetomidin |
| QN05CM92 | Xylazin |
| QN05CM93 | Romifidin |
| QN05CM94 | Metomidat |
| QN05CM96 | Tasipimidin |
| QN05CM99 | Kombinationer |
| QN05CX | Hypnotika og sedativa i komb., excl. barbiturater |
| QN05CX01 | Meprobamat, komb. |
| QN05CX02 | Methaqualon, komb. |
| QN05CX03 | Methylpentynol, komb. |
| QN05CX04 | Clomethiazol, komb. |
| QN05CX05 | Emepronium, komb. |
| QN05CX06 | Dipiperonylaminoethanol, komb. |
| QN06 | Psykoanaleptika |
| QN06A | Antidepressiva |
| QN06AA | Non-selektive monoamin re-optagelse inhibitorer |
| QN06AA01 | Desipramin |
| QN06AA02 | Imipramin |
| QN06AA03 | Imiprominoxid |
| QN06AA04 | Clomipramin |
| QN06AA05 | Opipramol |
| QN06AA06 | Trimipramin |
| QN06AA07 | Lofepramin |
| QN06AA08 | Dibenzepin |
| QN06AA09 | Amitriptylin |
| QN06AA10 | Nortriptylin |
| QN06AA11 | Protriptylin |
| QN06AA12 | Doxepin |
| QN06AA13 | Iprendol |
| QN06AA14 | Melitracen |
| QN06AA15 | Butriptylin |
| QN06AA16 | Dosulepin |
| QN06AA17 | Amoxapin |
| QN06AA18 | Dimetacrin |
| QN06AA19 | Amineptin |
| QN06AA21 | Maprotilin |
| QN06AA23 | Quinupramin |
| QN06AB | Selektive serotonin reoptagelse-inhibitorer |
| QN06AB02 | Zimeldin |
| QN06AB03 | Fluoxetin |
| QN06AB04 | Citalopram |
| QN06AB05 | Paroxetin |
| QN06AB06 | Sertralin |
| QN06AB07 | Alaproclat |
| QN06AB08 | Fluvoxamin |
| QN06AB09 | Etoperidon |
| QN06AB10 | Escitalopram |
| QN06AF | Monoamin-oxidasehæmmere, non-selektive |
| QN06AF01 | Isocarboxazid |
| QN06AF02 | Nialamid |
| QN06AF03 | Phenelzin |
| QN06AF04 | Tranylcypromin |
| QN06AF05 | Iproniazid |
| QN06AF06 | Iproclozid |
| QN06AG | Monoamin-oxidase-a-hæmmere |
| QN06AG02 | Moclobemid |
| QN06AG03 | Toloxaton |
| QN06AX | Andre antidepressiva |
| QN06AX01 | Oxitriptan |
| QN06AX02 | Tryptophan |
| QN06AX03 | Mianserin |
| QN06AX04 | Nomifensin |
| QN06AX05 | Trazodon |
| QN06AX06 | Nefazodon |
| QN06AX07 | Minaprin |
| QN06AX08 | Bifemalan |
| QN06AX09 | Viloxazin |
| QN06AX10 | Oxaflozan |
| QN06AX11 | Mirtazapin |
| QN06AX12 | Bupropion |
| QN06AX13 | Medifoxamin |
| QN06AX14 | Tianeptin |
| QN06AX15 | Pivagabin |
| QN06AX16 | Venlafaxin |
| QN06AX17 | Milnacipran |
| QN06AX18 | Reboxetin |
| QN06AX19 | Gepiron |
| QN06AX21 | Duloxetin |
| QN06AX22 | Agomelatin |
| QN06AX23 | Desvenlafaxin |
| QN06AX24 | Vilazodon |
| QN06AX25 | Perikon |
| QN06AX26 | Vortioxetin |
| QN06AX27 | Esketamin |
| QN06AX28 | Levomilnacipran |
| QN06AX29 | Brexanolon |
| QN06AX31 | Zuranolon |
| QN06AX62 | Bupropion og dextromethorphan |
| QN06AX90 | Selegilin |
| QN06B | Psykostimulantia, midler for adhd og nootropika |
| QN06BA | Centralt virkende sympatomimetika |
| QN06BA01 | Amfetamin |
| QN06BA02 | Dexamfetamin |
| QN06BA03 | Metamfetamin |
| QN06BA04 | Methylphenidat |
| QN06BA05 | Pemolin |
| QN06BA06 | Fencamfamin |
| QN06BA07 | Modafinil |
| QN06BA08 | Fenozolon |
| QN06BA09 | Atomoxetin |
| QN06BA10 | Fenetyllin |
| QN06BA11 | Dexmethylphenidat |
| QN06BA12 | Lisdexamfetamin |
| QN06BA13 | Armodafinil |
| QN06BA14 | Solriamfetol |
| QN06BA15 | Dexmethylphenidat og serdexmethylphenidat |
| QN06BC | Xanthin-derivater |
| QN06BC01 | Caffein |
| QN06BC02 | Propentofyllin |
| QN06BX | Andre psykostimulantia og nootropika |
| QN06BX21 | Temgicoluril |
| QN06BX22 | Phenibut |
| QN06C | Psykoleptika og psykoanaleptika i komb. |
| QN06CA01 | Amitriptylin og psykoleptika |
| QN06CA02 | Melitracen og psykoleptika |
| QN06CA03 | Fluoxetin og psykoleptika |
| QN06D | Midler mod demens |
| QN06DA | Anticholinesteraser |
| QN06DA01 | Tacrin |
| QN06DA02 | Donepezil |
| QN06DA03 | Rivastigmin |
| QN06DA04 | Galantamin |
| QN06DA05 | Ipidacrin |
| QN06DA52 | Donepezil og memantin |
| QN06DA53 | Donepezil, memantin og ginkgoblad |
| QN06DX | Andre midler mod demens |
| QN06DX01 | Memantin |
| QN06DX02 | Ginkgoblad |
| QN06DX03 | Aducanumab |
| QN06DX04 | Lecanemab |
| QN06DX05 | Donanemab |
| QN06DX30 | Kombinationer |
| QN07 | Andre midler med virkn. på centralnervesystemet |
| QN07A | Parasympatomimetika |
| QN07AA | Anticholinesteraser |
| QN07AA01 | Neostigmin |
| QN07AA02 | Pyridostigmin |
| QN07AA03 | Distigmin |
| QN07AA30 | Ambenonium |
| QN07AA51 | Neostigmin, komb. |
| QN07AB | Cholin-estere |
| QN07AB01 | Carbachol |
| QN07AB02 | Bethanechol |
| QN07AX | Andre parasympatomimetika |
| QN07AX01 | Pilocarpin |
| QN07AX02 | Cholinalfoscerat |
| QN07AX03 | Cevimelin |
| QN07B | Midler mod afhængighedsforstyrrelser |
| QN07BA | Midler mod nicotinafhængighed |
| QN07BA01 | Nicotin |
| QN07BA03 | Vareniclin |
| QN07BA04 | Cytisiniclin |
| QN07BB | Midler mod alkoholafhængighed |
| QN07BB01 | Disulfiram |
| QN07BB02 | Calciumcarbimid |
| QN07BB03 | Acamprosat |
| QN07BB04 | Naltrexon |
| QN07BB05 | Nalmefen |
| QN07BB06 | Ondelopran |
| QN07BC | Midler mod opioidafhængighed |
| QN07BC01 | Buprenorphin |
| QN07BC02 | Methadon |
| QN07BC03 | Levacetylmethadol |
| QN07BC04 | Lofexidin |
| QN07BC05 | Levomethadon |
| QN07BC06 | Diamorphin |
| QN07BC51 | Buprenorphin, komb. |
| QN07C | Midler mod svimmelhed |
| QN07CA | Midler mod svimmelhed |
| QN07CA01 | Betahistin |
| QN07CA02 | Cinnarizin |
| QN07CA03 | Flunarizin |
| QN07CA04 | Acetylleucin |
| QN07CA52 | Cinnarizin, komb. |
| QN07X | Andre midler med virkn. på centralnervesystemet |
| QN07XA | Gangliosider og gangliosid-derivater |
| QN07XX | Andre midler med virkn. på centralnervesystemet |
| QN07XX01 | Tirilazad |
| QN07XX02 | Riluzol |
| QN07XX03 | Xaliproden |
| QN07XX04 | Natriumoxybat |
| QN07XX05 | Amifampridin |
| QN07XX06 | Tetrabenazin |
| QN07XX07 | Fampridin |
| QN07XX08 | Tafamidis |
| QN07XX10 | Laquinimod |
| QN07XX11 | Pitolisant |
| QN07XX12 | Patisiran |
| QN07XX13 | Valbenazin |
| QN07XX14 | Edaravon |
| QN07XX15 | Inotersen |
| QN07XX16 | Deutetrabenazin |
| QN07XX17 | Arimoclomol |
| QN07XX18 | Vutrisiran |
| QN07XX19 | Natriumphenylbutyrat og ursodoxicoltaurin |
| QN07XX21 | Eplontersen |
| QN07XX22 | Tofersen |
| QN07XX23 | Troriluzol |
| QN07XX24 | Trofinetid |
| QN07XX25 | Omaveloxolon |
| QN07XX59 | Dextromethorphan, kombinationer |
| QN51 | Midler til aflivning |
| QN51A | Midler til aflivning |
| QN51AA | Barbiturater |
| QN51AA01 | Pentobarbital |
| QN51AA02 | Secobarbital |
| QN51AA30 | Barbiturater i komb. |
| QN51AA51 | Pentobarbital, komb. |
| QN51AA52 | Secobarbital, komb. |
| QN51AX | Andre midler til aflivning |
| QN51AX50 | Kombinationer |
| QP | Antiparasiticider, insecticider og repellanter |
| QP01 | Antiprozoals |
| QP02 | Anthelmintika |
| QP03 | Ectoparasiticider, incl. scabicider, insecticider og repellanter |
| QP51 | Antiprotozo-midler |
| QP51A | Midler mod protozo-sygdomme |
| QP51AA | Nitroimidazol-derivater |
| QP51AA02 | Tinidazol |
| QP51AA03 | Ornidazol |
| QP51AA04 | Azanidazol |
| QP51AA05 | Propenidazol |
| QP51AA06 | Nimorazol |
| QP51AA07 | Dimetridazol |
| QP51AA10 | Ipronidazol |
| QP51AB | Antimonforbindelser |
| QP51AB02 | Natriumstibogluconat |
| QP51AC | Nitrofuran-derivater |
| QP51AC01 | Nifurtimox |
| QP51AC02 | Nitrofural |
| QP51AD | Arsenforbindelser |
| QP51AD01 | Arsthinol |
| QP51AD02 | Difetarson |
| QP51AD03 | Glycobiarsol |
| QP51AD04 | Melarsoprol |
| QP51AD05 | Acetarsol |
| QP51AD53 | Glycobiarsol, kombinationer |
| QP51AE | Carbanilider |
| QP51AE02 | Suraminnatrium |
| QP51AE03 | Nicarbazin |
| QP51AF | Aromatiske diamidiner |
| QP51AF03 | Phenamidin |
| QP51AG | Sulfonamider, usammensatte og i kombinationer |
| QP51AG01 | Sulfadimidin |
| QP51AG30 | Sulfonamider i kombination |
| QP51AG51 | Sulfadimidin, kombinationer |
| QP51AG53 | Sulfaquinoxalin, kombinationer |
| QP51AX | Other antiprotozoal agents |
| QP51AX01 | Chiniofon |
| QP51AX02 | Emetin |
| QP51AX03 | Phanquinon |
| QP51AX04 | Mepacrin |
| QP51AX05 | Nifursol |
| QP51AX11 | Arprinocid |
| QP51AX15 | Tiamulin |
| QP51AX17 | Ethopabat |
| QP51AX18 | Diaveridin |
| QP51AX23 | Fumagillin |
| QP51AX30 | Combinations of other protozoal agents |
| QP51B | Midler mod coccidiose |
| QP51BA | Sulfonamider, usammensatte og kombinationer mod coccidiose |
| QP51BA01 | Sulfadimethoxin |
| QP51BA02 | Sulfaquinoxalin |
| QP51BA03 | Sulfaclozin |
| QP51BB | Ionoforer mod coccidiose |
| QP51BB01 | Salinomycin |
| QP51BB02 | Lasalocid |
| QP51BB03 | Monensin |
| QP51BB04 | Narasin |
| QP51BB05 | Maduramicin |
| QP51BB54 | Narasin, kombinationer |
| QP51BC | Triaziner mod coccidiose |
| QP51BC01 | Toltrazuril |
| QP51BC02 | Clazuril |
| QP51BC03 | Diclazuril |
| QP51BC04 | Ponazuril |
| QP51BC51 | Toltrazuril, kombinationer |
| QP51BX | Andre midler mod coccidiose |
| QP51BX01 | Halofuginon |
| QP51BX02 | Amprolium |
| QP51BX03 | Robenidin |
| QP51BX04 | Decoquinat |
| QP51BX05 | Clopidol |
| QP51BX06 | Dinitolmid |
| QP51BX52 | Amprolium, kombinationer |
| QP51BX56 | Pyrimethamin, kombinationer |
| QP51C | Midler mod amoebiasis og histomonose |
| QP51CA | Nitroimidazol-derivater mod amøbiasis og histomoniasis |
| QP51CA01 | Metronidazol |
| QP51CA02 | Ronidazol |
| QP51CA03 | Carnidazol |
| QP51CX | Andre midler mod amøbiasis og histomoniasis |
| QP51CX01 | Aminonitrothiazol |
| QP51D | Midler mod leishmaniose og trypanosomose |
| QP51DF | Aromatiske diamidiner mod leishmaniasis og trypanosomiasis |
| QP51DF01 | Diminazen |
| QP51DF02 | Pentamidin |
| QP51DX | Andre midler mod leishmaniasis og trypanosomiasis |
| QP51DX01 | Megluminantimonat |
| QP51DX02 | Melarsamin |
| QP51DX03 | Homidium |
| QP51DX04 | Isometamid |
| QP51DX05 | Quinapyramin |
| QP51DX06 | Domperidon |
| QP51DX07 | Miltefosin |
| QP51E | Midler mod babesiose og theileriose |
| QP51EX | Andre midler mod babesiose og theileriose |
| QP51EX01 | Imidocarb |
| QP51EX02 | Parvaquon |
| QP51EX03 | Buparvaquon |
| QP51X | Andre antiprotozo-midler |
| QP52 | Anthelmintika |
| QP52A | Antitrematode-,antinematode- og anticestodemidler |
| QP52AA | Quinolin-derivater og beslægtede stoffer |
| QP52AA01 | Praziquantel |
| QP52AA02 | Oxamniquin |
| QP52AA04 | Epsiprantel |
| QP52AA30 | Quinolin-derivater og beslægtede stoffer i komb. |
| QP52AA51 | Praziquantel, kombinationer |
| QP52AA54 | Esiprantel, komb. |
| QP52AB | Organiske phosphorforbindelser |
| QP52AB01 | Metrifonat |
| QP52AB02 | Bromfenofos |
| QP52AB03 | Dichlorvos |
| QP52AB04 | Haloxon |
| QP52AB06 | Naftalofos |
| QP52AB51 | Metrifonat, kombinationer |
| QP52AC | Benzimidazoler og beslægtede stoffer |
| QP52AC01 | Triclabendazol |
| QP52AC02 | Oxfendazol |
| QP52AC03 | Parbendazol |
| QP52AC04 | Thiophanat |
| QP52AC05 | Febantel |
| QP52AC06 | Netobimin |
| QP52AC07 | Oxibendazol |
| QP52AC08 | Cambendazol |
| QP52AC09 | Mebendazol |
| QP52AC10 | Thiabendazol |
| QP52AC11 | Albendazol |
| QP52AC12 | Flubendazol |
| QP52AC13 | Fenbendazol |
| QP52AC30 | Benzimidazoler og beslægtede stoffer i komb. |
| QP52AC52 | Oxfendazol, komb. |
| QP52AC55 | Febantel, kombinationer |
| QP52AC57 | Oxibendazol |
| QP52AC59 | Mebendazol, kombinationer |
| QP52AE | Imidazothiazoler |
| QP52AE01 | Levamisol |
| QP52AE02 | Tetramisol |
| QP52AE30 | Imidazothiazoler i kombination |
| QP52AE51 | Levamisol, kombinationer |
| QP52AE52 | Tetramisol, kombinationer |
| QP52AF | Tetrahydropyrimidiner |
| QP52AF01 | Morantel |
| QP52AF02 | Pyrantel |
| QP52AF03 | Oxantel |
| QP52AF30 | Tetrahydropyrimidiner i kombination |
| QP52AG | Phenol-derivater, incl. salicylanilider |
| QP52AG01 | Dichlorophen |
| QP52AG02 | Hexachlorophen |
| QP52AG03 | Niclosamid |
| QP52AG04 | Resorantel |
| QP52AG05 | Rafoxanid |
| QP52AG06 | Oxyclozanid |
| QP52AG07 | Bithionol |
| QP52AG08 | Nitroxolin |
| QP52AG09 | Closantel |
| QP52AH | Piperazin og derivater |
| QP52AH01 | Piperazin |
| QP52AH02 | Diethylcarbamazin |
| QP52AX | Andre anthelmintika |
| QP52AX01 | Nitroscanat |
| QP52AX02 | Bunamidinhydrochlorid |
| QP52AX03 | Phenothiazin |
| QP52AX04 | Dibutyltindilaurat |
| QP52AX05 | Destomycin a |
| QP52AX06 | Halodon |
| QP52AX07 | Butylchlorid |
| QP52AX08 | Thiacetarsamidnatrium |
| QP52AX09 | Monepantel |
| QP52AX60 | Emodepsid og toltrazuril |
| QP52B | Midler mod trematodose |
| QP52C | Midler mod nematodose |
| QP52D | Midler mod cestodose |
| QP52X | Andre anthelmintika |
| QP53 | Ectoparasiticider, insecticider og repellanter |
| QP53A | Ectoparasiticider til udvortes brug, inkl. insekticider |
| QP53AA | Svovlholdige produkter |
| QP53AA01 | Mesulfen |
| QP53AA02 | Cymiazol |
| QP53AB | Chlorholdige produkter |
| QP53AB01 | Clofenotan |
| QP53AB02 | Lindan |
| QP53AB03 | Bromociclen |
| QP53AB04 | Tosylchloramid |
| QP53AB51 | Clofenotan, kombinationer |
| QP53AB52 | Lindan, kombinationer |
| QP53AC | Pyrethriner og pyrethroider |
| QP53AC01 | Pyrethrum |
| QP53AC02 | Bioallethrin |
| QP53AC03 | Phenothrin |
| QP53AC04 | Permethrin |
| QP53AC05 | Flumethrin |
| QP53AC06 | Cyhalothrin |
| QP53AC07 | Flucythrinat |
| QP53AC08 | Cypermethrin |
| QP53AC10 | Fluvalinat |
| QP53AC11 | Deltamethrin |
| QP53AC12 | Cyfluthrin |
| QP53AC13 | Tetramethrin |
| QP53AC14 | Fenvalerat |
| QP53AC15 | Acrinathrin |
| QP53AC30 | Pyrethriner i kombination |
| QP53AC51 | Pyrethrum, kombinationer |
| QP53AC54 | Permethrin, komb. |
| QP53AC55 | Flumethrin, kombinationer |
| QP53AD | Amidiner |
| QP53AD01 | Amitraz |
| QP53AD51 | Amitraz, komb. |
| QP53AE | Carbamater |
| QP53AE01 | Carbaril |
| QP53AE02 | Propoxur |
| QP53AE03 | Bendiocarb |
| QP53AF | Organiske phosphorforbindelser |
| QP53AF01 | Phoxim |
| QP53AF02 | Metrifonat |
| QP53AF03 | Diazinon |
| QP53AF04 | Dichlorvos |
| QP53AF05 | Heptenofos |
| QP53AF06 | Phosmet |
| QP53AF07 | Fenthion |
| QP53AF08 | Coumafos |
| QP53AF09 | Propetamphos |
| QP53AF10 | Cythioat |
| QP53AF11 | Bromofos |
| QP53AF12 | Malathion |
| QP53AF13 | Quintiofos |
| QP53AF14 | Tetrachlorvinphos |
| QP53AF16 | Bromfenvinphos |
| QP53AF17 | Azamethiphos |
| QP53AF54 | Dichlorvos, kombinationer |
| QP53AG | Organiske syrer |
| QP53AG01 | Myresyre |
| QP53AG02 | Mælkesyre |
| QP53AG03 | Oxalsyre |
| QP53AG30 | Kombinationer |
| QP53AX | Andre ectoparasiticider til udvortes brug |
| QP53AX02 | Fenvalerat |
| QP53AX03 | Kvassia |
| QP53AX04 | Crotamiton |
| QP53AX11 | Benzylbenzoat |
| QP53AX13 | Nicotin |
| QP53AX14 | Bromoprofylat |
| QP53AX15 | Fipronil |
| QP53AX16 | Malachitgrøn |
| QP53AX17 | Imidacloprid |
| QP53AX18 | Calciumoxid |
| QP53AX19 | Formaldehyd |
| QP53AX22 | Thymol |
| QP53AX23 | Pyriproxifen |
| QP53AX24 | Dicyclanil |
| QP53AX25 | Metaflumizon |
| QP53AX26 | Pyriprol |
| QP53AX27 | Indoxacarb |
| QP53AX28 | Methopren |
| QP53AX29 | Hexaflumuron |
| QP53AX30 | Komb. af andre ectoparasiticider til udvortes brug |
| QP53AX31 | Spinetoram |
| QP53AX65 | Fipronil, komb. |
| QP53AX73 | Pyriproxifen, komb. |
| QP53AX78 | Methopren, kombinationer |
| QP53B | Ectoparasiticider til systemisk brug |
| QP53BB | Organiske phosphorforbindelser |
| QP53BB01 | Cythionat |
| QP53BB02 | Fenthion |
| QP53BB03 | Phosmet |
| QP53BB04 | Stirofos |
| QP53BC | Kitin-hæmmere |
| QP53BC01 | Lufenuron |
| QP53BC02 | Diflubenzuron |
| QP53BC03 | Teflubenzuron |
| QP53BC51 | Lufenuron, komb. |
| QP53BE | Isoxazoliner |
| QP53BE01 | Afoxolaner |
| QP53BE02 | Fluralaner |
| QP53BE03 | Sarolaner |
| QP53BE04 | Lotilaner |
| QP53BX | Andre ectoparasiticider til systemisk brug |
| QP53BX02 | Nitenpyram |
| QP53BX03 | Spinosad |
| QP53F | Insecticider |
| QP53FX | Andre insecticider |
| QP53G | Repellanter |
| QP53GX | Diverse repellanter |
| QP53GX01 | Diethyltoluamid |
| QP53GX02 | Dimethylphthalat |
| QP53GX03 | Dibutylsuccinat |
| QP53GX04 | Ethohexadiol |
| QP54 | Endectocider |
| QP54A | Macrocycliske lactoner |
| QP54AA | Avermectiner |
| QP54AA01 | Ivermectin |
| QP54AA02 | Abamectin |
| QP54AA03 | Doramectin |
| QP54AA04 | Eprinomectin |
| QP54AA05 | Selamectin |
| QP54AA06 | Emamectin |
| QP54AA51 | Ivermectin, komb. |
| QP54AA52 | Abamectin, komb. |
| QP54AA54 | Eprinomectin, kombinationer |
| QP54AA55 | Selamectin, kombinationer |
| QP54AB | Milbemyciner |
| QP54AB01 | Milbemycin |
| QP54AB02 | Moxidectin |
| QP54AB51 | Milbemycin, komb. |
| QP54AB52 | Moxidectin, komb. |
| QP54AX | Andre macrocycliske lactoner |
| QR | Respirationssystemet |
| QR01 | Midler til nasalt brug |
| QR01A | Decongestanter og andre nasalmidler t. lokalt brug |
| QR01AA | Sympatomimetika, usammensatte |
| QR01AA02 | Cyclopentamin |
| QR01AA03 | Ephedrin |
| QR01AA04 | Phenylephrin |
| QR01AA05 | Oxymetazolin |
| QR01AA06 | Tetryzolin |
| QR01AA07 | Xylometazolin |
| QR01AA08 | Naphazolin |
| QR01AA09 | Tramazolin |
| QR01AA10 | Metizolin |
| QR01AA11 | Tuaminoheptan |
| QR01AA12 | Fenoxazolin |
| QR01AA13 | Tymazolin |
| QR01AA14 | Adrenalin |
| QR01AA15 | Indanazolin |
| QR01AB | Sympatomimetika, komb. excl. kortikosteroider |
| QR01AB01 | Phenylephrin |
| QR01AB02 | Naphazolin |
| QR01AB03 | Tetryzolin |
| QR01AB05 | Ephedrin |
| QR01AB06 | Xylometazolin |
| QR01AB07 | Oxymetazolin |
| QR01AB08 | Tuaminoheptan |
| QR01AC | Midler mod allergi, excl. kortikosteroider |
| QR01AC01 | Cromoglicinsyre |
| QR01AC02 | Levocabastin |
| QR01AC03 | Azelastin |
| QR01AC04 | Antazolin |
| QR01AC05 | Spaglumsyre |
| QR01AC06 | Thonzylamin |
| QR01AC07 | Nedocromil |
| QR01AC51 | Cromoglicinsyre, komb. |
| QR01AD | Kortikosteroider |
| QR01AD01 | Beclometason |
| QR01AD02 | Prednisolon |
| QR01AD03 | Dexamethason |
| QR01AD04 | Flunisolid |
| QR01AD05 | Budesonid |
| QR01AD06 | Betamethason |
| QR01AD07 | Tixocortol |
| QR01AD08 | Fluticason |
| QR01AD09 | Mometason |
| QR01AD11 | Triamcinolon |
| QR01AD12 | Fluticasonfuroat |
| QR01AD13 | Ciclesonid |
| QR01AD52 | Prednisolon, komb. |
| QR01AD53 | Dexamethason, komb. |
| QR01AD57 | Tixocortol, komb. |
| QR01AD58 | Fluticason, kombinationer |
| QR01AD59 | Mometason, kombinationer |
| QR01AD60 | Hydrocortison, komb. |
| QR01AX | Andre midler til nasalt brug |
| QR01AX01 | Calciumhexaminthiocyanat |
| QR01AX02 | Retinol |
| QR01AX03 | Ipratropiumbromid |
| QR01AX05 | Ritiometan |
| QR01AX06 | Mupirocin |
| QR01AX07 | Hexamidin |
| QR01AX08 | Framycetin |
| QR01AX09 | Hyaluronsyre |
| QR01AX10 | Diverse nasalmidler |
| QR01AX30 | Kombinationer |
| QR01B | Nasale decongestanter til systemisk brug |
| QR01BA | Sympatomimetika |
| QR01BA01 | Phenylpropanolamin |
| QR01BA02 | Pseudoephedrin |
| QR01BA03 | Phenylephrin |
| QR01BA51 | Phenylpropanolamin, komb. |
| QR01BA52 | Pseudoephedrin, komb. |
| QR01BA53 | Phenylephrin, komb. |
| QR02 | Halsmidler |
| QR02A | Halsmidler |
| QR02AA | Antiseptika |
| QR02AA21 | Octenidin |
| QR02AB | Antibiotika |
| QR02AD | Lokalanæstetika |
| QR02AD01 | Benzocain |
| QR02AD02 | Lidocain |
| QR02AD03 | Cocain |
| QR02AD04 | Dyclonin |
| QR02AD05 | Ambroxol |
| QR02AX | Andre halsmidler |
| QR02AX01 | Flurbiprofen |
| QR02AX02 | Ibuprofen |
| QR02AX03 | Benzydamin |
| QR03 | Midler mod obstruktiv lungesygdom |
| QR03A | Adrenergika til inhalation |
| QR03AA | Alfa- og beta-adrenoreceptor agonister |
| QR03AA01 | Adrenalin |
| QR03AB | Non-selektive beta-adrenoreceptor agonister |
| QR03AB02 | Isoprenalin |
| QR03AB03 | Orciprenalin |
| QR03AC | Selektive beta-2-adrenoreceptor agonister |
| QR03AC02 | Salbutamol |
| QR03AC03 | Terbutalin |
| QR03AC04 | Fenoterol |
| QR03AC05 | Rimiterol |
| QR03AC06 | Hexoprenalin |
| QR03AC07 | Isoetarin |
| QR03AC08 | Pirbuterol |
| QR03AC09 | Tretoquinol |
| QR03AC10 | Carbuterol |
| QR03AC11 | Tulobuterol |
| QR03AC12 | Salmeterol |
| QR03AC13 | Formoterol |
| QR03AC14 | Clenbuterol |
| QR03AC15 | Reproterol |
| QR03AC16 | Procaterol |
| QR03AC17 | Bitolterol |
| QR03AC18 | Indacaterol |
| QR03AC19 | Olodaterol |
| QR03AH | Adrenergika i komb. |
| QR03AK | Adrenergika og andre midler mod obstruktiv lungesygdom |
| QR03AK01 | Adrenalin og andre midler mod obstruktiv lungesygdom |
| QR03AK02 | Isoprenalin og andre midler mod obstruktiv lungesygdom |
| QR03AK04 | Salbutamol og andre midler mod obstruktiv lungesygdom |
| QR03AK05 | Reproterol og andre midler mod obstruktiv lungesygdom |
| QR03AK06 | Salmeterol og andre midler mod obstruktiv lungesygdom |
| QR03AK07 | Formoterol og andre midler mod obstruktiv lungesygdom |
| QR03AK08 | Formoterol og beclometason |
| QR03AK09 | Formoterol og mometason |
| QR03AK10 | Vilanterol og fluticasonfuroat |
| QR03AK11 | Formoterol og fluticason |
| QR03AK12 | Salmeterol og budesonid |
| QR03AK13 | Salbutamol og beclometason |
| QR03AK14 | Indacaterol og mometason |
| QR03AK15 | Salbutamol og budesonid |
| QR03AL | Adrenergika komb m antikolinergika inkl 3-stof komb m kortikosteroider |
| QR03AL01 | Fenoterol og ipratropiumbromid |
| QR03AL02 | Salbutamol og ipratropiumbromid |
| QR03AL03 | Vilanterol og umeclidiniumbromid |
| QR03AL04 | Indacaterol og glycopyrroniumbromid |
| QR03AL05 | Formoterol og aclidiniumbromid |
| QR03AL06 | Olodaterol og tiotropiumbromid |
| QR03AL07 | Formoterol og glycopyrroniumbromid |
| QR03AL08 | Vilanterol, umeclidiniumbromid og fluticasonfuroat |
| QR03AL09 | Formoterol, glycopyrroniumbromid og beclometason |
| QR03AL10 | Formoterol og tiotropiumbromid |
| QR03AL11 | Formoterol, glycopyrroniumbromid og budesonid |
| QR03AL12 | Indacaterol, glycopyrroiniumbromid og mometason |
| QR03B | Andre midler mod obstruktiv lungesygdom, inhalation |
| QR03BA | Glucocorticoider |
| QR03BA01 | Beclometason |
| QR03BA02 | Budesonid |
| QR03BA03 | Flunisolid |
| QR03BA04 | Betamethason |
| QR03BA05 | Fluticason |
| QR03BA06 | Triamcinolon |
| QR03BA07 | Mometason |
| QR03BA08 | Ciclesonid |
| QR03BA09 | Fluticasonfuroat |
| QR03BB | Antikolinergika |
| QR03BB01 | Ipratropiumbromid |
| QR03BB02 | Oxitropiumbromid |
| QR03BB03 | Stramonium-præparater |
| QR03BB04 | Tiotropiumbromid |
| QR03BB05 | Aclidiniumbromid |
| QR03BB06 | Glycopyrroniumbromid |
| QR03BB07 | Umeclidiniumbromid |
| QR03BB08 | Revefenacin |
| QR03BB54 | Tiotropiumbromid, kombinationer |
| QR03BC | Midler mod allergi, excl. kortikosteroider |
| QR03BC01 | Cromoglicinsyre |
| QR03BC02 | Nedocromil |
| QR03BX | Andre midler mod obstruktiv lungesygdom, inhalation |
| QR03BX01 | Fenspirid |
| QR03C | Adrenergika til systemisk brug |
| QR03CA | Alpha- og beta adrenoceptor agonister |
| QR03CA02 | Ephedrin |
| QR03CB | Non-selektive beta-adrenoreceptor agonister |
| QR03CB01 | Isoprenalin |
| QR03CB02 | Methoxyphenamin |
| QR03CB03 | Orciprenalin |
| QR03CB51 | Isoprenalin, komb. |
| QR03CB53 | Orciprenalin, komb. |
| QR03CC | Selektive beta2-adrenoceptor agonister |
| QR03CC02 | Salbutamol |
| QR03CC03 | Terbutalin |
| QR03CC04 | Fenoterol |
| QR03CC05 | Hexoprenalin |
| QR03CC06 | Isoetarin |
| QR03CC07 | Pirbuterol |
| QR03CC08 | Procaterol |
| QR03CC09 | Tretoquinol |
| QR03CC10 | Carbuterol |
| QR03CC11 | Tulobuterol |
| QR03CC12 | Bambuterol |
| QR03CC13 | Clenbuterol |
| QR03CC14 | Reproterol |
| QR03CC15 | Formoterol |
| QR03CC53 | Terbutalin, komb. |
| QR03CC63 | Clenbuterol og ambroxol |
| QR03CC90 | Clenbuterol, komb. |
| QR03CK | Adrenergika og andre midler mod obstruktiv lungesygdom |
| QR03D | Andre systemiske midler mod obstruktiv lungesygdom |
| QR03DA | Xanthiner |
| QR03DA01 | Diprophyllin |
| QR03DA02 | Cholintheophyllinat |
| QR03DA03 | Proxyphyllin |
| QR03DA04 | Theophyllin |
| QR03DA05 | Aminophyllin |
| QR03DA06 | Etamiphyllin |
| QR03DA07 | Theobromin |
| QR03DA08 | Bamifyllin |
| QR03DA09 | Acefyllinpiperazin |
| QR03DA10 | Bufyllin |
| QR03DA11 | Doxofyllin |
| QR03DA12 | Mepyramin-theophyllinacetat |
| QR03DA20 | Xanthiner i komb. |
| QR03DA51 | Diprophyllin, komb. |
| QR03DA54 | Theophyllin, komb. excl. psykoleptika |
| QR03DA55 | Aminophyllin, komb. |
| QR03DA57 | Theobromin, komb. |
| QR03DA74 | Theophyllin, komb. med psykoleptika |
| QR03DA90 | Propentofyllin |
| QR03DB | Xanthiner og adrenergika |
| QR03DB01 | Diprophyllin og adrenergika |
| QR03DB02 | Cholintheophyllinat og adrenergika |
| QR03DB03 | Proxyphyllin og adrenergika |
| QR03DB04 | Theophyllin og adrenergika |
| QR03DB05 | Aminophyllin og adrenergika |
| QR03DB06 | Etamiphyllin og adrenergika |
| QR03DC | Leukotrienreceptor-antagonister |
| QR03DC01 | Zafirlukast |
| QR03DC02 | Pranlukast |
| QR03DC03 | Montelukast |
| QR03DC04 | Ibudilast |
| QR03DC53 | Montelukast, kombinationer |
| QR03DX | Andre systemiske midler mod obstruktiv lungesygdom |
| QR03DX01 | Amlexanox |
| QR03DX02 | Eprozinol |
| QR03DX03 | Fenspirid |
| QR03DX05 | Omalizumab |
| QR03DX06 | Seratrodast |
| QR03DX07 | Roflumilast |
| QR03DX08 | Reslizumab |
| QR03DX09 | Mepolizumab |
| QR03DX10 | Benralizumab |
| QR03DX11 | Tezepelumab |
| QR05 | Midler mod hoste og forkølelse |
| QR05C | Expectorantia, excl. komb. m. antitussiva |
| QR05CA | Expectorantia |
| QR05CA01 | Tyloxapol |
| QR05CA02 | Kaliumiodid |
| QR05CA03 | Guaifenesin |
| QR05CA04 | Ipecacuanha |
| QR05CA05 | Altæarod |
| QR05CA06 | Senega |
| QR05CA07 | Antimonpentasulfid |
| QR05CA08 | Creosot |
| QR05CA09 | Guaiacolsulfonat |
| QR05CA10 | Expectorantia i komb. |
| QR05CA11 | Levoverbenon |
| QR05CA12 | Vedbendblad |
| QR05CA13 | Cineol |
| QR05CB | Mucolytika |
| QR05CB01 | Acetylcystein |
| QR05CB02 | Bromhexin |
| QR05CB03 | Carbocistein |
| QR05CB04 | Eprazinon |
| QR05CB05 | Mesna |
| QR05CB06 | Ambroxol |
| QR05CB07 | Sobrerol |
| QR05CB08 | Domiodol |
| QR05CB09 | Letostein |
| QR05CB10 | Mycolytica i komb. |
| QR05CB11 | Stepronin |
| QR05CB13 | Dornase alfa (desoxiribonuclease) |
| QR05CB14 | Neltenexin |
| QR05CB15 | Erdostein |
| QR05CB16 | Mannitol |
| QR05CB90 | Dembrexinhydrochlorid |
| QR05D | Hostedæmpende midler, excl. komb. m. expectorantia |
| QR05DA | Opium-alkaloider og derivater |
| QR05DA01 | Ethylmorphin |
| QR05DA03 | Hydrocodon |
| QR05DA04 | Codein |
| QR05DA05 | Opium-alkaloider med morphin |
| QR05DA06 | Normethadon |
| QR05DA07 | Noscapin |
| QR05DA08 | Pholcodin |
| QR05DA09 | Dextromethorphan |
| QR05DA10 | Thebacon |
| QR05DA11 | Dimemorfan |
| QR05DA12 | Acetyldihydrocodein |
| QR05DA20 | Opium-alkaloider og derivater i komb. |
| QR05DA90 | Butorphanol |
| QR05DB | Andre hostedæmpende midler |
| QR05DB01 | Benzonatat |
| QR05DB02 | Benproperin |
| QR05DB03 | Clobutinol |
| QR05DB04 | Isoaminil |
| QR05DB05 | Pentoxyverin |
| QR05DB07 | Oxolamin |
| QR05DB09 | Oxeladin |
| QR05DB10 | Clofedanol |
| QR05DB11 | Pipazetat |
| QR05DB12 | Bibenzoniumbromid |
| QR05DB13 | Butamirat |
| QR05DB14 | Fedrilat |
| QR05DB15 | Zipeprol |
| QR05DB16 | Dibunat |
| QR05DB17 | Droxypropin |
| QR05DB18 | Prenoxdiazin |
| QR05DB19 | Dropropizin |
| QR05DB20 | Andre hostedæmpende midler i komb. |
| QR05DB21 | Cloperastin |
| QR05DB22 | Meprotixol |
| QR05DB23 | Piperidion |
| QR05DB24 | Tipepidin |
| QR05DB25 | Morclofon |
| QR05DB26 | Nepinalon |
| QR05DB28 | Dimethoxanat |
| QR05DB29 | Gefapixant |
| QR05F | Hostedæmpende midler og expectorantia, komb. |
| QR05FA | Opium-derivater og expectorantia |
| QR05FA01 | Opium-alkaloider og mucolytika |
| QR05FA02 | Opium-derivater og expectorantia |
| QR05FB | Andre hostedæmpende midler og expectorantia |
| QR05FB01 | Hostedæmpende midler og mucolytika |
| QR05FB02 | Hostedæmpende midler og expectorantia |
| QR05X | Andre midler mod forkølelse |
| QR06 | Antihistaminer til systemisk brug |
| QR06A | Antihistaminer til systemisk brug |
| QR06AA | Aminoalkylethere |
| QR06AA01 | Bromazin |
| QR06AA02 | Diphenhydramin |
| QR06AA04 | Clemastin |
| QR06AA06 | Chlorphenoxamin |
| QR06AA07 | Diphenylpyralin |
| QR06AA08 | Carbinoxamin |
| QR06AA09 | Doxylamin |
| QR06AA10 | Trimethobenzamid |
| QR06AA11 | Dimenhydrinat |
| QR06AA52 | Diphenhydramin, komb. |
| QR06AA54 | Clemastin, komb. |
| QR06AA56 | Chlorphenoxamin, komb. |
| QR06AA57 | Diphenylpyralin, komb. |
| QR06AA59 | Doxylamin, kombinationer |
| QR06AA61 | Dimenhydrinat, kombinationer |
| QR06AB | Substituerede alkylaminer |
| QR06AB01 | Brompheniramin |
| QR06AB02 | Dexchlorpheniramin |
| QR06AB03 | Dimetinden |
| QR06AB04 | Chlorpheniramin |
| QR06AB05 | Pheniramin |
| QR06AB06 | Dexbrompheniramin |
| QR06AB07 | Talastin |
| QR06AB51 | Brompheniramin, komb. |
| QR06AB52 | Dexchlorpheniramin, komb. |
| QR06AB54 | Chlorpheniramin, komb. |
| QR06AB56 | Dexbrompheniramin, komb. |
| QR06AC | Substituerede ethylendiaminer |
| QR06AC01 | Mepyramin |
| QR06AC02 | Histapyrrodin |
| QR06AC03 | Chlorpyramin |
| QR06AC04 | Tripelennamin |
| QR06AC05 | Methapyrilen |
| QR06AC06 | Thonzylamin |
| QR06AC52 | Histapyrrodin, komb. |
| QR06AC53 | Chlorpyramin, komb. |
| QR06AD | Phenothiazin-derivater |
| QR06AD01 | Alimemazin |
| QR06AD02 | Promethazin |
| QR06AD03 | Thiethylperazin |
| QR06AD04 | Methdilazin |
| QR06AD05 | Hydroxyethylpromethazin |
| QR06AD06 | Thiazinam |
| QR06AD07 | Mequitazin |
| QR06AD08 | Oxomemazin |
| QR06AD09 | Isothipendyl |
| QR06AD52 | Promethazin, komb. |
| QR06AD55 | Hydroxyethylpromethazin, komb. |
| QR06AE | Piperazin-derivater |
| QR06AE01 | Buclizin |
| QR06AE03 | Cyclizin |
| QR06AE04 | Chlorcyclizin |
| QR06AE05 | Meclozin |
| QR06AE06 | Oxatomid |
| QR06AE07 | Cetirizin |
| QR06AE09 | Levocetirizin |
| QR06AE51 | Buclizin, komb. |
| QR06AE53 | Cyclizin, komb. |
| QR06AE55 | Meclozin, komb. |
| QR06AK | Antihistaminer i komb. |
| QR06AX | Andre antihistaminer til systemisk brug |
| QR06AX01 | Bamipin |
| QR06AX02 | Cyproheptadin |
| QR06AX03 | Thenalidin |
| QR06AX04 | Phenindamin |
| QR06AX05 | Antazolin |
| QR06AX07 | Triprolidin |
| QR06AX08 | Pyrrobutamin |
| QR06AX09 | Azatadin |
| QR06AX11 | Astemizol |
| QR06AX12 | Terfenadin |
| QR06AX13 | Loratadin |
| QR06AX15 | Mebhydrolin |
| QR06AX16 | Deptropin |
| QR06AX17 | Ketotifen |
| QR06AX18 | Acrivastin |
| QR06AX19 | Azelastin |
| QR06AX21 | Tritoqualin |
| QR06AX22 | Ebastin |
| QR06AX23 | Pimethixen |
| QR06AX24 | Epinastin |
| QR06AX25 | Mizolastin |
| QR06AX26 | Fexofenadin |
| QR06AX27 | Desloratadin |
| QR06AX28 | Rupatadin |
| QR06AX29 | Bilastin |
| QR06AX31 | Quifenadin |
| QR06AX32 | Sequifenadin |
| QR06AX53 | Thenalidin, komb. |
| QR06AX58 | Pyrrobutamin, komb. |
| QR07 | Andre midler m. virkn. på respirationssystemet |
| QR07A | Andre midler m. virkn. på respirationssystemet |
| QR07AA | Lunge-surfactanter |
| QR07AA01 | Colfoscerilpalmitat |
| QR07AA02 | Naturlige phospholipider |
| QR07AA30 | Komb. af lunge-surfactanter |
| QR07AB | Respirationsstimulerende midler |
| QR07AB01 | Doxapram |
| QR07AB02 | Niketamid |
| QR07AB03 | Pentetrazol |
| QR07AB04 | Etamivan |
| QR07AB05 | Bemegrid |
| QR07AB06 | Prethcamid |
| QR07AB07 | Almitrin |
| QR07AB08 | Dimeflin |
| QR07AB09 | Mepixanox |
| QR07AB52 | Niketamid, komb. |
| QR07AB53 | Pentetrazol, komb. |
| QR07AB99 | Respirationsstimulerende midler, komb. |
| QR07AX | Andre midler til respirationssystemet |
| QR07AX01 | Nitrogenoxid |
| QR07AX02 | Ivacaftor |
| QR07AX30 | Ivacaftor og lumacaftor |
| QR07AX31 | Ivacaftor og tezacaftor |
| QR07AX32 | Ivacaftor, tezacaftor og elexacaftor |
| QR07AX33 | Deutivacaftor, tezacaftor og vanzacaftor |
| QS | Sanseorganer |
| QS01 | Oftalmologika |
| QS01A | Antiinfektiva |
| QS01AA | Antibakterielle midler |
| QS01AA01 | Chloramphenicol |
| QS01AA02 | Chlortetracyclin |
| QS01AA03 | Neomycin |
| QS01AA04 | Oxytetracyclin |
| QS01AA05 | Tyrothricin |
| QS01AA07 | Framycetin |
| QS01AA09 | Tetracyclin |
| QS01AA10 | Natamycin |
| QS01AA11 | Gentamicin |
| QS01AA12 | Tobramycin |
| QS01AA13 | Fusidinsyre |
| QS01AA14 | Benzylpenicillin |
| QS01AA15 | Dihydrostreptomycin |
| QS01AA16 | Rifamycin |
| QS01AA17 | Erythromycin |
| QS01AA18 | Polymyxin b |
| QS01AA19 | Ampicillin |
| QS01AA20 | Antibiotika i kombination med andre stoffer |
| QS01AA21 | Amikacin |
| QS01AA22 | Micronomicin |
| QS01AA23 | Netilmicin |
| QS01AA24 | Kanamycin |
| QS01AA25 | Azidamfenikol |
| QS01AA26 | Azithromycin |
| QS01AA27 | Cefuroxim |
| QS01AA28 | Vancomycin |
| QS01AA29 | Dibekacin |
| QS01AA30 | Komb. af forskellige antibiotika |
| QS01AA31 | Cefmenoxim |
| QS01AA32 | Bacitracin |
| QS01AA90 | Cloxacillin |
| QS01AB | Sulfonamider |
| QS01AB01 | Sulfamethizol |
| QS01AB02 | Sulfafurazol |
| QS01AB03 | Sulfadicramid |
| QS01AB04 | Sulfacetamid |
| QS01AB05 | Sulfafenazol |
| QS01AD | Antivirale midler |
| QS01AD01 | Idoxuridin |
| QS01AD02 | Trifluridin |
| QS01AD03 | Aciclovir |
| QS01AD05 | Interferon |
| QS01AD06 | Vidarabin |
| QS01AD07 | Famciclovir |
| QS01AD08 | Fomivirsen |
| QS01AD09 | Ganciclovir |
| QS01AE | Fluoroquinoloner |
| QS01AE01 | Ofloxacin |
| QS01AE02 | Norfloxacin |
| QS01AE03 | Ciprofloxacin |
| QS01AE04 | Lomefloxacin |
| QS01AE05 | Levofloxacin |
| QS01AE06 | Gatifloxacin |
| QS01AE07 | Moxifloxacin |
| QS01AE08 | Besifloxacin |
| QS01AE09 | Tosufloxacin |
| QS01AX | Andre antiinfektiva |
| QS01AX01 | Kviksølv-forbindelser |
| QS01AX02 | Sølv-forbindelser |
| QS01AX03 | Zink-forbindelser |
| QS01AX04 | Nitrofural |
| QS01AX05 | Bibrocathol |
| QS01AX06 | Resorcinol |
| QS01AX07 | Natriumborat |
| QS01AX08 | Hexamidin |
| QS01AX09 | Chlorhexidin |
| QS01AX10 | Natriumpropionat |
| QS01AX14 | Dibrompropamidin |
| QS01AX15 | Propamidin |
| QS01AX16 | Picloxydin |
| QS01AX18 | Povidon-iod |
| QS01AX24 | Polihexanid |
| QS01AX25 | Lotilaner |
| QS01B | Antiinflammatorika |
| QS01BA | Kortikosteroider, usammensatte |
| QS01BA01 | Dexamethason |
| QS01BA02 | Hydrocortison |
| QS01BA03 | Cortison |
| QS01BA04 | Prednisolon |
| QS01BA05 | Triamcinolon |
| QS01BA06 | Betamethason |
| QS01BA07 | Fluorometholon |
| QS01BA08 | Medryson |
| QS01BA09 | Clobetason |
| QS01BA10 | Alclometason |
| QS01BA11 | Desonid |
| QS01BA12 | Formocortal |
| QS01BA13 | Rimexolon |
| QS01BA14 | Loteprednol |
| QS01BA15 | Fluocinolonacetonid |
| QS01BA16 | Difluprednat |
| QS01BB | Kortikosteroider og mydriatika i komb. |
| QS01BB01 | Hydrocortison og mydriatika |
| QS01BB02 | Prednisolon og mydriatika |
| QS01BB03 | Fluorometholon og mydriatika |
| QS01BB04 | Betamethason og mydriatika |
| QS01BC | Antiinflammatorika, non-steroide |
| QS01BC01 | Indometacin |
| QS01BC02 | Oxyphenbutazon |
| QS01BC03 | Diclofenac |
| QS01BC04 | Flurbiprofen |
| QS01BC05 | Ketorolac |
| QS01BC06 | Piroxicam |
| QS01BC07 | Bendazac |
| QS01BC08 | Salicylsyre |
| QS01BC09 | Pranoprofen |
| QS01BC10 | Nepafenac |
| QS01BC11 | Bromfenac |
| QS01C | Antiinflammatorika og antiinfektiva i kombination |
| QS01CA | Kortikosteroider og antiinfektiva i kombination |
| QS01CA01 | Dexamethason og antiinfektiva |
| QS01CA02 | Prednisolon og antiinfektiva |
| QS01CA03 | Hydrocortison og antiinfektiva |
| QS01CA04 | Fluocortolon og antiinfektiva |
| QS01CA05 | Betamethason og antiinfektiva |
| QS01CA06 | Fludrocortison og antiinfektiva |
| QS01CA07 | Fluorometholon og antiinfektiva |
| QS01CA08 | Methylprednisolon og antiinfektiva |
| QS01CA09 | Chlorprednisolon og antiinfektiva |
| QS01CA10 | Fluocinolon og antiinfektiva |
| QS01CA11 | Clobetason og antiinfektiva |
| QS01CA12 | Loteprednol og antiinfektiva |
| QS01CB | Kortikosteroid/antiinfekt./sympathomim. i komb. |
| QS01CB01 | Dexametason |
| QS01CB02 | Prednisolon |
| QS01CB03 | Hydrocortison |
| QS01CB04 | Betamethason |
| QS01CB05 | Fluorometholon |
| QS01CC | Antiinflammatorika,non-steroid, og antiinfektiva i komb. |
| QS01CC01 | Diclofenac og antiinfektiva |
| QS01CC02 | Indometacin og antiinfektiva |
| QS01E | Midler mod glaucom og miotika |
| QS01EA | Sympatomimetika i glaucombehandling |
| QS01EA01 | Adrenalin |
| QS01EA02 | Dipivefrin |
| QS01EA03 | Apraclonidin |
| QS01EA04 | Clonidin |
| QS01EA05 | Brimonidin |
| QS01EA51 | Adrenalin, komb. |
| QS01EA55 | Brimonidin og ripasudil |
| QS01EB | Parasympatomimetika |
| QS01EB01 | Pilocarpin |
| QS01EB02 | Carbachol |
| QS01EB03 | Ecothiopat |
| QS01EB04 | Demecarium |
| QS01EB05 | Physostigmin |
| QS01EB06 | Neostigmin |
| QS01EB07 | Fluostigmin |
| QS01EB08 | Aceclidin |
| QS01EB09 | Acetylcholin |
| QS01EB10 | Paraoxon |
| QS01EB51 | Pilocarpin, komb. |
| QS01EB58 | Aceclidin, komb. |
| QS01EC | Carbo-anhydrase inhibitorer |
| QS01EC01 | Acetazolamid |
| QS01EC02 | Diclofenamid |
| QS01EC03 | Dorzolamid |
| QS01EC04 | Brinzolamid |
| QS01EC05 | Methazolamid |
| QS01EC54 | Brinzolamid, kombinationer |
| QS01ED | Beta-blokerende midler |
| QS01ED01 | Timolol |
| QS01ED02 | Betaxolol |
| QS01ED03 | Levobunolol |
| QS01ED04 | Metipranolol |
| QS01ED05 | Carteolol |
| QS01ED06 | Befunolol |
| QS01ED51 | Timolol, komb. |
| QS01ED52 | Betaxolol, komb. |
| QS01ED54 | Metipranolol, komb. |
| QS01ED55 | Carteolol, komb. |
| QS01EE | Prostaglandin-analoger |
| QS01EE01 | Latanoprost |
| QS01EE02 | Unoproston |
| QS01EE03 | Bimatoprost |
| QS01EE04 | Travoprost |
| QS01EE05 | Tafluprost |
| QS01EE06 | Latanoprostenbunod |
| QS01EE51 | Latanoprost og netarsudil |
| QS01EE52 | Latanoprost og dorzolamid |
| QS01EX | Andre glaucom-midler |
| QS01EX01 | Guanethidin |
| QS01EX02 | Dapiprazol |
| QS01EX05 | Netarsudil |
| QS01EX06 | Omidenepag |
| QS01EX07 | Ripasudil |
| QS01F | Mydriatika og cycloplegica |
| QS01FA | Antikolinergika |
| QS01FA01 | Atropin |
| QS01FA02 | Scopolamin |
| QS01FA03 | Methylscopolamin |
| QS01FA04 | Cyclopentolat |
| QS01FA05 | Homatropin |
| QS01FA06 | Tropicamid |
| QS01FA54 | Cyclopentolat, kombinationer |
| QS01FA56 | Tropicamid, komb. |
| QS01FB | Sympatomimetika, excl. glaucom-midler |
| QS01FB01 | Phenylephrin |
| QS01FB02 | Ephedrin |
| QS01FB03 | Ibopamin |
| QS01FB51 | Phenylephrin og ketorolac |
| QS01FB90 | Oxedrin (ban) |
| QS01FB99 | Sympatomimetika, komb. |
| QS01G | Dekongestanter og antiallergika |
| QS01GA | Sympatomimetika anvendt som dekongestanter |
| QS01GA01 | Naphazolin |
| QS01GA02 | Tetryzolin |
| QS01GA03 | Xylometazolin |
| QS01GA04 | Oxymetazolin |
| QS01GA05 | Phenylephrin |
| QS01GA06 | Oxedrin |
| QS01GA07 | Brimonidin |
| QS01GA51 | Naphazolin, komb. |
| QS01GA52 | Tetryzolin, komb. |
| QS01GA53 | Xylometazolin, komb. |
| QS01GA55 | Phenylephrin, komb. |
| QS01GA56 | Oxedrin, komb. |
| QS01GX | Andre antiallergika |
| QS01GX01 | Cromoglicinsyre |
| QS01GX02 | Levocabastin |
| QS01GX03 | Spagluminsyre |
| QS01GX04 | Nedocromil |
| QS01GX05 | Lodoxamid |
| QS01GX06 | Emedastin |
| QS01GX07 | Azelastin |
| QS01GX08 | Ketotifen |
| QS01GX09 | Olopatadin |
| QS01GX10 | Epinastin |
| QS01GX11 | Alcaftadin |
| QS01GX12 | Cetirizin |
| QS01GX13 | Bilastin |
| QS01GX51 | Cromoglicinsyre, komb. |
| QS01H | Lokalanæstetika |
| QS01HA | Lokalanæstetika |
| QS01HA01 | Cocain |
| QS01HA02 | Oxybuprocain |
| QS01HA03 | Tetracain |
| QS01HA04 | Proxymetacain |
| QS01HA05 | Procain |
| QS01HA06 | Cinchocain |
| QS01HA07 | Lidocain |
| QS01HA08 | Chlorprocain |
| QS01HA30 | Kombinationer |
| QS01J | Diagnostika |
| QS01JA | Farvestoffer |
| QS01JA01 | Fluorescein |
| QS01JA02 | Rose bengalnatrium |
| QS01JA51 | Fluorescein, komb. |
| QS01JX | Andre oftalmologiske diagnostika |
| QS01K | Kirurgiske hjælpemidler |
| QS01KA | Viscoelastiske stoffer |
| QS01KA01 | Hyaluronsyre |
| QS01KA02 | Hypromellose |
| QS01KA51 | Hyaluronsyre, komb. |
| QS01KX | Andre kirurgiske hjælpemidler |
| QS01KX01 | Chymotrypsin |
| QS01KX02 | Trypanblå |
| QS01L | Midler mod okular vaskulær lidelse |
| QS01LA | Antineovaskularisationsmidler |
| QS01LA01 | Verteporfin |
| QS01LA02 | Anecortav |
| QS01LA03 | Pegaptanib |
| QS01LA04 | Ranibizumab |
| QS01LA05 | Aflibercept |
| QS01LA06 | Brolucizumab |
| QS01LA07 | Abicipar pegol |
| QS01LA08 | Bevacizumab |
| QS01LA09 | Faricimab |
| QS01X | Andre oftalmologika |
| QS01XA | Andre oftalmologika |
| QS01XA01 | Guaiazulen |
| QS01XA02 | Retinol |
| QS01XA03 | Natriumchlorid, hypertonisk |
| QS01XA04 | Kaliumiodid |
| QS01XA05 | Natriumedetat |
| QS01XA06 | Ethylmorphin |
| QS01XA07 | Alun |
| QS01XA08 | Acetylcystein |
| QS01XA09 | Iodoheparinat |
| QS01XA10 | Inosin |
| QS01XA11 | Nandrolon |
| QS01XA12 | Dexpanthenol |
| QS01XA13 | Alteplase |
| QS01XA14 | Heparin |
| QS01XA15 | Ascorbinsyre |
| QS01XA18 | Ciclosporin |
| QS01XA19 | Limbale stamceller, autologe |
| QS01XA20 | Kunstig tårevæske og andre neutrale midler |
| QS01XA21 | Mercaptamin |
| QS01XA22 | Ocriplasmin |
| QS01XA23 | Sirolimus |
| QS01XA24 | Cenegermin |
| QS01XA25 | Lifitegrast |
| QS01XA26 | Riboflavin |
| QS01XA27 | Voretigenneparvovec |
| QS01XA28 | Vareniclin |
| QS01XA29 | Sepofarsen |
| QS01XA31 | Pegcetacoplan |
| QS01XA32 | Avacincaptad pegol |
| QS01XA33 | Diquafosol |
| QS01XA91 | Pirenoxin |
| QS02 | Otologika |
| QS02A | Antiinfektiva |
| QS02AA | Antiinfektiva |
| QS02AA01 | Chloramphenicol |
| QS02AA02 | Nitrofural |
| QS02AA03 | Borsyre |
| QS02AA04 | Aluminiumacetotartrat |
| QS02AA05 | Clioquinol |
| QS02AA06 | Hydrogenperoxid |
| QS02AA07 | Neomycin |
| QS02AA08 | Tetracyclin |
| QS02AA09 | Chlorhexidin |
| QS02AA10 | Eddikesyre |
| QS02AA11 | Polymyxin b |
| QS02AA12 | Rifamycin |
| QS02AA13 | Miconazol |
| QS02AA14 | Gentamicin |
| QS02AA15 | Ciprofloxacin |
| QS02AA16 | Ofloxacin |
| QS02AA17 | Fosfomycin |
| QS02AA18 | Cefmenoxim |
| QS02AA30 | Antiinfektiva, komb. |
| QS02AA57 | Neomycin, komb. |
| QS02B | Kortikosteroider |
| QS02BA | Kortikosteroider |
| QS02BA01 | Hydrocortison |
| QS02BA03 | Prednisolon |
| QS02BA06 | Dexamethason |
| QS02BA07 | Betamethason |
| QS02BA08 | Fluocinolonacetonid |
| QS02BA99 | Kortikosteroider kombinationer |
| QS02C | Kortikosteroider og antiinfektiva i komb. |
| QS02CA | Kortikosteroider og antiinfektiva i komb. |
| QS02CA01 | Prednisolon og antiinfektiva |
| QS02CA02 | Flumetason og antiinfektiva |
| QS02CA03 | Hydrocortison og antiinfektiva |
| QS02CA04 | Triamcinolon og antiinfektiva |
| QS02CA05 | Fluocinolonacetonid og antiinfektiva |
| QS02CA06 | Dexamethason og antiinfektiva |
| QS02CA07 | Fludrocortison og antiinfektiva |
| QS02CA90 | Betamethason og antiinfektiva |
| QS02CA91 | Mometason og antiinfektiva |
| QS02D | Andre otologika |
| QS02DA | Analgetika og anæstetika |
| QS02DA01 | Lidocain |
| QS02DA02 | Cocain |
| QS02DA03 | Phenazon |
| QS02DA04 | Cinchocain |
| QS02DA30 | Kombinationer |
| QS02DC | Neutrale midler |
| QS02Q | Antiparasitica |
| QS02QA | Antiparasitica |
| QS02QA01 | Lindan |
| QS02QA02 | Monosulfiram |
| QS02QA03 | Ivermectin |
| QS02QA51 | Lindan, komb. |
| QS03 | Oftalmologika og otologika |
| QS03A | Antiinfektiva |
| QS03AA | Antiinfektiva |
| QS03AA01 | Neomycin |
| QS03AA02 | Tetracyclin |
| QS03AA03 | Polymyxin b |
| QS03AA04 | Chlorhexidin |
| QS03AA05 | Hexamidin |
| QS03AA06 | Gentamicin |
| QS03AA07 | Ciprofloxacin |
| QS03AA08 | Chloramphenicol |
| QS03AA30 | Antiinfektiva, komb. |
| QS03B | Kortikosteroider |
| QS03BA | Kortikosteroider |
| QS03BA01 | Dexamethason |
| QS03BA02 | Prednisolon |
| QS03BA03 | Betamethason |
| QS03C | Kortikosteroider og antiinfektiva i komb. |
| QS03CA | Kortikosteroider og antiinfektiva i komb. |
| QS03CA01 | Dexamethason og antiinfektiva |
| QS03CA02 | Prednisolon og antiinfektiva |
| QS03CA04 | Hydrocortison og antiinfektiva |
| QS03CA05 | Fludrocortison og antiinfektiva |
| QS03CA06 | Betamethason og antiinfektiva |
| QS03CA07 | Methylprednisolon og antiinfektiva |
| QS03D | Andre oftalmologika og otologika |
| QV | Diverse |
| QV01 | Allergener |
| QV01A | Allergener |
| QV01AA | Allergenekstrakter |
| QV01AA01 | Fjer |
| QV01AA02 | Græspollen |
| QV01AA03 | Husstøvmider |
| QV01AA04 | Skimmel- og gærsvampe |
| QV01AA05 | Træpollen |
| QV01AA07 | Insekter |
| QV01AA08 | Fødevarer |
| QV01AA09 | Tekstiler |
| QV01AA10 | Blomster |
| QV01AA11 | Dyr |
| QV01AA20 | Diverse allergenekstrakter |
| QV03 | Alle andre terapeutiske midler |
| QV03A | Alle andre terapeutiske midler |
| QV03AA | Midler til behandling af kronisk alkoholisme |
| QV03AB | Antidoter |
| QV03AB01 | Ipecacuanha |
| QV03AB02 | Nalorphin |
| QV03AB03 | Edetater |
| QV03AB04 | Pralidoxim |
| QV03AB05 | Prednisolon og promethazin |
| QV03AB06 | Thiosulfat |
| QV03AB08 | Natriumnitrit |
| QV03AB09 | Dimercaprol |
| QV03AB13 | Obidoxim |
| QV03AB14 | Protamin |
| QV03AB15 | Naloxon |
| QV03AB16 | Ethanol |
| QV03AB17 | Methylthionin |
| QV03AB18 | Kaliumpermanganat |
| QV03AB19 | Physostigmin |
| QV03AB20 | Kobbersulfat |
| QV03AB21 | Kaliumiodid |
| QV03AB22 | Amylnitrit |
| QV03AB23 | Acetylcystein |
| QV03AB24 | Digitalis antitoxin |
| QV03AB25 | Flumazenil |
| QV03AB26 | Dl-methionin |
| QV03AB27 | 4-dimethylaminophenol |
| QV03AB29 | Cholinesterase |
| QV03AB30 | Naltrexon |
| QV03AB31 | Berlinerblåt |
| QV03AB32 | Glutathion |
| QV03AB33 | Hydroxocobalamin |
| QV03AB34 | Fomepizol |
| QV03AB35 | Sugammadex |
| QV03AB36 | Phentolamin |
| QV03AB37 | Idarucizumab |
| QV03AB38 | Andexanet alfa |
| QV03AB54 | Pralidoxim og atropin |
| QV03AB90 | Atipamezol |
| QV03AB91 | Sarmazenil |
| QV03AB92 | Diprenorfin |
| QV03AB93 | Yohimbin |
| QV03AB94 | Tolazolin |
| QV03AB95 | Apomorphin |
| QV03AB96 | Ropinirol |
| QV03AC | Jern-chelaterende stoffer |
| QV03AC01 | Deferoxamin |
| QV03AC02 | Deferipron |
| QV03AC03 | Deferasirox |
| QV03AE | Midler til behandling af hyperkalæmi |
| QV03AE01 | Polystyrensulfonat |
| QV03AE02 | Sevelamer |
| QV03AE03 | Lanthancarbonat |
| QV03AE04 | Calciumacetat og magnesiumcarbonat |
| QV03AE05 | Sucroferrioxyhydroxid |
| QV03AE06 | Colestilan |
| QV03AE07 | Calciumacetat |
| QV03AE08 | Ferricitrat |
| QV03AE09 | Patiromercalcium |
| QV03AE10 | Natriumzirconiumcyclosilicat |
| QV03AF | Afgiftningsmidler ved cytostatikabehandling |
| QV03AF01 | Mesna |
| QV03AF02 | Dexrazoxan |
| QV03AF03 | Calciumfolinat |
| QV03AF04 | Calciumlevofolinat |
| QV03AF05 | Amifostin |
| QV03AF06 | Natriumfolinat |
| QV03AF07 | Rasburicase |
| QV03AF08 | Palifermin |
| QV03AF09 | Glucarpidase |
| QV03AF10 | Natriumlevofolinat |
| QV03AF11 | Arginin og lysin |
| QV03AF12 | Trilaciclib |
| QV03AG | Midler til behandling af hypercalcæmi |
| QV03AG01 | Natriumcellulosephosphat |
| QV03AG05 | Natriumphosphat |
| QV03AH | Midler til behandling af hypoglycæmi |
| QV03AH01 | Diazoxid |
| QV03AK | Vævsklæbere |
| QV03AM | Midler for embolisering |
| QV03AN | Medicinske gasser |
| QV03AN01 | Oxygen |
| QV03AN02 | Kuldioxid |
| QV03AN03 | Helium |
| QV03AN04 | Nitrogen |
| QV03AN05 | Medicinsk luft |
| QV03AX | Andre terapeutiske midler |
| QV03AX02 | Nalfurafin |
| QV03AX03 | Cobicistat |
| QV03AX04 | Difelikefalin |
| QV03AZ | Nerve-depressanter |
| QV03AZ01 | Ethanol |
| QV04 | Diagnostika |
| QV04B | Urin-tests |
| QV04C | Andre diagnostika |
| QV04CA | Tests for diabetes |
| QV04CA01 | Tolbutamid |
| QV04CA02 | Glucose |
| QV04CB | Tests for fedtabsorption |
| QV04CB01 | Vitamin a koncentrater |
| QV04CC | Tests for bile duct patency |
| QV04CC01 | Sorbitol |
| QV04CC02 | Magnesiumsulfat |
| QV04CC03 | Sincalid |
| QV04CC04 | Ceruletid |
| QV04CD | Tests for hypofysefunktion |
| QV04CD01 | Metyrapon |
| QV04CD03 | Sermorelin |
| QV04CD04 | Corticoliberin |
| QV04CD05 | Somatorelin |
| QV04CD06 | Macimorelin |
| QV04CE | Tests for leverfunktionskapacitet |
| QV04CE01 | Galactose |
| QV04CE02 | Sulfobromphthalein |
| QV04CE03 | Methacetin (13-c) |
| QV04CF | Tuberculose-diagnostika |
| QV04CF01 | Tuberculin |
| QV04CG | Tests for gastrisk sekretion |
| QV04CG01 | Kation-byttere |
| QV04CG02 | Betazol |
| QV04CG03 | Histaminphosphat |
| QV04CG04 | Pentagastrin |
| QV04CG05 | Methylthionin |
| QV04CG30 | Caffein og natriumbenzoat |
| QV04CH | Tests for nyrefunktion og ureterlæsioner |
| QV04CH01 | Inulin og andre polyfructosaner |
| QV04CH02 | Indigocarmin |
| QV04CH03 | Phenolsulfonphthalein |
| QV04CH04 | Alsactid |
| QV04CH30 | Aminohippursyre |
| QV04CJ | Tests for thyreoidea-funktion |
| QV04CJ01 | Tyrotropin |
| QV04CJ02 | Protirelin |
| QV04CK | Tests for pancreas-funktion |
| QV04CK01 | Secretin |
| QV04CK02 | Pancreozymin (cholecystokinin) |
| QV04CK03 | Bentiromid |
| QV04CL | Tests for allergiske sygdomme |
| QV04CM | Tests for fertilitets-forstyrrelser |
| QV04CM01 | Gonadorelin |
| QV04CQ | Tests for mastitis |
| QV04CV | Tests for åndedrætsfunktion |
| QV04CV01 | Lobelin |
| QV04CX | Andre diagnostika |
| QV04CX01 | Indocyaningrønt |
| QV04CX02 | Folsyre |
| QV04CX03 | Methacholin |
| QV04CX04 | Mannitol |
| QV04CX05 | 13-c-urea |
| QV04CX06 | Hexaminolevulinat |
| QV04CX07 | Edrophonium |
| QV04CX08 | Carbonmonoxid |
| QV04CX09 | Patent blue |
| QV04CX10 | Pafolacianin |
| QV04CX11 | Lithiumchlorid |
| QV04CX12 | Xenon |
| QV06 | Generelle næringsmidler |
| QV06A | Diætpræparater til fedmebehandling |
| QV06AA | Lavenergi-diæter |
| QV06B | Proteintilskud |
| QV06C | Præparater til spædbørn |
| QV06D | Andre næringsmidler |
| QV06DA | Kulhydrat/protein/mineral/vitamin, komb. |
| QV06DB | Fedt/kulhydrat/protein/mineral/vitamin, komb. |
| QV06DC | Kulhydrater |
| QV06DC01 | Glucose |
| QV06DC02 | Fructose |
| QV06DD | Aminosyrer, incl. komb. med polypeptider |
| QV06DE | Aminosyrer/kulhydrat/mineral/vitamin, komb. |
| QV06DF | Mælkeerstatninger |
| QV06DX | Andre næringsmidler i komb. |
| QV07 | Alle andre non-terapeutiske produkter |
| QV07A | Alle andre non-terapeutiske produkter |
| QV07AA | Plastre |
| QV07AB | Opløsnings- og fortyndingsmidler, incl. skyllevæsker |
| QV07AC | Blodtransfusion, hjælpeprodukter |
| QV07AD | Blodprøver, hjælpeprodukter |
| QV07AN | Inkontinens-udstyr |
| QV07AQ | Andre non-terapeutiske veterinære produkter |
| QV07AQ01 | Lubabegron |
| QV07AQ02 | Ractopamin |
| QV07AR | Følsomhedstests, disk og tabletter |
| QV07AT | Kosmetika |
| QV07AV | Tekniske desinfektionsmidler |
| QV07AX | Midler til vaskbehandling |
| QV07AY | Andre non-terapeutiske hjælpeprodukter |
| QV07AZ | Kemikalier og reagenser til analytisk brug |
| QV08 | Kontrastmidler |
| QV08A | Røntgenkontrastmidler, ioderede |
| QV08AA | Vandopl.,nefrotrope,højosm. røntgenkontrastmidl. |
| QV08AA01 | Diatrizoinsyre |
| QV08AA02 | Metrizoinsyre |
| QV08AA03 | Iodamid |
| QV08AA04 | Iotalaminsyre |
| QV08AA05 | Ioxitalaminsyre |
| QV08AA06 | Ioglicinsyre |
| QV08AA07 | Acetrizoinsyre |
| QV08AA08 | Iocarminsyre |
| QV08AA09 | Methiodal |
| QV08AA10 | Diodon |
| QV08AB | Vandopl.,nefrotrope,lavosmolære røntgenkontrastmidler |
| QV08AB01 | Metrizamid |
| QV08AB02 | Iohexol |
| QV08AB03 | Ioxaglinsyre |
| QV08AB04 | Iopamidol |
| QV08AB05 | Iopromid |
| QV08AB06 | Iotrolan |
| QV08AB07 | Ioversol |
| QV08AB08 | Iopentol |
| QV08AB09 | Iodixanol |
| QV08AB10 | Iomeprol |
| QV08AB11 | Iobitridol |
| QV08AB12 | Ioxilan |
| QV08AC | Vandopl. hepatotrope røntgenkontrastmidler |
| QV08AC01 | Iodoxamsyre |
| QV08AC02 | Iotroxinsyre |
| QV08AC03 | Ioglycamsyre |
| QV08AC04 | Adipiodon |
| QV08AC05 | Iobenzamsyre |
| QV08AC06 | Iopanoinsyre |
| QV08AC07 | Iocetamsyre |
| QV08AC08 | Natriumiopodat |
| QV08AC09 | Tyropanoinsyre |
| QV08AC10 | Calciumiopodat |
| QV08AD | Ikke-vandopløselige røntgenkontrastmidler |
| QV08AD01 | Ethylestere af ioderede fedtsyrer |
| QV08AD02 | Iopydol |
| QV08AD03 | Propyliodon |
| QV08AD04 | Iofendylat |
| QV08B | Røntgenkontrastmidler, ikke-ioderede |
| QV08BA | Bariumsulfat-holdige røntgenkontrastmidler |
| QV08BA01 | Bariumsulfat med suspensionsmidler |
| QV08BA02 | Bariumsulfat uden suspensionsmidler |
| QV08C | Kontrastmidler til magnetisk resonans imaging |
| QV08CA | Paramagnetiske kontrastmidler |
| QV08CA01 | Gadopentetinsyre |
| QV08CA02 | Gadoterinsyre |
| QV08CA03 | Gadodiamid |
| QV08CA04 | Gadoteridol |
| QV08CA05 | Mangafodipir |
| QV08CA06 | Gadoversetamid |
| QV08CA07 | Ferriammoniumcitrat |
| QV08CA08 | Gadobensyre |
| QV08CA09 | Gadobutrol |
| QV08CA10 | Gadoxetinsyre |
| QV08CA11 | Gadofosveset |
| QV08CA12 | Gadopiclenol |
| QV08CB | Superparamagnetiske kontrastmidler |
| QV08CB01 | Ferumoxsil |
| QV08CB02 | Ferristen |
| QV08CB03 | Jernoxid, nanopartikler |
| QV08CX | Andre kontrastmidler t. magnetisk resonans imaging |
| QV08CX01 | Perflubron |
| QV08D | Kontrastmidler til ultralyd |
| QV08DA | Kontrastmidler til ultralyd |
| QV08DA01 | Perflutren, human albumin mikrosfærer |
| QV08DA02 | Mikropartikler af galactose |
| QV08DA03 | Perflenapent |
| QV08DA04 | Perflutren, phospholipid mikrosfærer |
| QV08DA05 | Svovlhexafluorid, phospholipid mikrosfærer |
| QV08DA06 | Perflubutan, phospholipid mikrosfærer |
| QV09 | Radiofarmaka til diagnostisk brug |
| QV09A | Centralnervesystemet |
| QV09AA | Technetium (99m-tc) forbindelser |
| QV09AA01 | Technetium (99m-tc) exametazim |
| QV09AA02 | Technetium (99m-tc) bicisat |
| QV09AB | Iod (123-i)-forbindelser |
| QV09AB01 | Iod (123-i) iofetamin |
| QV09AB02 | Iod (123-i) ioloprid |
| QV09AB03 | Iod (123-i)-ioflupan |
| QV09AX | Andre diagnostiske radiofarmaka til centralnervesystemet |
| QV09AX01 | Indium (111-in) pentetat |
| QV09AX03 | Iod (124i) 2beta-carbomethoxy-3beta-(4 iodophenyl)-tropan |
| QV09AX04 | Flutemetamol (18f) |
| QV09AX05 | Florbetapir (18f) |
| QV09AX06 | Florbetaben (18f) |
| QV09AX07 | Flortaucipir (18f) |
| QV09B | Skelet |
| QV09BA | Technetium (99m-tc) forbindelser |
| QV09BA01 | Technetium (99m-tc) oxidronat |
| QV09BA02 | Technetium (99m-tc) medronat |
| QV09BA03 | Technetium (99m-tc) pyrophosphat |
| QV09C | Renale system |
| QV09CA | Technetium (99m-tc) forbindelser |
| QV09CA01 | Technetium (99m-tc) pentetat |
| QV09CA02 | Technetium (99m-tc) succimer |
| QV09CA03 | Technetium (99m-tc) mertiatid |
| QV09CA04 | Technetium (99m-tc) glucoheptonat |
| QV09CA05 | Technetium (99m-tc) gluconat |
| QV09CA06 | Technetium (99m-tc) ethylenedicystein |
| QV09CX | Andre diagnostiske radiofarmaka til renale system |
| QV09CX01 | Iod (123-i) iodohippurat |
| QV09CX02 | Iod (131-i) iodohippurat |
| QV09CX03 | Iod (125-i) iothalamat |
| QV09CX04 | Chrom (51-cr) edetat |
| QV09FX04 | Natriumiodid (124i) |
| QV09G | Kardiovaskulære system |
| QV09GA | Technetium (99m-tc)-forbindelser |
| QV09GA01 | Technetium (99m-tc) sestamibi |
| QV09GA02 | Technetium (99m-tc) tetrofosmin |
| QV09GA03 | Technetium (99m-tc) teboroxim |
| QV09GA04 | Technetium (99m-tc) human albumin |
| QV09GA05 | Technetium (99m-tc) furifosmin |
| QV09GA06 | Technetium (99m-tc) stanno-agent mærkede celler |
| QV09GA07 | Technetium (99m-tc) apcitid |
| QV09GB | Iod (125-i)-forbindelser |
| QV09GB01 | Iod (125-i) fibrinogen |
| QV09GB02 | Iod (125-i) human albumin |
| QV09GX | Andre diagnostiske radiofarmaka til det kardiovaskulære system |
| QV09GX01 | Thallium (201-tl) chlorid |
| QV09GX02 | Indium (111-in) imciromab |
| QV09GX03 | Chrom (51-cr) chromat mærkede celler |
| QV09GX04 | Rubidium (82rb) chlorid |
| QV09GX05 | Ammoniak (13-n) |
| QV09I | Tumordetektion |
| QV09IA | Technetium (99m-tc)-forbindelser |
| QV09IA01 | Technetium (99m-tc) anticarcinoembryoniskantigen antistof |
| QV09IA02 | Technetium (99m-tc) antimelanom antistof |
| QV09IA03 | Technetium (99m-tc) pentavalent succimer |
| QV09IA04 | Technetium (99m-tc votumumab |
| QV09IA05 | Technetium (99m-tc)-depreotid |
| QV09IA06 | Technetium (99m-tc)-arcitumomab |
| QV09IA07 | Technetium (9mtc) hydrazin nicotinsyre-octreotid |
| QV09IA08 | Technetium (99mtc) etarfolatid |
| QV09IA09 | Technetium (99mtc) tilmanocept |
| QV09IA10 | Technetium (99m-tc) trofolastatchlorid |
| QV09IB | Indium (111-in)-forbindelser |
| QV09IB01 | Indium (111-in) pentetreotid |
| QV09IB02 | Indium (111-in) satumomabpendetid |
| QV09IB03 | Indium (111-in) antiovariumcarcinom antistof |
| QV09IB04 | Indium(111-in)-capromabpendetid |
| QV09IX | Andre diagnostiske radiofarmaka til tumordetektion |
| QV09IX01 | Iod (123-i) iobenguan |
| QV09IX02 | Iod (131-i) iobenguan |
| QV09IX03 | Iod (125-i) cc49 monoklonalt antistof |
| QV09IX04 | Fludeoxyglucose (18-f) |
| QV09IX05 | Fluorodopa (18f) |
| QV09IX06 | Natriumfluorid (18f) |
| QV09IX07 | Fluorocholin (18f) |
| QV09IX08 | Fluoroethylcholin (18f) |
| QV09IX09 | Gallium (68ga) edotreotid |
| QV09IX10 | Fluoroethyl-l-tyrosin (18f) |
| QV09IX11 | Fluoroestradiol (18-f) |
| QV09IX12 | Fluciclovin (18-f) |
| QV09IX13 | Methionin (11-c) |
| QV09IX14 | Gallium (68-ga) gozetotid |
| QV09IX15 | Kobber (64cu) dotatate |
| QV09IX16 | Piflufolastat (18f) |
| QV09IX17 | Fluor (18f) psma-1007 |
| QV09IX18 | Flotufolastat (18f) |
| QV09XA03 | Iod (131-i) human albumin |
| QV10 | Radiofarmaka til terapeutisk brug |
| QV10X | Andre radiofarmaka til terapeutisk brug |
| QV10XA | Iod (131-i)-forbindelser |
| QV10XA01 | Iod (131-i) natriumiodid |
| QV10XA02 | Iod (131-i) iobenguan |
| QV10XA03 | Iod (131-i) omburtamab |
| QV10XA04 | Iod (131i) apamistamab |
| QV10XA53 | Tositumomab/iod (131-i) tositumomab |
| QV10XX | Diverse radiofarmaka til terapeutisk brug |
| QV10XX01 | Natriumphosphat (32-p) |
| QV10XX02 | Ibritumomab tiuxetan (90-y) |
| QV10XX03 | Radium (223ra) dichlorid |
| QV10XX04 | Lutetium (177lu) oxodotreotid |
| QV10XX05 | Lutetium (177lu) vipivotid tetraxetan |
| QV20 | Kirurgiske forbindinger |
